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SUMMARY OF RESEARCH.
Vir~ (avirulent) strains of B. pertussis were selected, via 
increased resistance to erythromycin, which were isogenic with 
parental Vir^ strains. Chromosomal DNA from these pairs of 
strains were studied with a number of probes and with 
methylation-sensitive restriction endonucleases. These
experiments suggested that DNA rearrangements were not involved 
in the Vir+ to Vit—  switch, and that the méthylation status of 
the DNA was not altered during the switch.
A B. pertussis gene library was probed with an 
oligonucleotide specific for the fimbrial subunit genes. This 
probe revealed that the chromosome of B. pertussis strain 
Taberman contained three fimbrial subunit genes:- i) an active 
fim 3 gene, ii) an inactive fim 2 gene, and iii) a gene 
dissimilar from the previously characterised fim X gene. The 
behaviour of the fim 3 gene in various AGG 3“ strains was 
investigated, and these studies revealed that a cis-acting 
factor was responsible for inactivation of the chromosomal 
fim 3 gene in these strains. It was also shown that the fim 3 
locus encoded fimbrial structures when conjugated into an 
afimbrial B. pertussis strain. No evidence was found to suggest 
that DNA rearrangements were involved in serotype variation.
A probe made from the hin gene, which controls the 
invertible region of Salmonella typhimurium, was found to 
hybridise to chromosomal DNA from B. pertussis, under reduced 
stringency conditions.
xvi
The gene library was probed with this probe and a cosmid 
clone isolated, This clone did not appear to produce an active 
invertase in E, coll, when tested in two different inversion 
assays. An oligonucleotide probe was produced which was 
homologous with the recombination sites recognised by the Ain- 
like family of invertase proteins and this also hybridised to 
B, pertussis chromosomal DNA under reduced stringency 
conditions.
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1. INTRODUCTION.
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1.1. THE GENUS BORDETELLA.
The genus Bordetella is currently made up of four species,
B. pertussis, B. parapertussis, B. bronchi sept ica and B. avium
All members of the genus cause upper respiratory tract 
infections in mammalian or avian species.
1.1.1.Bordetella pertussis.
B. pertussis was first isolated by Bordet and Gengou (1906) 
and subsequently shown to be the causative organism of the 
disease whooping cough. The l?acterium was originally isolated 
on a medium composed of glycerated potato extract and 50% (v/v) 
defibrinated blood. This apparent requirement for blood
resulted in placement of the pertussis bacilli in the genus 
Haemophilus. However, the work of Hornibrook (1940) revealed 
that blood was not essential for growth and this led to 
placement of the species in the novel genus Bordetella.
B. pertussis is a strictly aerobic Gram-negative, minute 
coccobacillus. It is chemoorganotrophic, requiring organic 
nitrogen, in the form of glutamate, organic sulphur, in the 
form of cysteine, and nicotinamide.
In vivo growth of the pathogen is highly specific and
normally only occurs on and among human ciliated respiratory 
cells. In vitro growth is supported by a number of media, some 
of which are chemically defined; growth conditions and media 
have been reviewed by Stainer (1968). The organism is 
fastidious and growth is easily inhibited by numerous factors. 
Little Is known of the metabolism of B. pertussis as research
- 2 -
has concentrated on the genetics and molecular mechanisms of 
virulence.
Several repeated DNA sequences have been isolated from the 
genome of B. pertussis. McPheat and McNally (1987) Isolated a 
sequence present as approximately twenty copies throughout the 
genome. The sequence of two of these copies revealed that they 
were related to. the insertion sequence (IS) element IS481 
Isolated by McLafferty et al. (1988). The chromosomal location 
of the two copies was established; lS481vl is located 3kb 
upstream of the adenylate cyclase locus, whilst IS481v2 is 
located immediately adjacent to the C-terminal end of the 
agglutinogen 2 fimbrial subunit gene (McPheat et ai., 1989). 
Probing of B. pertussis chromosomal DNA isolated from strains 
which varied in expression of AGG 2 (section 1.4.1) and from 
avirulent phase variants (section 1.5,1) revealed no 
rearrangements around either of these two insertion sequences. 
However, DNA rearrangements were observed at other 
uncharacterized loci using a probe internal to the IS (McPheat 
et ai. , 1989). Park et al, (1989) have isolated a highly
conserved 530bp repeat sequence from the B. pertussis genome. 
The sequence is specific to B. pertussis and is thought to be 
present in approximately 60-80 copies throughout the genome, 
accounting for almost 1% of the DNA.
Alshelkhly and Ltifdahl (1989) have identified a repeat 
sequence differing from IS481 within the genome of B. 
pertussis. The sequence consists ol an inverted repeat sequence 
surrounding a 200bp central segment. This sequence is also 
present in the B. parapertussis genome. Alshelkhly and LÔfdahl
- 3 -
(1989) suggest that this IS-Iike element exists as an integral
entity in Just a few locations within the genome, but that the
inverted repeat sequence is present in multiple copies.
1.1.2. Other bordetellae.
B. parapertussis was first recognised as a separate species 
by Eldering and Kendrick (1938) and is believed to cause a 
similar but less severe disease than B. pert ussis (Lautrop, 
1971).
B. bronchiseptica has been Implicated as the primary cause 
of numerous veterinary diseases such as kennel cough and swine 
atrophic rhinitis . The biology of B. bronchiseptica has been 
reviewed by Goodnow (1980).
B. avium was proposed as a member of the genus by Kersters
et al, (1984). B, avium is the causative agent of turkey coryza
and respiratory disease in other birds. The species had 
previously been identified as "bronchlseptlca-llke” bacteria 
(Hinz et al. , 1978).
1. 1. 3. Evolutionary relationships within the bordetellae.
Several studies have been performed on the genetic 
relatedness of the species within the genus Bordetella. DNA-DNA 
reassociation experiments (Kloos et al., 1979; 1981) have
revealed a high degree of homology between the chromosomal DNA 
from B. pertussis , B. parapertussis and B. bronchiseptica. 
Auxotrophic mutants of B. pertussis could be complemented with 
DNA from both B. parapertussis and B, bronchiseptica (Kloos et 
al., 1979). Musser et al. (1986) studied the electrophoretic 
mobilities of 15 metabolic enzymes from strains of all three
species. The results of this study split the genus into three 
groups; i) all B. bronchiseptica strains, ii) all B.
parapertussis strains and B. pertussis strain 18-323, a strain 
commonly used in vaccine production, and 111) all remaining B. 
pertussis strains.
A major phenotypic difference between B. pertussis and 
other members of the genus Is the production of pertussis toxin 
(PT), PT genes are present in B. parapertussis and B.
bronchiseptica (Locht & Keith, 1986) but are not expressed. 
Sequencing of these genes revealed DNA homology of over 95% 
between the PT genes of all’ 3 species (Arlcô and Rappuoll,
1987), The major difference between the sequences consisted of 
the accumulation of deleterious mutations in the promoter 
regions of PT genes from B. parapertussis and B. 
bronchiseptica. Computer analysis of this sequence Information
allowed Arlcô et al. (1987) to propose a phylogenetic tree of
the genus Bordetella. This study supported the conclusions of 
Musser et al. (1986) by finding that strain B. pertussis 18-323 
was more genetically related to B. parapertussis and 
B. bronchiseptica than to current clinical Isolates of B. 
pertussis. However, Altschul (1989) has re-assessed the 
sequence data of Arlcô and Rappuoll (1987) and proposed an 
evolutionary tree which places B. pertussis 18-323 within the 
boundaries of other B, pertussis strains.
1.2. THE DISEASE.
Pertussis Is primarily a paediatric infection, affecting 
children under the age of twelve. The disease is endemic with 
epidemics occurlng every three to four years (Cherry et al. ,
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1988). The transmission dynamics of the disease have been 
modelled mathematically with regard to the efficacy of 
vaccination programmes (Grenfell and Anderson, 1989). This 
investigation concluded that vaccination of 88% of each birth 
cohort before the age of 1 year would eliminate bacterial 
transmission if the protection conferred by the vaccine was 
lifelong. However, if the vaccine-induced immunity is 
significantly less than lifelong, repeated cohort vaccination 
would be required to prevent transmission.
Pertussis Is highly contagious, having an attack rate 
exceeding 90% In unlmmunlsed 'individuals (Lambert, 1965). The 
classical disease syndrome has three symptomatic stages: 
catarrhal, paroxysmal and convalescent.
After Initial Infection there is an incubation period of 
6-20 days (Lapin, 1943) before the disease enters the catarrhal 
stage. Symptoms during the catarrhal stage are non-specific and 
resemble a common cold with low fever and slight cough. This 
stage may last several weeks, during which B. pertussis can be 
recovered from the patient. Severe violent coughing fits begin 
as the disease enters the paroxysmal stage. The violent 
coughing serves to clear the airways of accumulated mucus and 
cell debris. Immediately after a coughing bout air is inspired 
past the swollen glottis and causes the characteristic whoop. 
Antibiotic therapy at this stage has little or no effect.
The paroxysmal stage usually lasts between 1-4 weeks then 
symptoms slowly begin to decrease as the patient enters the 
convalescent phase.
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Many of the complications associated with the disease are 
the result of the force involved in the coughing fits. More 
serious sequelae such as seizures, encephalopathy, secondary 
bacterial infections and death, usually from the secondary 
infections, can occur at ter the paroxysmal stage.
The severity, duration and likelihood of complications 
decreases with the age of the patient and although outbreaks in 
adults are uncommon they can occur (Linneman and Nasenbury, 
1977).
1. 3.PERTUSSIS VACCINES.
1. 3. 1. Whole-cell vaccines.
The majority of pertussis vaccines in current use are 
suspensions of whole killed cells which have been detoxified 
by heat or chemical methods and adsorbed onto a carrier such as 
aluminium hydroxide. Detoxification does not remove any 
lipopolysaccharide endotoxin from the cells, and this component 
may be linked to reactions against the vaccine (Griffith, 1978; 
Cameron, 1979). Pertussis vaccine is most commonly administered 
in combination with dipktke-w'ic^  and tetanus toxoids in the DTP 
vaccine.
The development and efficacy of whole-cell pertussis 
vaccines has been reviewed by Griffiths (1988). These vaccines 
are biologically complex, and their exact composition is rarely 
known, A number of methods have been used to standardise the
potency of pertussis vaccines; these include, a) the use of
standard opacity units in the cell suspensions and b) the
intracerebral mouse protection test (Kendrick et al, 1947).
The methods involved in the control testing of pertussis 
vaccines and their components are reviewed by Cameron (1988).
Despite the known efficacy of these vaccines, public 
acceptance of them has dropped since the mid 1970's following 
the alleged association between pertussis vaccines and rare, 
but serious, slde-effacts, the most severe of these being 
encephalopathy. However, in a recent High Court case the 
association between whole-cell pertussis vaccines and brain 
damage could not be proven. The case is reviewed by Dyer (1988) 
and Griffith (1989). Despite this verdict, acceptance of the 
vaccine is still low and this has led to research being 
concentrated on the production of defined component vaccines 
with high immunogenicity and minimal toxicity,
1.3.2. Acellular vaccines.
Several reasons exist for the development of effective 
defined component acellular pertussis vaccines. These include 
the need to increase acceptance of pertussis vaccine and the 
need for greater protective efficacy (Robinson and Ashworth,
1988).
Acellular pertussis vaccines have been used in Japan since 
1981, They consist mainly of toxoided FT (PTd) and filamentous 
haemagglutinin (FHA), whilst some contain small amounts of other 
components such as fimbrial agglutinogens (Sato et aJ. , 1984). 
This vaccine is protective in children (Biritwura et al., 1985;
Isoraura et al, , 1985) and less reactive than whole-cell
vaccines (Kimura and Hikino, 1985).
Two acellular vaccines were field-tested in Sweden 
recently. The vaccines consisted of PTd, either alone or in 
combination with FHA. The results of the field test (Ad Hoc 
Group for the Study of Pertussis Vaccines, 1988) indicated that 
the acellular vaccines had somewhat lower protective efficacy 
than that reported for established whole-cell vaccines. This 
finding, and the deaths of three children in the vaccinated 
group, led to withdrawal of the application for licensing of 
the vaccine for use in Sweden.
An acellular vaccine composed of equal amounts of PTd, FHA 
and fimbrial agglutinogens has been developed (Robinson et al. , 
1986). This vaccine is protective in mice challenged 
intranasally with B. pertussis and may be included in 
forthcoming field trials of new pertussis vaccines in the UK,
The next generation of acellular vaccines will probably 
contain either immunogenic peptide fragments or 'genetically 
toxoided* virulence factors (Robinson and Ashworth, 1988). The 
catalytic amino acids responsible for the toxic action of 
several virulence factors such as PT and adenylate cyclase (AC) 
have been identified (Burnette et al. 1988; Au et al. 1989; 
Glaser et al. , 1989). Site-directed mutagenesis of the genes
encoding these factors may allow the expression of non­
functional yet immunogenic toxins. These altered toxins will 
hopefully retain their protectivity but will have reduced 
reactogenicity.
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1. 4. VIRULENCE FACTORS OF B. PERTUSSIS
Virulence factors can be defined as 'any bacterial
component that promotes pathogenicity by enabling the pathogen 
to infect the host and cause disease. ' (Wardlaw, 1988).
The rational design of a defined acellular pertussis
vaccine requires an understanding of the virulence factors 
responsible for causing disease and the components which elicit 
a protective immune response.
During typical pertussis infection, B. pertussis often 
cannot be isolated from the patient after the onset of the
paroxysmal stage. This, and the failure of antibiotic treatment 
during the later stages of the disease, led researchers to
believe that pertussis was a toxin-mediated disease. It was 
originally thought that the symptoms of pertussis were mediated 
by pertussis toxin (PT) alone, with the aid of several adhesins 
(Pittman, 1979). However, subsequent studies have revealed that 
a large number of virulence-associated factors appear to play a 
role in B. pertussis infection.
Many B. pertussis virulence-associated factors have not yet 
been assigned definite roles in the disease process. The task 
of assessing the contribution of individual factors to the 
disease has been greatly aided by the construction of a number 
of B, pertussis strains containing single Tn5 insertions within 
genes encoding various virulence-associated factors (Weiss et 
al. , 1983). The properties of a mutant strain lacking a given
factor were then compared in an infant mouse model to those of 
the wild-type strain.
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The following is a list of virulence-associated factors 
implicated in the disease process:-
1.4. 1. Agglutinogens.
Agglutinogens (AGGs) are defined as surface antigens able 
to elicit cell-agglutinating antibodies (agglutinins). The 
pattern of AGGs produced by a B. pertussis strain is referred 
to as the serotype of that strain.
In the most widely used serotyping system, developed by 
Eldering et al. (1957), B. pertussis strains produce eight 
AGGs: numbered 1 to 7 and 13. AGGs 1 to 6 are specific for
B. pertussis, AGG 7 is present in both B. parapertussis and B. 
bronchiseptica, whilst AGG 13 is shared with B. bronchi septica. 
B. avium shares several heat-labile AGGs with B. bronchiseptica 
(Kersters et al., 1984).
The AGGs of B. pertussis have been divided into two 
classes : AGGs 1, 2 and 3 are known as major AGGs , whilst AGGs 
4, 5 and 6 are the minor AGGs (Preston et al. , 1982). Purified
major AGGs are protective in mice (Zhang et al. , 1985; Robinson 
et aJ. ,1985a). Robinson et al. (1989) have found that 
protection afforded by purified fimbrial AGGs is serospecific. 
Since the protection afforded by whole-cell pertussis vaccines 
is correlated with agglutinin production in children and mice 
(MRC, 1959) the WHO have recommended that whole-cell pertussis 
vaccines include all three major AGGs (Robinson et aJ, , 1985b).
AGG 1 is typically expressed in virulent-phase B. pertussis 
strains. The expression of the other specific AGGs is subject 
to serotype variation (Cameron, 1967).
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The biochemical nature of several B. pertussis AGGs has 
recently been defined.
1.4. 1. 1 Agglutinogen 1.
Li et al. (1988) have presented evidence that AGG 1 may 
correspond to the lipooligosaccharide A (LOS A) of 
B. pertussis. However, discrepancies in their data prevent them 
from definitely associating LOS A with AGG 1.
1.4. 1.2. Fimbrial agglutinogens.
Ashworth et al, (1982) observed that specific antibodies to 
AGG 2 bound to the fimbriae of B, pertussis. This work was 
confirmed by the same group (Ashworth et al. , 1985) using gold-
labelled monoclonal antibodies. However, there has been 
considerable debate over the nature of AGG-3, Different groups 
with different antisera have obtained apparently contradictory 
results. Carter & Preston (1984) used mono-specific antisera to 
type several strains of B. pertussis. Strains positive for AGG 
3 in this scheme were found to be afimbriate by electron 
microscopy. However, Ashworth et al. (1985) found that their 
gold-labelled monoclonal antibody to AGG 3 bound specifically 
to fimbrial structures on the surface of B. pertussis strains. 
Fredriksen et al. (1988) also used gold-labelled antibodies to 
AGG 3 in electron microscopy studies of B. pertussis fimbriae. 
Anomalous results led them to conclude ' that the term 
agglutinogen 3 covers more than one structure; or, possibly, 
that not all agglutinogen 3 is assembled into fimbria-like 
structures. '
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The fimbriae of B, pertussis are classed as 'very thin' 
fimbriae (Paranchych and Frost, 1988), with a diameter of 
3-4 nra CBlom et al,, 1983). The length of the fimbriae has not 
been determined accurately. Purified fimbriae aggregate at a 
characteristic pH; pH 6.0 for AGG 2 fimbriae (Zhang et al.,
1985) and pH 7.4 for AGG 3(6) fimbriae (Cowell et al,, 1987). 
Both fimbrial AGGs are composed of subunit proteins arranged in 
a helical structure. The antigenic heterogeneity between the 
two fimbrial types is caused by differences in the amino acid 
composition of the subunits. The molecular weights of the two 
distinct subunits have been found to be 22 500 for the AGG 2 
subunit and 22 000 for the AGG 3 subunit (Irons et al., 1984).
Mooi et al. (1987) studied the amino acid sequences of 
the fimbrial subunit proteins from B. pertussis and found that 
the AGG 2 and 3 subunits are very closely related. In a similar 
comparative study Cowell et al, (1987) reported amino acid 
sequences for the AGG 2 subunit and the subunit protein of 
fimbriae they define as AGG 6 which were almost identical to 
those reported by Mooi et al. (1987) for the AGG 2 and 3 
subunits respectively. The amino-terminal amino acid sequence 
of these subunits shares 50% homology with that of E. coll K99 
fimbrial subunits (Mooi et al., 1987).
The gene encoding the AGG 2 subunit, fim 2, has been cloned 
and sequenced by Livey et al. (1987) and a putative AGG 3 
subunit gene, fim 3, has been isolated (Mooi et al. , 1987) and 
sequenced (Mooi et al. , 1990). Pedroni et al. (1988) have
characterised a gene distinct from those above. The sequence of 
this gene, fim X, has revealed an open reading frame
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corresponding to a fimbrial subunit protein of molecular weight 
20 000 differing from the AGG 2 and 3 subunits. It is possible 
that this gene is a silent copy analogous to the silent copies 
of pilin genes found in the Neisseria gonorhoeae chromosome 
(Meyer et al, 1984). The three different fimbrial subunit genes 
do not appear to be linked on the chromosome (Pedroni et al. , 
1988).
Despite the homology between B. pertussis fimbriae and 
the fimbriae of other bacterial pathogens there is little 
evidence to support the role of fimbriae in the attachment of 
B, pertussis to human ciliated respiratory cells (Tuomanen and 
Weiss, 1985), Current evidence only implicates fimbriae in 
adhesion to non-ciliated tissue culture cells (Gorringe et al, , 
1985; Redhead, 1985).
1.4. 1.3. Other agglutinogens.
Little research has been carried out on the 'minor* AGGs of 
B. pertussis. Preston et al. (1982) linked AGGs 4 and 5 with 
AGG 2, deciding that AGG 4 was probably a minor component of 
AGG 2 and unlikely to be a separate immunogen, This group could 
not differentiate between AGGs 3 and 6.
A 69 Kd protein has been detected in B. pertussis which 
reacts with the U.S. Reference AGG 3 antisera (Brennan et al.,
1988), This protein has not been characterised, but is known to 
be non-firabrial. Novotny et al. (1985) have also found 
antigenically-related proteins in both B. parapertussis and 
B. bronchiseptica.
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1. 4. 2. Pertussis toxin.
PT has many diverse patho-physiological effects in man and 
experimental animals. These Include histamine sensitization, 
lymphocytosis promotion, haemagglutInation and the activation 
of pancreatic islets. These effects are reviewed by Ui (1986), 
Furman et al. (1988) and Munoz (1988),
Purified PT is capable of conferring protection to mice 
against both intranasal and intracerebral challenge with B. 
pertussis (Munoz et al., 1981). This protection is the major 
reason for the inclusion of detoxified PT in acellular
vaccines. .
PT is a hexameric protein composed of five different sub­
units. The molecule can be divided into two functional moieties 
(Tamura et al., 1982), The first, comprised of the SI, or A, 
subunit, is an enzymatic moiety which causes ADP-ribosylation 
of several host cell proteins. The second, or B subunit,
comprised of subunits S2, S3, S4 and S5, is responsible for
binding the toxin to target cells and facilitating the entry of 
the A subunit. The B subunit is also a T-cell mitogen and 
enhances glucose oxidation in adipocytes. A review of the
structure and activity of PT has been written by Burns (1988).
The SI subunit has a molecular weight of 26kD (Locht and 
Keith, 1986) and alone is unable to enter cells (Tamura et
aJ,,1982). It acts by ADP-ribosylating several membrane-bound 
regulatory G proteins. Following ADP-ribosylation the G 
proteins no longer exert control over intra-cellular processes 
such as cAMP metabolism, thus PT disrupts normal cell function.
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The G proteins affected by PT are different from the G protein 
(G.) attacked by cholera toxin.
Cieplak et al. (1988) identified the active site of the SI 
subunit and showed that it formed part of the protective
antigenic determinant. Subsequently the amino acid residues 
responsible for ADP-ribosylation activity have been identified 
(Burnette et al., 1988). This information has allowed the 
construction of a 'genetically toxoided' PT molecule which is 
fully protective yet possesses no enzymatic activity (Nencioni, 
et al. , 1990).
The genes encoding the various subunits of PT have been 
cloned and sequenced (Locht and Keith, 1986; Nicosia et al. ,
1986), The genes are arranged in an operon under the control of 
a single positively— regulated promoter. Transcriptionally 
silent copies of the PT operon are present in the genomes of 
B. parapertussis and B. bronchiseptica (Aricô and Rappuoli,
1987). Cloned PT genes from B. pertussis are expressed in both 
of these species (Lee et al. , 1989) but PT is not secreted, 
suggesting that the PT transport mechanisms of the species are 
either different or non-functional,
1,4,3. Filamentous haemagglut inin.
PT and filamentous haemagglutinin (FHA) are responsible for 
the ability of B. pertussis to agglutinate erythrocytes from 
several species. FHA is 5 - 7 times more active as a
haemagglutinin than PT but is sensitive to inhibition by 
micromolar concentrations of cholesterol (Sato et al. , 1983).
FHA consists of fine filaments approximately 2nm in diameter 
and 40 - lOOnm in length (Arai and Sato, 1976), The filaments
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are composed of highly hydrophobic 220Kd subunits (Sato et al. ,
1983). The molecule has been purified by a number of methods 
and confers immunity against aerosol challenge in mice (Oda et 
al., 1984). A Tn5 mutant of B. pertussis deficient in FHA 
(Weiss et al. , 1983) was no less virulent in intranasal
challenge of mice than the wild-type parental strain. However, 
this strain did adhere less well to rabbit ciliated cells than 
the wild-type (Tuomanen et al. , 1985). The addition of
exogenous purified FHA to this strain allowed the recovery of 
full adherence (Tuomanen and Weiss, 1985). FHA and PT are 
thought to act in concert as adhesins for human ciliated 
epithelial cells. Both molecules are secreted and will bind to 
other bacteria; these bacteria are then able to adhere to 
human ciliated cells (Tuomanen, 1986). This 'piracy' of both 
FHA and PT is discussed by Tuomanen (1988),
The FHA gene has been cloned by a number of groups, and 
immunogenic FHA has been expressed in E. coll in both its 
native form (Brown and Parker, 1987) and as a fusion protein 
(Reiser et al. , 1985). Nucleotide sequencing of the locus
encoding FHA (Stibitz et al. , 1988; Reiman et al. , 1989) has
revealed that the FHA structural gene, fha B, is closely linked 
to the bvg locus (see section 1.4.3,). This analysis also 
revealed two other genes, fba C and fha A, thought to be 
involved in the export of FHA to the cell surface.
1. 4. 4. Dermonecrotising toxin.
First discovered by Bordet and Gengou (1909), 
dermonecrotising, or heat-labile, toxin causes necrotic lesions 
in mice when injected subcut aneously at low doses, and is
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lethal if the dose is increased (Livey and Wardlaw, 1984). 
Despite the unstable nature of this toxin several purification 
schemes exist (Nakase and Endoh, 1965; Endoh et al,, 1986). The 
purified protein has an apparent molecular weight of 102 000, 
composed of subunits weighing 20Kd and 30Kd (Endoh et al. , 
1986). Purified toxin causes vasoconstriction in peripheral 
murine blood vessels followed by local ischaemia and petechial 
haemorrhage.
The molecular mechanism of toxin action is not known but 
both dermonecrotising and lethal effects are lessened if the 
experimental animal is treated with prednisolone (Parton,
1985).
1. 4. 5. Adenylate cyclase toxin.
B. pertussis produces an adenylate cyclase toxin with 
unique properties which is secreted into the culture medium 
during exponential growth (Hewlett et al., 1976). The activity 
of this ACT is increased a thousand-fold in the presence of the 
eukaryotic calcium-binding protein calmodulin (Wolff et al. , 
1980). The properties, purification schemes and possible 
functions of ACT have been reviewed (Hanski, 1989; Hewlett and 
Gordon, 1988; Masure et al., 1987),
B. pertussis adenylate cyclase has been identified in two 
forms; one, the adenylate cyclase enzyme (AC), has the ability 
to convert ATP into cAMP in solution, whilst the other, 
adenylate cyclase toxin (ACT), is able to enter eukaryotic 
cells and increase cAMP levels within them. The molecular 
weights determined for AC range from 50 000 (Ladant et al. ,
1986) to 70 000 (Hewlett and Wolff, 1976). The molecular weight
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of ACT was determined to be -200 000 (Hanski and Farfel, 1985). 
The 200Kd protein alone is sufficient for penetration into 
target cells and subsequent intoxication (Hewlett et al. , 
1988b; Rogel et al. 1988). Rogel et al. (1988) concluded that
the 50Kd non-toxic form was probably formed by proteolytic
cleavage of the 200Kd protein. Bellalou et al. (1989) have 
produced evidence that suggests production of the 50Kd form may 
not occur under physiological conditions.
B. pertussis ACT acts by penetrating the plasma membrane of
a target cell (Farfel et aJ. , 1987) and rapidly increasing the
intracellular cAMP concentrations. ACT affects a number of cell 
types including the phagocytic cells of the immune system,
whose functions are severely Inhibited.
The ACT locus has been cloned (Glaser et al. , 1988;
Brownlie et al., 1988) and sequenced (Glaser et al., 1988), The
sequence data of Glaser et al. (1988) revealed four genes 
cya A, -B, -D and -E. The cya A gene encodes the 200Kd ACT
protein, whilst cya B and -D are homologous to the E. coll hly 
B and D genes necessary for haemolysin secretion. This group 
also found that the carboxy terminal 1300 amino acids encoded 
by cya A are highly homologous to the haemolysin of £. coll, 
suggesting that ACT may be responsible for the haemolytic
activity of B. pertussis. Brownlie et al. (1988) cloned a 
similar locus and were able to express AC activity in E. coll. 
This group also detected homologous genes in B. parapertussis 
and B. bronchiseptica but not in B. avium
A transposon mutant of B. pertussis which does not produce 
ACT was found to be avirulent in mice (Weiss et al., 1984).
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Virulence was restored by cloned ACT (Brownlie et al., 1988). 
Although essential for disease, ACT may not be necessary for 
colonisation and persistent infection of the host (Brownlie et 
al., 1988).
Both polyclonal and monoclonal antibodies raised against 
purified ACT are protective in mice (Brézin et al., 1987; Guiso 
et al., 1989). A transposon mutant deficient in all virulence 
factors except adenylate cyclase activity was found to 
partially protect mice against in-challenge by a fully virulent 
strain (M, J. Ward, personal communication). The sites and amino 
acid residues responsible for catalysis (Au et al. , 1989;
Glaser et al. , 1989) and calmodulin binding (Glaser et al. ,
1989) have been identified. As with PT this information should 
allow the construction of an enzymatically nontoxic immunogenic 
ACT molecule.
1. 4. 6. Tracheal cytotoxln.
The major cytopathological symptom of B. pertussis 
infection is the damage to and subsequent extrusion of ciliated 
cells from the respiratory epithelium, leading to congestion of 
the airways with mucus and bacteria. A toxin which may be 
responsible for this activity was isolated by Goldman et al, 
(1982) and was found to be a low molecular weight (900) 
glycopeptide, tracheal cytotoxin (TCT). TCT can be purified 
from log-phase culture supernates of virulent and avirulent 
strains of B. pertussis. TCT has been chemically analysed and 
is thought to come from the enzymatic degradation of the cell 
wall component peptidoglycan (Cookson et al. , 1989).
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The other three members of the genus Bordetella produce 
identical toxins, M  gonorrhoeae also produces a chemically 
similar toxin which damages ciliated cells CMelly et al. , 1984). 
Goldman (1988) speculates that these toxins 'may in fact 
represent (one particular example of) a virulence mechanism 
common among mucosal pathogens'.
1.4.7. Lipopolysaccharide endotoxin.
Lipopolysaccharide (LPS) endotoxins are components of Gram- 
negative bacterial cell walls which cause toxicity and 
pyrogenicity, B. pertussis produces two chemically and 
immunologically distinct LPSs (LeDur et al. , 1980; Peppier,
1984). Both molecules lack the long chain polysaccharide 0 
antigen characteristic of the LPS of enteric organisms. The B. 
pertussis endotoxin has thus been designated a 
lipooligosachharide (LOS). Despite this difference, the LOS 
endotoxin is in many respects similar to the LPS endotoxins of 
enteric bacteria (Ayme et al. , 1980), The chemical structure,
isolation and properties of the B. pertussis LPS are reviewed 
by Chaby and Caroff (1988). Purified LPS is pyrogenic in mice 
and is able to activate mononuclear phagocytes (Haeffner- 
Cavaillon et aJ. , 1984), An unusual property of B. pertussis LPS 
is the ability to induce non-specific resistance to viral 
infections in mice (Winters et al. , 1985).
Li et al. (1988) have presented evidence suggesting that 
LOS A may correspond to AGG-1.
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1.4.8. Virulence factors and disease.
Hewlett and Weiss (1986) have proposed a simple three-stage 
model for B. pertussis infection. The model commences with 
attachment of the bacteria to the ciliated cells of the 
respiratory tract. This is followed by local tissue damage and, 
subsequently, systemic pathology. Accompanying these stages are 
processes carried out by the infecting bacteria to disrupt the 
host immune defences.
One of the major difficulties encountered in the study of 
pertussis is the lack of a suitable animal model. The disease 
is specific for humans and' no animal model is capable of 
mimicking the entire disease process. The animal models used in 
pertussis research, and their limitations, are reviewed by Sato 
and Sato, 1988.
Information collected from several lines of research 
allowed Hewlett and Weiss (1986) to suggest that the virulence 
factors of B. pertussis can be fitted into this three stage 
sequence, as illustrated in Figure 1. Hewlett and Weiss concede 
that this model is just a 'rough picture' of the disease 
process, but, hopefully, one which will 'represent a beginning 
in the understanding of this disease and how best to design 
approaches to its control and prevention. '
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FIGURE 1. A POSSIBLE SEQUENCE FOR ESTABLISHMENT OF 
PERTUSSIS AND THE INVOLVEMENT OF VARIOUS 
VIRULENCE FACTORS IN THE DISEASE PROCESS.
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1.5. ANTIGENIC VARIATION OF BORDETELLA PERTUSSIS.
One aspect of B, pertussis infection not considered in the 
sequence illustrated in Figure 1 is the variation in the 
antigenic nature of the bacteria which may occur during 
infection. The three types of variation described below have 
all been observed in vitro and are thought to occur In vivo,
1.5.1. Phase variation.
Leslie and Gardner (1931) observed that, after repeated 
subculture, isolates of B. pertussis suffered a loss of 
toxicity for guinea pigs. They called this process phase 
variation and classified four antigenically-distinct phases 
ranging from fully toxic, phase I, to fully non-toxic and able 
to grow on nutrient agar, phase IV. Phase IV strains also 
possess increased resistance to certain antibiotics (Bannatyne 
and Cheung, 1984) and to levels of fatty acids in the growth 
media (Peppier and Schrumpf, 1984). Phase IV strains have been 
isolated from patients in the later stages of disease (Kasuga 
et al,, 1954). Classification has subsequently become confused 
by the loss of the original antisera and by the existence of a 
substantial body of apparently contradictory work concerning
the process of phase variation.
. /
Weiss and Falkow (1984) proposed a new classification 
system for phase variants. Isolates which possessed all 
virulence factors were labelled virulent (Vlr^) strains whilst 
those which had lost the involved virulence factors were 
labelled avirulent (Vli— ) strains. Avirulent strains can be 
easily identified on a number of solid media by their inability 
to take up dyes such as Congo red (Parton, 1988). The DNA of
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avirulent strains may also differ in the amount of méthylation 
from that of the parent virulent strain (Goldman et al., 1987).
The loss of toxicity during phase variation is caused by 
the loss of several virulence factors including PT, ACT, FHA, 
dermonecrotising toxin and the fimbrial AGGs. This loss is 
generally thought to be irreversible, although Vii—  to Vir^ 
revertants have been reported at low frequencies (Weiss and 
Falkow, 1984; Stibitz et al. , 1989).
Weiss and Falkow (1984) observed that a single Tn5 
insertion into the B. pertussis chromosome was sufficient to 
create the avirulent phenotype. This led them to propose that a 
single locus, the vlr locus, produces a transacting factor 
which positively regulates the expression of genes encoding the 
virulence factors. This vlr locus has been cloned by several 
groups (Brown and Parker, 1987; Brownlie et al., 1988; Stibitz
et al., 1988; McGillivray et al., 1989), and fully sequenced 
(Stibitz et al., 1989; Aricô et ai., 1989).
1.5.2. Antigenic modulation.
The virulence factors lost during phase variation can also 
be lost through antigenic modulation. Unlike phase variation 
the loss of expression is more readily reversible and is 
dependent upon the presence of modulators in the growth media. 
Lacey (1960) noticed a loss of antigen expression when growing 
B. pertussis under a wide range of conditions including high 
concentrations of MgSO^ . Subsequently, other workers have 
confirmed and extended these observations on antigenic 
modulation, e.g. using nicotinic acid (Pusztai and Joô, 1967), 
quinaldic acid and other pyridines (Schneider and Parker,
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1982), Ka^SO^, sodium lactate and sodium succinate (Brownlie et 
ai. , 1985).
Cells expressing virulence factors are known as X-mode 
cells; cells which do not express virulence factors due to 
growth conditions are referred to as C-mode cells (Lacey, 
1960). C-mode cells are more hydrophilic than virulent X-mode 
cells (Robinson et ai. , 1983) and adhere less well to mouse
lung cells (Burns and Freer, 1982) or unciliated human tissue 
culture cells (Gorringe et ai. , 1985; Redhead, 1985). The
mechanism of antigenic modulation was investigated by Knapp and 
Mekalanos (1988) using the Tn5 derivative TnphoA (Manoil and 
Beckwith, 1985). This transposon is designed to allow the 
detection of genes producing proteins exported to the cell
surface. They described a locus, mod, which is thought to
encode a trans-acting factor required for the expression of the 
vlr locus or for activity of a vlr gene product. The mod gene 
is closely linked to the vlr locus defined by Weiss and Falkow 
(1984). A constitutive mutant in the mod gene was found which 
produced virulence factors in the presence of known modulators.
1.5.3. A mechanism controlling both phase variation and 
antigenic modulation.
The sequence of the vlr locus revealed three open reading 
frames. These open reading frames were designated bvgA, bvgB
and bvgC and were calculated to encode proteins of 23kD, 30kD 
and 102kD, respectively (Aricô et al, , 1989). Homology exists
within these genes to previously characterised transmitter and 
receiver domains within prokaryotic signal transducing proteins 
(Kofoid and Parkinson, 1988). Aricô et al. (1989) proposed a
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model for both antigenic modulation and phase variation using 
this data. The gene product of bvgC, BvgC, is a membrane 
spanning protein and in the absence of modulators this protein 
activates BvgA (the bvgh gene product) which then acts as the 
transcriptional activator (Roy et al., 1989). In the presence
of modulators, detected by either the periplasmic portion of 
BvgC or the smaller, totally periplasmic BvgB, the activation 
of BvgA does not occur and transcription of vir-dependent genes 
ceases. Phase variation in this model occurs by the insertion 
of an extra cytosine residue in a string of cytosine residues 
(Stibitz et al., 1989) within bvgO (Aricô et al., 1989).
Galderwood et al. (1988) used TnphoA to detect a number of 
genes which are positively regulated by the vlr locus; and 
several genes which are repressed by the same mechanism,
The environraentally-dependent, coordinate regulation of 
virulence factors has been observed in a range of bacterial 
species. The mechanisms behind these phenomena have been 
reviewed (Miller et al., 1989).
1.5.4. Possible roles for phase variation and antigenic 
modulation.
Evidence exists to suggest that phase variation and 
antigenic modulation occur In vivo (Kasuga et al. , 1954; Lacey,
1960). Suggestions for the role of these phenomena during the 
disease and transmission of the bacteria are purely 
speculative. Wardlaw and Parton (1988) suggest that children or 
adults colonised by avirulent B. pertussis may serve as 
carriers in a 'pertussis cycle'. Robinson et al. (1986b) 
observed that C-mode cells adhere less well to mammalian cells
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suggesting that antigenic modulation may aid transmission 
during later stages of the disease.
1.5.5. Serotype variation.
Pure cultures of B. pertussis can display heterogeneity 
with regards to serotype (Cameron, 1967). Variants of a single 
clone of B. pertussis can independently gain or lose fimbrial 
AGGs 2 and 3 (Stanbridge and Preston, 1974a). This variation 
can occur in experimental animal infections (Stanbridge and 
Preston, 1974b; Preston et ai., 1980) and in the infected child
(Preston and Stanbridge, 1972). The frequency of serotype 
variation, the loss or gain of AGG 2 or 3, has been 
investigated only In vitro. Stanbridge and Preston (1974a) 
estimated the frequency to be between 10"^ to 10~-*, a range of 
frequencies similar to those quoted for flagellar variation in 
Salmonella typbimurlum (Stocker, 1949).
The role of serotype variation in the disease process is 
not known, but it is believed that the change in fimbrial 
antigens may allow the bacteria to evade the host immune 
response. Robinson et al, (1989) have demonstrated that 
immunisation of mice with a purified fimbrial AGG exerts a 
selective pressure against organisms expressing the homologous 
AGG. B. pertussis recovered from the lungs of mice immunised 
with AGG 3 were shown to have altered from the serotype 1.2.3 
and 1.0.3. of the infecting strains to predominantly 1.2.0. or 
1. 0. 0. , respectively. A similar result was observed in mice 
immunized with purified AGG 2 and challenged intranasally with 
strains bearing AGG 2. Robinson et al, (1989) were unable to 
determine whether this specific protection represents genuine
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serotype conversion or the selection of a small number of
organisms with the appropriate serotype present in the
infecting inoculum.
The genes encoding the two fimbrial subunits have been
isolated (Livey et al., 1987, Mooi et al. , 1987) as has a third,
homologous gene (Pedroni et al., 1988). These genes are
unlinked on the chromosome. There are no published reports on 
the possible mechanism(s) of serotype variation.
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1.6. MECHANISMS OF ANTIGENIC VARIATION.
Antigenic variation can be defined as 'the ability of a 
single strain to express several antigenic variants of a 
cellular component with the rate of change of the component 
being significantly higher than the mutation rate* (Seifert and 
So, 1968). The primary purpose of antigenic variation appears 
to be an avoidance of host immune response and it is one of a 
number of common themes in microbial pathogenicity (Finlay and 
Falkow, 1989).
In many of these genetic mechanisms, rearrangement of 
genomic DNA is responsible for the variation in the expressed 
characters (see Starlinger, 1977; Silverman and Simon, 1983; 
Plasterk and Van de Put te, 1984; Saunders, 1986 for reviews).
Several distinct types of DNA rearrangements have been 
observed which include invertible DNA sequences, the shuffling 
of coding ‘minicassettes' and the deletion of specific 
sequences.
1. 6. 1. Invertible DNA.
In mechanisms of antigenic variation involving invertible 
DNA, the orientation of a specific segment of DNA governs the 
expression of the genes encoding the factors which are varied.
Several of these invertible DNA mechanisms are very closely 
related. The hîn system of Salmonella typbimurlum, involved in 
flagellar phase variation, the gin system of bacteriophage Mu 
and the cln system of bacteriophage PI, both involved in 
determining the host range of the phages, and the pin system of 
E. coll, which has no known function, form a single family of
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invertible DNA systems known as the din (for Z3NA inversion) 
systems. All of these mechanisms consist of a recombinase, two 
inverted recombination sites and a recombination enhancer 
sequence. The recombinases, and the sequences they interact 
with, are highly conserved and mutations in one system can be 
complemented by components from the others. The DNA enzymology 
of these systems would also appear to be conserved. The 
invertible DNA systems involved with fimbrial phase variation 
in E. coll and pilin variation in Moraxella bovls are not 
related to the hin-like systems.
1.6. 1. 1. The bin system of Salmonella typbimurlum.
Variation between two serospecific flagellar filaments of 
S. typbimurlum was first observed by Andrewes (1923), and shown 
to occur at the rate of 10“® ~ 10"* per division (Stocker,
1949). The structure of each flagellar antigen is specified by 
separate, unlinked genes, HI and H2.
Initial studies by Lederberg and lino (1956) revealed that 
the element responsible for the variation was a DNA structure 
closely linked to the H2 gene. Further study of this area 
demonstrated the basic mechanism of flagellar phase variation 
in S. typbimurlum (Zeig et al. , 1977; Silverman et al. , 1979a;
Simon et al., 1980). The element responsible for phase 
determination was found to be a discrete 970bp DNA segment 
bounded by two inverted 26bp imperfect palindromic repeats, 
hlK L and blx R. The DNA segment also contains two further 
loci, the bin gene, which encodes a DNA invert ase, and a 
promoter region.
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When the DNA segment is in the "ON" orientation the 
promoter is proximal to the H2 gene and allows transcription. 
Under the influence of the DNA invertase produced by the hin 
gene, a site-specific recombination event occurs between the 
two inverted repeats causing inversion of the DNA segment. In 
this "OFF" orientation the promoter is removed from the H2 gene 
and transcription cannot occur, A second gene has been
characterised which is co-transcribed with the H2 gene. This 
gene, rhl, encodes a repressor protein of the HI gene 
(Silverman et aJ. , 1979b). Thus a single recombination event
can halt the synthesis of H2 flagella and lift repression of HI 
flagellar synthesis. The inversion event, and the genes
involved, are diagrammed in Figure 2. The nucleotide sequence
of this region has been determined (Simon et al. , 1980) and is
given in Figure 3.
Each of the two recombination sites consist of two
imperfect 12-bp inverted repeats separated by a 2-bp core. The 
two sites are not identical and they may have different origins 
(Szekely and Simon, 1983). The sites also appear to have 
different properties when used in artificial substrates. 
Inversion of a segment bounded by inverted repeats of hix R is 
less efficient than inversion of segments bounded by both sites 
or by inverted copies of hix L (Scott and Simon, 1982). The Hin 
protein, 21Kd, binds to these 26bp hix ihin crossover) 
sequences as a dimer, one monomer of Hin is thought to bind to 
each of the inverted repeat half-sites (Glasgow et al,, 1989),
The 2-bp central core is essential for site function, but the 
sequence of the 2 nucleotides is unimportant as long as it is
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FIGURE 2. A DIAGRAMATIC REPRESENTATION OF THE
hin SYSTEM OF S. typhimurium
A = H2 ' ON' STATE, H1 EXPRESSION REPRESSED. 
B = H2 'OFF' STATE, H1 EXPRESSED,
hixL and hixR = RECOMBINATION SITES.
= PROMOTER.
AhixL
in
hixR
H 2 flagella
H 2
I
rh 1
Irepressor
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FIGURE 3. NUCLEOTIDE SEQUENCE OF THE INVERTIBLE
hin SYSTEM OF S. typhimurium.
This nucleotide sequence is taken from Zeig and Simon <1980). The 
codons encoding the hin gene itself are given in capitals. The residues 
that make up the 671bp bin-specific probe (section 3.4.2) are underlined. 
The inverted repeat sequences at the boundaries of the invertible region 
are overlined, and the recombination breakpoint is shown by the small 
arrow.
1 cgatttattg gttcttgaaa accaaggttt
ttccttatct
ttgataaagc aatcctccat
51 gagaaaagcg actaaaattc gatgtaaagg agaaaatcAT
101 GGCTACTATT GGGTATATTC GGGTGTGAAC AATTGACGAA AATATCGATT
151 TACAGCGTAA TGCGCTTACT AGTGGAAATT GTGACGGGAT TTTTGAAGAC
201 CGTATCAGTG GCAAGATTGC AAACGGGCGC GGCCTGAAAC GGGCGTTAAA
251 GTATGTAAAT AAAGGCGATA GTGTTGTCGT GTGGAAATTA GAGAGAGTGG
301 GCCGTAGGGT GAAAAATCTG GTGGGGTTAA TATGAGAATT AGATGAAGGT
351 GGAGCTCACT TCCATTCTTT AAGGGATAGT ATTGATAGGA GTAGGGGGAT
401 GGGGCGATTC TTTTTTCATG TAATGTGAGG AGTGGGCGAG ATGGAGGGAG
451 AATTAATCGT CGAGCGAACC GTTGGCGGAC TGGGTGCGGG GAGAGGGGAA
501 GGACGAGTGG GAGGGCGCCC TCGGGGGATC AAGAAACATG AAGAGGAAGA
551 GATTAGTCGG CTATTAGAGA AAGGGGATGG TGGGCAGGAA TTAGGTATTA
601 TTTTTGGTAT TGGCGTATGC ACGTTATAGA GATAGTTTGG GGGAAGGAGT
651 ATAAAAAAAC GAATGAATTA Aaataaaaat cacaacaeea teeatataac
701 atttttgtaa tacaggcgta teecataaat aaacceaaae srsrtatacaaa
751 aaaeacaeca tctaattaaa aaeaeaaaaa attcaaceta ttaacatata
801 taetetaace csrctcacsrat aaeecctate ttacatccae ctatascacsra
851 catcgctcaa aacactacca gacacagtat tcacctggaa aggcttttta
901 atcaaaatgt tagatgtaag caattacgga cagaaaaaat agtaaagttt
951 atgcctcaag tgtcgataac ctggatgaca caggtaagcc tggcataaca
1001 ttggttatca aaaacct^ tcc aaaaggaaaa ttttatggca caagtaatca
1051 acactaacag tctgtcgctg ctgacccaga ataacctgaa caaa
identical in both recombination sites (Johnson and Simon,
1985), The essential bases for Hin binding are those +4 to +11 
from the point of dyad symmetry. Hin binds only one face of the 
DNA helix on adjacent major and minor grooves of the hix half­
sites. The Hin carboxy-terminal region contains a helix-turn- 
helix motif implicated in binding to the major groove of DNA. 
The Hin molecule may also contain another structure which 
recognizes features within the adjacent minor groove. The 
recognition and binding of Hin to the hix half-sites is 
mediated by the glycine 139 and arginine 140 amino acids.
The -35 region of the hin gene overlaps into the hix 
sequences and, consequently, the gene has a different -35 
region depending on the orientation of the invertible segment. 
This obviously influences the rate of hin expression since the 
inversion rates are not equal in both directions.
In vitro studies of this system revealed the need for an 
acessory DNA sequence to give optimal rates of inversion. In a 
cell-free system derived from an E, coli strain moderately 
overproducing the Hin protein, Johnson et ai. (1984) could 
specify the substrate requirements for efficient inversion. 
Using a relatively crude preparation Johnson et al. were able 
to demonstrate that inversion required a circular supercoiled 
DNA substrate containing two hix sites. The enhancer sequence 
required for optimal inversion rates is a 60bp sequence 
normally located within the amino-terminal coding region of the 
hin gene. The positioning of the enhancer sequence is not 
critical and it is able to function at various sites within a 
plasmid substrate (Johnson et ai. ,1987). The Hin protein was
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demonstrated to have topolsomerase activity on suitable 
substrates (Johnson et al., 1984).
Further purification of the above cell extract to near 
homogeneity revealed a requirement for two host cell proteins 
(Johnson et al., 1986). One of the required proteins is the 
major histone-like protein of E. coli, HU. This protein 
promotes unwinding of DNA in the presence of topolsomerase I, 
and in dimerised form may promote bending of DNA. The other 
protein involved is Fis (Factor for inversion stimulation). Fis 
is a 12Kd protein which is not essential for the growth of E. 
coll. The carboxy-terminal 74-93 amino acids of Fis bear 
similarity to the helix-turn-helix motif known to bind to DNA, 
The gene encoding Fis in E. coll has been cloned and sequenced, 
and is located at 72min on the chromosome (Johnson et al, ,
1988).
Fis binds to 2 sites within the enhancer sequence, the 
sites differ in sequence and are designated the proximal and 
distal domains with respect to the hix L site in the ' ON'
position. Fis binds independently to the 2 domains, with a 
greater affinity for the distal domain. Bruist et al. (1987) 
have presented evidence which suggests that Fis may be able to 
recruit secondary enhancer sites with partial homology to act
in the absence of a functional enhancer, explaining the low
rate of inversion observed in substrates with non-functional 
enhancer sequences. Fis binds primarily to one side of the DNA 
helix and spans 2 major grooves, making contacts in the major 
and minor grooves. The pentanucleotide sequence TGACC present 
in both domains may serve as the recognition sequence. These
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two sequences are 48bp apart and separated by -4. 5 turns of the 
helix. Thus, it would appear that the Fis molecules must be 
bound to opposite sides of the helix to stimulate inversion. A 
binding site for Fis has been described near the Xls binding 
site in bacteriophage X (Thompson et al. , 1987). This binding
site does not contain the pentanucleot ide sequence and it is 
possible that Fis may recognise a particular structural feature 
of the DMA rather than, or in addition to, a specific 
recognition sequence.
Bruist et al. (1987) have proposed a model for the 
inversion reaction in which the Hin protein and Fis interact to 
give a synapteneraal complex which holds the DNA in the correct 
orientation for recombination. This model was investigated by 
Johnson and Bruist (1989) who isolated various intermediates in 
the recombination reaction and were able to expand the proposed 
model. They proposed that the Hin dimers bind to the hix sites 
and make a staggered 2-bp double-stranded cut within the 
central core. The bound Hin protein forms a phosphoester
covalent linkage with the 5' end of the DNA and leaves a free 
hydroxyl at the 3' end. This transient linkage between the
cleaved DNA and the recombinase allows the energy of the broken
phosphodiester bond to be conserved and alleviates the need for 
high energy co-factors in the reaction, The Fis protein bound 
to the enhancer sequence is thought to mediate the rotation of 
the DNA molecules to allow religation into the inverted
configuration. A possible route for the formation of the 
recombination complex is shown in Figure 4.
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FIGURE 4. DIAGRAM ILLUSTRATING HOW FIs BINDING TO 
THE ENHANCER SEQUENCE MAY AID FORMATION 
OF THE RECOMBINATIONAL COMPLEX.
A). The invertible hin region.
B). Molecules of Hin bind to the hix sites 
and molecules of Fis bind to the enhancer,
C). The Hin bound to hixR is positioned into 
the nascent recorabinational complex.
D). Binding of HU loops the shorter stretch of 
DNA to bring the Hin bound to hixL within 
the recorabinational complex.
h i x L e n h a n c e r HixR
\
Hin
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Analysis of the sequence of the invertible region reveals 
that the H2 gene and its 5' proximal sequence are homologous 
with the flagellin genes from other Salmonella species and E. 
coll. The hin sequence on the other hand is closely related to 
sequences found in bacteriophage Mu. The two hix sites may have 
different origins, with sequence data showing that hix L and 
hin are more closely related to glx R, the right hand Inverted 
repeat sequence of the invertible DNA segment in Mu, and gin, 
the gene encoding the Mu invertase (Szekely and Simon ,1983), 
This group have suggested that the hin system evolved in three 
stages. Firstly, a transposon, or a bacteriophage, carrying a 
site-specific recombinase entered the chromosome approximately 
lOObp upstream from a single flagellin gene. In the second step 
the transposon and the flagellin gene are translocated to a 
different region of the Salmonella chromosome, as compared to 
the E. coll chromosome. The third step involved an aberrant 
recombination event which could have 'captured' the flagellin 
promoter. A sequence present in the regulatory region of the 
flagellin gene which had partial homology with the sequence of 
the recombinase recognition site may have been used by the 
recombinase. Since the site was, presumably, in the opposite 
orientation from that normally used by the recombinase, 
excision was replaced by inversion. Szekely and Simon (1983) 
further suggest that this recruitment of novel recombination 
sites may be a general phenomenon, giving rise to new genetic 
configurations by exchanging specific functions between 
transposable elements and chromosomal genes.
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1.6. 1.2, The gin system of bacteriophage Mu.
Bacteriophage Mu contains a 3kb invertible segment known as 
the G region (Kamp et al., 1978; van de Putte et al., 1980). 
When this G region is in the C+) orientation the bacteriophage
is able to infect a certain set of host species including E.
coll K12; in the (-) orientation the bacteriophage can infect a 
different set of host species, including Citrobacter and 
Shigella strains. This change in host specificity is brought 
about by differences in the tail fibres expressed by the phage 
(Giphart-Gassler et al. , 1982). In the (+) orientation the tail
fibre genes S and U are expressed, whereas in the <-) 
orientation the genes S' and U' are expressed, altering the
tail fibres produced. Unlike the hin system the gene encoding
the recombinase is not within the invertible segment but is 
located in the DNA adjacent to the G region.
The S gene is composed of two regions, a constant sequence, 
Sc and a variable region, S^ . The variable region is contained 
at one end of the invertible segment, and the constant region 
in the stable adjacent DNA. The invertible segment also 
includes two further genes, U and U', completely within its 
boundaries, and at the other end the gene fragment S^ ' located 
in the opposite orientation to the S^ gene fragment (van de 
Putte et al. , 1980). This arrangement of genes is illustrated
in Figure 5.
In the (+) orientation, transcription is initiated at a 
promoter outside the invertible segment and continues through 
Sc and Sv and into the U gene. After inversion into the (-) 
orientation transcription reads through Sc as before but now
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FIGURE 5. DIAGRAM COMPARING THE INVERTIBLE REGIONS 
OF BACTERIOPHAGES MU AND PI.
1). The G region of the Mu chromosome showing 
the arrangement of genes.
2). The invertible C region of bacteriophage PI, not to scale 
with the diagram of the G region above.
The functions of the genes are detailed in the text.
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continues into S^ ' and U'. The inversion is thus responsible 
for altering the tail fibres produced by the phage.
The G region is flanked by two Identical 34bp imperfect
inverted repeat sites. Each IR site is composed of two binding 
sites for the Mu invertase Gin and the two sites do not appear 
to be equivalent; site II is occupied only if site I is present 
and occupied (Mertens et al., 198B). G inversion is catalysed 
by Gin, the product of the gin gene. The gene has been cloned, 
sequenced and compared with the genes encoding the other 
invertase molecules CPlasterk et al., 1983). As with the hin 
system a recombination enhancer sequence is located within the 
coding region of the gin gene CKahmann et al, , 1985). This
enhancer appears to function in the same manner as the enhancer 
of the hin system, requiring the presence of Fis for optimum 
Inversion.
G inversion occurs at very low levels, due to the low level 
of gin expression. This low level may be explained by the
unusual use of GTG as the initiation triplet rather than the
more effective ATG triplet CPlasterk et al., 1983).
1. 6. 1. 3. The cin system of bacteriophage PI.
Phage PI contains an invertible DNA segment 4200bp in 
length that is highly homologous to the G segment of Mu (Chow 
and Bukhari, 1976). The segment is flanked by 640bp inverted 
repeats with the recombination sites, cix L and clx R, located 
at the outer ends of the larger inverted repeats (Hiestand- 
Nauer and lida, 1983). This C segment performs the same 
function in PI as the G segment in Mu, and is organised in the 
same symmetrical manner, see Figure 5 for a comparative
- 37 -
diagram. The two inner genes, tfs and tfs\ are highly 
homologous to the Mu U and U' genes, and likewise encode tail 
fibres. The larger gene, 19, is split into a constant and two 
variable regions, again analogous to the S gene in Mu. 
Significant homology exists between the S gene and 19 at 
approximately the same known distance from the amino-terminal 
end of the tail-fibre gene, suggesting that the intervening 
region, within the large IR sequence, may have been deleted in 
Mu, leaving only the necessary core sequence.
As with the other Ain-like systems a 72bp enhancer sequence 
is required for optimal rates of inversion in vitro. The 
enhancer sequence is also contained within the coding region of 
the cin gene (Kahmann et ai., 1985). This enhancer sequence is 
thought to function in the same manner as the enhancers of the 
other Ain-like systems (Huber et ai. , 1985). Studies by Hübner
et ai. (1989) have revealed that Fis binds to two sites within 
the enhancer, and that the sequence between these sites is 
important for enhancer activity. The enhancer effect appears to 
involve DNA bending between the two bound Fis molecules. Hübner 
et ai. suggest that this DNA bending may either give rise to 
DNA perturbations that can propogate along the helix, or, this 
bent DNA may be required for the three dimensional 
configuration of the recombination complex suggested by Bruist 
et ai. (1987).
The major difference between the PI cin system and the 
other Ain-like system lies in the orientation of the invertase 
gene. The proposed promoters for the other Ain-like genes lie 
within the inverted repeat crossover sequences, in the case of
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the cin gene it is the carboxy terminus which overlaps the clx 
site. Analysis of the area around the cin gene promoter reveals 
a sequence with considerable homology to the clx site 
CHiestand-Nauer and lida, 1983). At some point in the evolution 
of the cin system the cin gene may have been inverted with the 
aid of this pseudo-cix site. The Cin molecule may also be able 
to utilise these pseudo-cix sites to form co-integrates and 
this may lead to the fusion of genomes (Kennedy et ai., 1983).
1. 6. 1. 4. The pin system of E. coll.
Enomoto et ai. (1983) identified a region within the 
E. coll genome that was able to cause inversion in a plasmid 
carrying a non-functional invertible region from S. 
typhimurium. They named this function pin and mapped it to 
approximately 26min on the E. coli chromosome. Enomoto et ai. 
found that the product of the pin gene was also able to 
complement mutants in the cin system of PI. The pin gene was 
sequenced by Plasterk et ai. (1983) and found to be homologous 
to the other invertase genes in the hin family. The pin gene 
was found to be adjacent to a ISOObp invertible region.
Van de Putte et ai. (1984) found that E. coll HBlOl, a 
derivative of E. coli K12, was able to complement mutations in 
the gin system. This group placed the pin gene, and attendant 
invertible region, within the cryptic prophage el4. This 
prophage possess an SOS-sensitive repressor and, consequently 
the pin function is lost in strains which have been exposed to 
UV radiation or other mutagens. Neither Plasterk et ai. (1983) 
nor Kutsukake et ai. (1985) were able to ascribe a function to 
this invertible segment. However, it is known that the
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inversion determines the differential expression of at least 
one protein CPlasterk and van de Putte, 1964), although this 
alteration in protein expression cannot be correlated with any 
apparent change in the phenotype of E. coll,
1.6. 1.5. Relationships between the Ain-like systems.
The greatest homology within the family of Ain-like systems 
lies in the amnio acid sequence of the recombinases. This 
homology is demonstrated in Figure 6, in which the amino acid 
sequences of the invertase proteins are compared. The homology 
is consistently over 60%, the exact degrees of homology are; 
70% sequence homology between Gin and Pin, 62% homology between 
Hin and Gin and 60% between Hin and Pin. The resolvase protein 
TnpR shares 33% homology with Hin, which suggests a common 
ancestry for these proteins (Simon et al. , 1980; Kamp et al. ,
1984). The DNA sequence homology between these genes is not as 
high, due to the preferred codon usage of the different 
species. However, the nucleotide sequence homology is high 
enough to permit DNA probes made from the invertible region of 
S. typhimurium to hybridise under reduced stringency conditions 
to the invertible regions of Mu and PI (Szekely and Simon, 
1981), This conservation between the proteins implies a 
selective pressure to maintain protein function, an important 
observation for the pin system which has not yet been assigned 
a role. Using similar reduced stringency conditions Foxall et 
al. (1990) have observed hybridisation between a probe carrying 
the invertible region from S. typhimurium and chromosomal DNA 
from B. pertussis.
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FIGURE 6. ALIGNMENT OF THE AMINO ACID SEQUENCES OF 
THE HIN, GIN, CIN, PIN AND TnpR PROTEINS.
Amino acids are denoted by the standard one-letter 
symbols (see Appendix 4).
Amino acids conserved in all four invertase proteins 
are boxed, as Is homology between TnpR and Hin.
Hin sequence from Zieg and Simon, 1980.
Gin and Pin sequences from Plasterk et al. , 1983. 
Cin sequence from Hiestand-Nauer and lida, 1983. 
TnpR sequence from Heffron ei al, , 1979.
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The nucleotide sequence of the various cross-over sites has 
also been compared, see Figure 7. This reveals an equally 
strong homology with a consensus inverted repeat of the 
following sequence:-
- A - G T T T  G A - A A
The high degree of homology between these systems is 
further demonstrated by their ability to complement one 
another. The pin system of E, coli was initially recognised by 
its ability to complement a gin mutation carried on a plasmid 
(van de Putte et al., 1984). Given the strong homology and
complementarity of these systems it is assumed that inversion 
will occur by the same mechanism in any other related systems 
which may be discovered,
Curran et al. (1984) exploited this complementarity and 
constructed a plasmid to test for Ain-like invertase activity 
in a number of Gram-negative bacteria. This group cloned the 
invertible region of S. typhimurium (H2 'OFF') into the broad 
host range plasmid RP4. This recombinant plasmid, pMD8, did not 
confer motility when conjugated into a non-raotlle E. coli 
strain. However, PI lysogens of the non-motile strain gave rise 
to motile colonies, the invertase encoded by the phage 
inverting the hin segment into the H2 'ON' configuration in a 
number of cases.
pMD8 was then conjugated into a variety of bacterial 
strains and grown overnight in the new hosts. The plasmid was 
subsequently reconjugated into the non-motile E. coli strain 
and transconjugants tested for motility. Plasmid pMD8 grown up 
in several strains of E. coli K-12 and E. coli C was found to
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FIGURE 7. COMPARISON OF THE NUCLEOTIDE SEQUENCES OF THE 
RECOMBINATION SITES OF VARIOUS INVERTIBLE DNA 
SYSTEMS.
Conserved nucleotides in capitals.
The sequence labelled beta is found at the 
boundaries of the invertible region found in 
M. bovls.
Sequences are derived from the same sources as 
Figure 6, except beta (Marrs et al., 1986).
hix L 
Aix R
SITE OF 
RECOMBINATION
VgatttattggTTCTtgaAAACCA AGGTTTTtGATAAagca 
tgccataaaaTTtTgtttttggA AGGTTTTtGATAAccaa
glx L 
glx R
tgtttaccgtTTCcTgtAAACCg AGGTTTTgGATAAacag 
gat11accgtTTCctgtAAACCg AGGTTTTgGATAAtggt
cix L 
cix R
tggtaccgagTTCTct tAAACCA AGGTTTagGATtgaaat 
tggtaccgagTTCTcttAAACCA AGGTaTTgGATAAcagc
pix L 
pix R
gttttgctccTTCTcccAAACCA AGGTTTTcGAgAgccgt 
atgcagagccTTCTcccAAACCA AcGTTTatGAaAAtgaa
consensus
sequences ~ A-GTTT— GA—AA
beta gagcgat tgcagCTaggAtACCA AtaaTggcGAtAAcaat
have inverted, as it also did when grown in strains of Proteus 
morgsnii.
The evolution of the Ain-like systems has been studied by 
Kamp et aL <1984) who analysed amino acid and nucleotide 
sequence data from the various systems, This group proposed the 
evolutionary tree shown in Figure 8, and suggested that all the 
Ain-like systems evolved from a Mu-like ancestral phage. This 
ancestral phage would have possessed an invertible recombinase
gene, deletion of one of its cross-over sites would have fixed
it in one orientation and capture of a pseudo-crossover site 
would give rise to invertible segments of DNA. The ancestral 
phage would, presumably, be able to infect several species of 
bacteria and thus be disseminated throughout a range of 
species. Integration of this ancestral phage near the 
S. typhimurium flagellin gene followed by fusion of a phage 
promoter to the flagellin gene and deletion of the majority of 
the prophage would give rise to the Ain system. A precedent for 
this method of evolution exists as Kamp et al. (1984) have 
found a cryptic gin gene and a portion of the G segment within 
the genome of E. coll C600.
1. 6. 1. 6. Non Ain-like invertible DNA in E. coll.
A system has been described in E. coll involving an 
invertible segment of DNA, separate from the Ain-like system 
located on el4, which is responsible for firabrial variation. 
The expression of type 1 fimbriae in E. coll is regulated by a 
314bp invertible DNA segment which contains the promoter for 
the fimbrial subunit gene fim A (Abraham et al., 1985). In a 
manner analogous to the S. typAimurium Invertible system the
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FIGURE 6. EVOLUTIONARY TREE FOR THE INVERTASE 
FAMILY OF PROTEINS.
Diagram adapted from Kamp et al. 1984.
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orientation of the promoter determines the expression of the 
fimbriae. The 314bp segment has been sequenced (Dorman and 
Higgins, 1987) and Is bounded by two 9bp Inverted repeats. The 
orientation of the segment Is controlled by the FlmB and FlmE 
proteins (Klemm, 1986), products of the closely linked genes 
flm B and fim E, and requires the host protein known as 
Integration host factor (Dorman and Higgins, 1987). Both the 
Flm B and Flm E proteins are required for efficient bi­
directional Inversion (Pallesen et al> , 1989). The amino acid
sequences of these two recomblnases share no apparent homology 
with the family of Hln-llke Invertases and are not 
complementary (Freltag et ai., 1985). However, homology Is 
found between the C-termlnal sequences of Flm B and Flm E and a 
number of Integrase-llke phage recomblnases (P2Int, Plint, 
XInt) (Dorman and Higgins, 1987). In this family of proteins 
one region is perfectly conserved and may act as the active 
site, Argos et ai, (1986) suggest that a tyrosine residue 
present In this region In all the proteins Is responsible for 
forming a transient covalent linkage to DMA during strand 
breakage and religation.
1.6. 1.7, Invertible DMA In Moraxella bovls.
The pill of Moraxella bovis, a cattle pathogen, undergo a 
variation between two pllln types, ct and p. The change between 
the two Is mediated by the Inversion of a 2kb DMA segment 
(Marrs et ai,, 1988), The amino-terminal portions of both the ot 
and p pllln subunits are encoded by the same locus, the 
differing amino-terminal portions are encoded by two different 
gene fragments within the Invertible segment. In one
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orientation the «-specific carboxy region is spliced into the 
expression site, after inversion the ^-specific region is in a 
position to be expressed. Homology exists between this system 
and the left Inverted repeat of the hin system (Marrs et al. , 
1988), see Figure 7. M  bovis also undergoes a phase variation 
between plliated and non-piliated cells; the mechanism behind 
this switch is unknown.
1.6.2. Variation in Neisseria gonorrhoeae.
Members of the genus Neisseria are Gram-negative diplococci 
that colonize the mucosal surfaces of mammals; the genus 
contains both pathogenic and commensal species, N, gonorrhoeae 
is a major cause of venereal disease in humans.
Two major surface proteins involved in the disease 
process are the pill and the opacity protein. Both of these 
proteins undergo phase and antigenic variation Independently,
Gonococcal pill are composed of repeating subunit proteins 
and mediate attachment to cell surfaces. The pllln subunits are 
composed of a constant amino-terminal region and a variable 
carboxy-termlnal region (Meyer et al, , 1984; Hagblom et al, ,
1985), The N, gonorrhoeae strain, MSI lus» studied by Meyer et 
al, (1984) carries two loci on the chromosome pilEl and piiE2, 
located approximately 20Kb apart, which can encode functional 
pill. Subsequent studies of clinical Isolates have shown that 
most strains possess only a single expression site, pilEl 
(Nlcolson et ai,, 1987; Swanson, 1987), Many other regions of 
the chromosome contain homologous sequences which do not encode 
pill (Meyer et al, , 1984; Swanson et al, , 1986). During phase
variation, from plliated to non-plllated cells, there is a
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deletion in one or both of the expression sites. A further 
control system represses expression of pilin from the 
expression site that has not been deleted (Segal et ai., 1985). 
The deletions occur between repeated sequences within the 
coding region and upstream of the gene. Pilus phase variation 
is closely linked to antigenic variation and the non-piliated 
state may be an obligatory intermediate in the process of 
antigenic variation,
Pilus antigenic variation is due to the placement of 
varying numbers of cassettes which code for portions of the 
variable region within the expression sites (Hagblom et al, ,
1985), These coding regions may come from the silent pilin 
sequences (Segal et aJ. , 1986) or from transformed DNA released
by autolysed gonococci (Seifert et al,, 1988).
The opacity protein, OPII, is another major gonococcal 
adhesin which can undergo phase and antigenic variation. The 
genome of N. gonorrhoeae contains at least nine loci which can 
produce variant OP molecules (Stern ef al, , 1984); all of these 
loci are const itutively transcribed. Translation to functional 
protein is controlled by the presence of pentanucleotide 
repeats known as control repeats. These repeats are located in 
the region of the DNA which codes for the hydrophobic portion 
of the leader peptide. The number of repeats determines whether 
the coAîv^  Nvxture P3E . is in or out of frame and,
consequently, whether the OP is expressed or not (Stern et al, ,
1986). The number of the repeats is also thought to account for 
antigenic variation.
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The enzymatic machinery responsible for the various 
recombination events occurring during pilus and OP phase and 
antigenic variation is not yet known. However, Saunders (1986) 
suggests that if a mechanism similar to the hin-like system is 
used the enzymes must have a 'fairly lax specificity' to 
explain the diversity of events and the occurrence of 
apparently unfavourable rearrangements.
1.6.3. Rearrangements during Anabaena differentiation.
Genomic rearrangement is also involved in the developmental 
cycle of the cyanobacterium Anabaena. During nitrogen 
deprivation a number of Anabaena cells in a given population 
will differentiate into heterocysts, This change is accompanied 
by at least two genomic rearrangements. One involves the 
excision of an llkb circular DMA molecule from within the 
S' end of a gene encoding a nitrogenase (Golden et al. , 1985).
The second rearrangement involves a conservative site-specific 
recombination event between two llbp direct repeats (Golden et 
al. , 1985). The repeat sequences identified as the breakpoints
in both these rearrangements share no homology with the target 
sites of either X integrase or Hin protein.
1.6.4. Variation of Borrelia VMP protein.
Members of the genus Borrelia are spirochetes known to 
cause relapsing fever in humans and several animal species 
(Felsenfeld, 1965). The disease is characterised by a repeated 
cycle of feverish and convalescent periods, Antigenlcally 
distinct spirochetes can be isolated from animals 
experimentally infected with Borrelia of a single serotype 
(Schuhardt and Wilkerson, 1951). The most extensively studied
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member of the genus Is Borrelia hermsii, which causes relapsing 
fever in mice. A single organism of this species can give rise 
to at least 24 different serotypes (Stoenner et ai., 1982). 
The frequency of this serotype variation is approximately 10““*- 
iO~®. The change in serotype has been correlated with changes 
in a major 40Kd surface protein known as the variable major 
protein, VMP. The serotype specificity is due to differences in 
the primary structure of the protein.
Meier et al, (1985) found that differential expression of 
VMP genes was accompanied by a DNA rearrangement. This group 
presented data which suggests that each different VMP gene 
exists as a silent copy in the borrelial genome and expression 
of a particular VMP gene is the result of duplication and 
placement of this gene into an expression site. The VMP genes 
may be located on a multicopy linear plasmid (Plasterk et al,,
1985). The silent VMP genes stored on the linear plasmids are 
complete copies of a structural gene lacking any upstream 
regulatory sequences. Site-specific recombination occurs 
between the the genes on the storage plasmid and an expression 
plasmid, This results in placement of an intact VMP gene 
downstream of the appropriate regulatory sequences in the 
expression site. The enzymatic machinery and DNA chemistry of 
this system has not been elucidated.
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AIM OF RESEARCH.
Bordetella pertussis produces a range of virulence factors 
which are implicated in the disease process. Through the 
process of phase variation the expression of these virulence 
factors is halted by a genetic event. Within this range of 
virulence factors the bacterium produces two distinct fimbriae, 
and the variation in their expression is controlled by a 
different system from the one controlling phase variation.
A variety of genetic control systems responsible for 
antigenic variation in a wide range of bacterial species have 
been characterised, and many of these control systems involve 
DNA rearrangements.
The aim of this study was to examine DNA from phase and 
serotype variants of B. pertussis to find out if any DNA 
rearrangements were occurring in association with the observed 
variations.
A previous study had revealed homology between the hin 
region of S, typhimurium and a region within the B. pertussis 
genome, is this homologous region responsible for either phase 
or serotype variation?
— 4& —
2. MATERIALS AND METHODS.
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2.1.BACTERIAL STRAINS AND PLASMIDS.
2. 1. 1. B, pertussis strains.
The fimbrlal serotypes of all B, pertussis strains were 
tested by slide agglutination (section 2.5.2) when the cultures 
were first opened and then regularly throughout the study.
The following B. pertussis strains were used in this 
study: -
1. Taberraan: This strain has a 1,0,3 serotype. Isolated 
pernasally before the death of an infant. Obtained from 
Professor G. T. Stewart, Ruchill Hospital, Glasgow.
2. Tohama: This strain has a 1,2,0 serotype. Obtained from 
the culture collection of the Microbiology Department, Glasgow 
University.
3. Wellcome 28: This strain has a 1,2,3 serotype. Obtained 
from Dr. P. Novotny, Wellcome Biotechnology, Beckenham, Kent.
4. L84 I (NCTC 11089): This strain is a virulent isolate of 
B, pertussis, originally isolated from a nasopharyngeal swab in 
1950 (Ackers and Dolby, 1972). Obtained from the culture 
collection of the Microbiology Department, Glasgow University.
5. L84 IV (NCTC 10902): This strain is an avirulent variant 
of L84 I (Ackers and Dolby, 1972). The properties of strains 
L84 I and L84IV are described by Part on (1988). Obtained from 
the culture collection of the Microbiology Department, Glasgow 
University.
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6. BP 347: A transposon-induced pleiotropic mutant of
strain Tohama deficient in haemolysin, ACT, AGGs, FHA, PT and 
dermonecrotising toxin production (Weiss et al, , 1983).
Obtained from Dr, A. A. Weiss, Virginia Commonwealth University, 
USA,
2. 1.2. B, pertussis serotype variants.
1. 106V: This strain has a 1,0,0 serotype and is
afimbriate, but is not a mouse avirulent strain. The strain was 
derived from a parent strain with a 1,0,3 serotype (Bronne- 
Shanbury and Dolby, 1976). Obtained from the culture collection 
of the Microbiology Department, Glasgow University.
2. ARG Strains: B. pertussis strains bearing the ARG prefix
are strains isolated from the lungs of infant mice three weeks 
after infection with the parental strains. The fimbrial
serotype of the strains and details of the parent strains are 
given in Table 1. Obtained from Dr. A. Robinson, PHLS, Porton 
Down.
2.1.3. B. parapertussis,
B. parapertussis strain NCTC 10520 was used throughout this 
study. Obtained from the culture collection of the Microbiology 
Department, Glasgow University.
2. 1.4. E. coli strains.
1. E, coli DHl. recAl endhl gyrh26 Thi"" bsdR17 supE44.
2. E, coli HBIOI. recA13 F~aral4 X“ galKZ lacYl proA2
rspLZO xyl~5 supE44.
3. E, coli C600. thi-1 leiBQ lacYl tonhZl X“ supE44.
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TABLE 1: THE FIMBRIAL SEROTYPES OF B. pertussis ARG 
STRAINS AND THEIR PARENT STRAINS.
STRAIN FIMBRIAL PARENT PARENT FIMBRIAL
_______________SEROTYPE_____STRAIN___________ SEROTYPE
ARG 40 2,0 Wellcome 28 2,3
ARG 41 0, 3 Wellcome 28 2, 3
ARG 43 0, 3 Tohama 2, 0
ARG 44 0,3 Tohama 2,0
4. E. coli K 12,
All the above strains obtained from the culture collection of 
the Microbiology Department, Glasgow University.
5. E, coll WA 3782 (lida, 1984). hsdtc recA met pin, The 
strain is negative for DNA inversion function and has been used 
in several inversion assays (Huber et al, , 1985; Kahmann et al, , 
1985). Obtained from Dr. H. HUbner, Basel University.
6. E, coll RZ211. Aipro-lac) ara strA recA56 att: : Xfia-406 
off. The original strain RZ211 (Johnson et al, , 1982) did not
contain the X phage insertion. The phage Xfia-406 off contains 
the lacZ gene under the control of the hin invertible DNA 
segment (Bruist and Simon, 1984), and has inserted 
lysogenically into the chromosome of strain RZ211. The phage is 
trapped in the 'off* orientation due to a deletion in the hin 
gene it carries. In this 'off state the phage does not 
transcribe the lacZ gene. In the presence of an exogenously 
provided invertase protein the hin region inverts and permits 
transcription of the lacZ gene. Inversion also causes the phage 
to express the H2 gene it carries and putative inversion events 
can be tested for by the presence of H2 flagellin in the cell. 
This strain was obtained from Dr. M. Simon, California 
Institute of Technology, California, USA.
2.2. PLASMIDS.
2. 2. 1. B, pertussis strain Tohama gene library.
The construction of this library from B. pertussis strain 
Tohama chromosomal DNA is described by Brownlie et al. (1986). 
Each clone contains approximately 30Kb B, pertussis DNA cloned
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into the single Eco R1 site of the cosmid vector pLAFRl 
(Freidman et al, , 1982). Plasmids from this library used:-
2. 2. 1. 1. pRMBl contains the adenylate cyclase locus and 
IS481V1,
2. 2. 1. 2. pRMB2 contains the bvg locus.
Both plasmids described by Brownlie et aJ. (1988).
2.2.2. Plasmids from other sources.
2.2.2.1. pRK2013: helper plasmid for three way conjugations 
(Figurski and Helenski, 1979). Obtained from the culture
collection of the Microbiology Department, Glasgow University.
2.2.2.2. pIL22; contains the fim 2 gene from B. pertussis 
strain Wellcome 28. Construction of this plasmid is detailed in 
Livey et al, (1987). Obtained from I. Livey, PHLS, Porton Down.
2. 2. 2. 3. pKKlOOlB: contains 8. 8kb S, typhimurium DNA cloned 
into pBR322 (Dr. K, Kutsukake, personal communication). The 
cloned DNA includes the entire invertible DNA segment of the 
hin system, the H2 gene and the rhl gene. Obtained from Dr. K. 
Kutsukake, University of Tokyo.
2.2.2.4. pSH1313: an indicator plasmid constructed by Huber
et al, (1985). The plasmid contains genes encoding kanaraycin 
resistance and chloramphenicol resistance within a short
discrete invertible DNA segment. The segment is bounded by two 
inverted repeat sequences from the cin invertible region of 
bacteriophage PI. Expression of these genes is controlled by a 
single promoter outwith the invertible region, see Figure 9 for 
diagram. In the 'ground* state the plasmid encodes
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FIGURE 9. DIAGRAM OF pSH1313.
Pt--fc = PROMOTER.
CAT = GENE ENCODING CHLORAMPHENICOL 
RESISTANCE.
KAN = GENE ENCODING KANAMYCIN RESISTANCE.
clxR and clxL = INVERTED REPEAT RECOMBINATION SITES 
FROM BACTERIOPHAGE PI cln SYSTEM.
AcIn = cln GENE FROM BACTERIOPHAGE PI 
CARRYING A LARGE DELETION.
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chloramphenicol resistance. In the presence of an active 
invertase the DNA segment containing the resistance genes is 
inverted and the plasmid then encodes kanamycin resistance. 
Obtained from Dr H. Hübner, Basel University.
2. 3. MEDIA AND GROWTH OF BACTERIA.
For details of media composition and preparation see 
Appendix 1.
Growth and manipulation of E. coli containing recombinant 
plasmids was done under category I containment according to 
ACGM guidelines (ACGM/HSE note 8, June 1988). B. pertussis 
containing recombinant plasmids was grown and manipulated under 
category II containment.
2.3.1. Growth of B. pertussis.
B. pertussis was grown on solid Bordet-Gengou (EG) medium 
(Gibco-BRL) containing 20%(v/v) defibrinated horse blood 
CInterMed) for 72 h at 36'C in a moist atmosphere. 
Alternatively, B. pertussis was grown on cyclodextrin solid 
media (CSM) containing 0. 002%(w/v) Congo red dye.
In liquid culture, B. pertussis was grown in Stainer and 
Scholte medium (Stainer and Scholte, 1971), with or without the 
growth stimulant heptakis (2,6-0-dimethyl) p-cyclodextrin, in 
100ml volumes in dimpled 250ml flasks. Cultures were incubated 
on an orbital incubator at 80rpm at 37'C.
2. 3. 2. Growth of E. coll.
E. coll was grown on nutrient agar (Oxoid) or on McConkey 
agar containing crystal violet (Difco). Liquid cultures were 
grown in nutrient broth number 2 (Oxoid) or L-broth. All
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cultures were incubated at 37°C; liquid cultures were 
incubated in 10ml or 100ml volumes on an orbital shaker at 
80rpm.
2.3.3. Antibiotics.
Antibiotics were made up in distilled water, except 
tetracycline (made up in ethanol), filter sterilised and 
stored at -20°C. They were included in media at the final 
concentration listed below.
Cephalexin CCeph) 50)xg/ml
Chloramphenicol (Cm) 50pg/ml
Kanamycin sulphate (Km) 50p.g/ml
Tetracycline (Tc) 25pg/ml
2. 4. MICROBIOLOGICAL TECHNIQUES.
2.4.1. Plate conjugations.
B. pertussis strains were grown on solid BG medium for 72h. 
Growth from these plates was scraped from the plate using 
sterile loops, streaked onto a fresh BG plate and Incubated 
overnight.
The donor E, coli strain and the helper strain 
HBIOICpRK2013] were incubated overnight in 10ml of nutrient 
broth containing appropriate antibiotics. The two cultures were 
then mixed into 100ml of sterile saline and an excess pipetted 
onto the lawn culture of B. pertussis on the surface of the BG 
plates. After gentle mixing, the excess E, coli suspension was 
removed and the plates incubated overnight. Growth was scraped
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from these plates and suspended in 10ml of sterile saline, A 
10“^ dilution of this suspension was made and lOOpl aliquots of 
the dilution plated onto the selective plates. The selective 
plates contained cephalexin (final concentration 50pg/ral) to 
select against E. coll and appropriate antibiotics to select 
for transconjugants. Plates were incubated for 7-10 days, or 
until single colonies of B. pertussis were isolated. Colonies 
were then restreaked to single colonies on selective plates to 
eliminate contamination with E, coll.
2.4.2. Selection of B. pertussis phase variants.
Virulent strains of B, pertussis were grown for 72h on BG 
plates, A large inoculum of these cells was used to inoculate 
100ml of Stainer and Scholte medium and grown for 46h. Several 
lOOpl aliquots of this culture were removed and plated onto BG 
plates containing erythromycin at a final concentration of
0.25pg/ml. A further 10ml of the culture was used to inoculate 
100ml of pre-incubated Stainer and Scholte medium. This culture 
was incubated overnight. Serial dilutions of the turbid culture 
were then plated onto BG plates containing erythromycin 
(0, 25|ig/ml final concentration). These plates were incubated 
and examined for single non-haemolytic colonies.
2.4.3. Assays for B. pertussis virulence factors.
2. 4. 3, 1. Haemolysin,
Haemolysin was assayed visually on BG sandwich plates. 
These plates have a lower layer of translucent BG agar without 
added blood, covered by a thin layer of BG agar containing 
20%(v/v) defibrinated horse blood. Virulent strains of B.
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pertussis produce small clear areas of haemolysis on these 
plates.
2.4, 3, 2, Filamentous haemagglutinin.
B. pertussis was scraped from BG plates and resuspended in 
sterile phosphate-buffered saline, pH7. 2 (PBS), to a 
concentration of 10 opacity units. The opacity of the 
suspension was checked against the WHO 5th International 
Reference Preparation of Opacity (Perkins et aJ, , 1973), 50pl
aliquots of this suspension were added to equal volumes of 
2%(v/v) washed horse erythrocytes in U-shaped wells of plastic 
microtitre trays. After mixing, the trays were incubated for 2h 
at room temperature before visual assay of haemagglutination. 
This assay does not appear to measure haemagglutination caused 
by PT (Parton, 1988).
2. 4. 3, 3, Dermonecrot ising toxin.
B, pertussis strains were grown in Stainer and Scholte 
liquid medium for 48 h at 37*C. Culture were harvested by 
centrifugation at 10 OOOg for 30min at 4*0. Packed cells were 
resuspended in saline and frozen. Whilst frozen the cells were 
disrupted by three passages through an X-press (Life Sciences 
Laboratories, Sarum Road, Luton), After thawing^ the suspension 
was centrifuged at 100 OOOg for 30min at 4*0. The supernate of 
the cell extract was distributed in small amounts and stored at 
- 20*0.
The presence of dermonecrotising toxin in these samples was 
tested in 3-4-week-old male HaM/IOR mice (Charles River UK Ltd, 
Mansion Road, Margate, Kent ). After ether anesthesia, groups
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of five or ten mice were given injections of 0.5ml of a 
suitable dilution of the extract sub-cutaneously in the dorsal 
region. After 24hrs the animals were killed with CO^ and the 
diameters of the haemorrhagic reactions within the skin 
measured.
2. 4. 3. 4. X-bands.
The presence of the major phase I (X-mode) specific
proteins (X-bands) of - 30Kd was determined by SDS-
polyacrylamide gele electrophoresis of whole-cell suspensions. 
B, pertussis strains were grown in Stainer and Scholte medium 
for 48hrs at 37“C and harvested as above. The harvested cells 
were washed once in sterile saline and then resuspended to ~2mg 
protein ml~'*. The suspension was then mixed with an equal
volume of 125mM Tris-HCl, pH 6. 8, 4% (w/v) SDS, 10% (v/v)
p-mercaptoethanol, 20% (v/v) glycerol and 0. 002% broraophenol
blue, and heated at 100*C for 5min. The solubilized samples 
(25pl) were applied to each track of the gel, which consisted 
of 10% (w/v) in the separating gel and 5% in the stacking gel. 
The protein profiles also served to confirm the identity of the 
samples as B. pertussis.
2.4.4. Transformation of E. coll.
The transformation procedure used throughout this study is 
based on the method of Lederberg and Cohen (1974).
A fresh overnight culture of the recipient E. coll strain 
was diluted into L-broth and grown until the culture reached an 
optical density of 0.5-0.6 at 650nra. The cells were then placed 
on ice for twenty min, recovered by centrifugation (10 OOOg at
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4*0 and resuspended in half the initial culture volume of ice- 
cold 0. IM magnesium chloride. The cells were immediately re- 
pelleted and resuspended in approximately l/20th of the initial 
culture volume of ice-cold 0. IM calcium chloride. The cells 
were then left on ice for 40 min. Approximately 0. 5-lpg of 
DNA was then added to 0.2ml of the cells and left on ice for 30 
min. The cells were then heat shocked at 42"C tor 2 min and 
returned to ice tor a further 30 min. 1ml of L-broth was then 
added to the suspension and incubated at 37*C for one hour 
before plating out lOOpl aliquots of the suspension onto 
selective plates containing appropriate antibiotics.
2. 5. IMMUNOLOGICAL TECHNIQUES.
2. 5. 1. Antibodies used in this study.
The agglutinating antibodies used in this study were rabbit 
polyclonal absorbedtype-specific antibodies obtained from Dr. 
N.W. Preston, University of Manchester.
The mouse monoclonal antibody raised against AGG-1 was 
supplied by Dr. A. Robinson, PHLS, Porton Down.
2.5.2. Slide agglutination tests.
A loopful of B. pertussis (approximately 5pl) was scraped 
from a BG plate and suspended on a clean, grease-free glass 
slide in two loopfuls of sterile saline. A loopful of the 
appropriate antiserum was then mixed with the suspension and 
left for several minutes. A positive agglutination gave large 
'granules' of bacteria, whereas a negative result did not alter 
the suspension. For negative controls the antisera was omitted 
and a third loopful of sterile saline added. This negative
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control procedure allowed any autoagglutination of bacteria to 
be detected.
2.5.3. Immunoblottlng.
Several loopfuls of B. pertussis or B. parapertussis were 
scraped from BG plates and resuspended In 2ml of sterile saline 
to give a fairly turbid suspension. Nitrocellulose membranes 
(Schleicher and Schull) were pre-wet ted in saline for five
minutes. The wetted membranes were then placed into the Dot
Blot apparatus (Bio-Rad) and the unit assembled as per
manufacturers instructions. The wells were then filled with the
cell suspensions and surplus wells covered with tape. A vacuum 
was applied until the cells were firmly attached to the
membrane. If lysis of the cells was required the membrane was 
placed above a dish of chloroform for 10 min. The membrane was 
then blocked overnight in 5%(w/v) BSA in PBS. After blocking, 
the filter was given three 15 min washes in PBS with gentle
agitation. This was followed by a 2h incubation in a 1 in 10 
dilution of the test antibody in BSA l%(w/v) in PBS. Again,
this was followed by three 15 min washes in PBS with gentle
agitation. The membrane was then incubated for 2 hours in a 
1/3000 dilution of anti-mouse IgG conjugated with horse-radish 
peroxidase in l%(w/v) BSA made up in PBS. After a further three 
15 min washes in PBS with gentle agitation the membrane was 
incubated for 30 min in freshly-prepared 4-chloro-l-nap'^ \bhol 
solution (see Appendix A. 1. 7). The membrane was then rinsed in 
distilled water to terminate the reaction.
All incubations and washes were carried out at room 
temperature in glass dishes.
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2. 6. DNA MANIPULATION TECHNIQUES.
The composition of all solutions and buffers not described 
in the text below is given in Appendix 2.
2.6.1. B. pertussis chromosomal DNA preparation.
B. pertussis strains were grown on BG plates for 72h. A 
large inoculum was taken and used to inoculate 200ml of
Stainer and Scholte medium. Liquid cultures were grown for 36- 
48h until turbid, but still in exponential phase. Cells were 
harvested at 10, OOOg for 10 min at 4’C and washed once in TE 
(Appendix A. 2.1) containing lOOmM NaCl. The cells were then 
resuspended in 50ml of chromosomal lysis buffer (Appendix
A.2.2) on ice. 50pl of freshly prepared lysozyrae (Sigma,
40mg/ral in TE) was added to the suspension and left at room
temperature for 5 rains. The following were then added in the 
given order:- lOpl of proteinase K (Sigma, 20mg/ml in distilled 
HgO), lOOpl RNase A (BRL, made up at lOmg/ml in distilled H^ O, 
then boiled for 15 minutes), 400pl of 0.5mM EDTA and 250pl of 
10%(w/v) sodium lauroyl sarcosinate (Sigma). The mixture was 
left on ice until lysis was complete. The lysate was then
incubated overnight at 50*0,
If the lysate was too viscous for easy handling after 
incubation, it was diluted further with lysis buffer. An equal 
volume of 1:1 TE-saturated phenol (Appendix A, 2. 3) and 
chloroform was added to the lysate. The mixture was then
emulsified gently and centrifuged at 5, OOOg for 5 min. The
upper phase was removed, avoiding the interphase material. The
phenol/chloroform extraction was repeated twice and followed by 
an extraction with chloroform alone. After the extractions,
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1/lOth volume 5M NaCl was added and mixed by inversion. Two 
volumes of ice-cold ethanol were added, mixed and left at -20'C 
for Ih. After precipitation the DNA was spooled out using a 
bent pasteur pipette and redissolved in 5ml TE buffer. The DNA 
solution was then placed in prepared dialysis tubing and 
dialysed at 4*C against 41 TE for 72h with four changes of TE.
2. 6. 2. Plasmid preparation.
This protocol, based upon the method of Birnboim and Doly 
(1979), was routinely used for preparation of plasmid DNA. The 
given protocol is suitable for a culture volume of 100ml, which 
yields “200pg plasmid DNA; the procedure can be scaled up or 
down according to the amount of DNA required.
The E. coli strain harbouring the plasmid was grown in 
100ml of nutrient broth containing the appropriate antibiotic. 
Cells were harvested at 10, OOOg for 10 min at 4°C. The pellet 
was resuspended in 2ml of ice-cold plasmid lysis buffer 
(Appendix A. 2. 4) and left for five rain at room temperature. 
Ice-cold 0.2M NaOH containing l%(w/v) SDS was freshly prepared 
from stock solutions (2N NaOH, 20%(w/v) SDS), 4ml added to the 
lysate and the mixture left on ice for 10 rain. Acidified 
potassium acetate solution (Appendix A. 2. 5)was freshly prepared 
and 3ml added to the mixture which was then left for a further 
10 min on ice. The suspension was centrifuged at 10,OOOg for 
10 rain at 4°C. The supernate was then filtered through tissue 
paper to remove any remaining proteinaceous debris. 
Approximately 0. 6 volumes of isopropanol were then added and 
the mixture left for 15 min at room temperature, then 
centrifuged at 10, OOOg for 10 min. The pellet was gently washed
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once with 70%(v/v) alcohol and then freeze-dried for 15 min. 
The dried pellet was resuspended in 0. 5ml TE and, if necessary, 
the buffer was heated to 65*C to aid dissolving the pellet.
After resuspension of the pellet 200pl of TE-saturated 
phenol and 200pl of chloroform were added and mixed gently, the 
mixture was again centrifuged at 10, OOOg for 10 min. The upper 
phase was removed to a fresh tube, avoiding the material at the 
interphase. The phenol/chloroform extraction was repeated, and 
then followed by an extraction with 400pl of chloroform alone. 
An equal volume of 5M ammonium acetate was added to the 
supernate and left on ice for 15 rain, then spun again. This 
step removes the majority of RNA in the solution. The supernate 
was decanted into a fresh tube and 2 volumes of isopropanol 
added. The mix was then left on ice for 15 min, spun at 10,OOOg 
for 15 rain and the supernate removed. The pellet was rinsed in 
70%(v/v) alcohol and freeze-dried for 10 min. The dried pellet 
was resuspended in 200pl TE, again being heated to 65“C if 
needed.
2.6.3. Concentration and purity of DNA.
DNA concentrations were estimated both spectro- 
photometrically and visually. The optical density of DNA 
solutions was measured at both 260nm and 280nm. Long chain 
duplex DNA solutions at 50pg/ml have an optical density at 
260nm of approximately 1. The ratio between the 260nm reading 
and the 280nm reading for a pure DNA solution is -1.7. 
Alternatively, the concentration of a DNA sample was estimated 
visually on agarose gels. A known volume of the sample to be 
tested was run into a 0. 5% agarose gel along with samples of X
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DNA (BRL) at known concentrations. After staining with ethidium 
bromide the intensities of the various bands could be compared 
to give an estimation of the concentration of the sample.
2.6.4. Digestion of DNA with restriction endonucleases.
The restriction enzymes and incubation buffers used in 
this study are detailed in Table 2. The méthylation sensitive 
enzymes used are detailed in Table 3.
Digests were routinely performed in a volume of 20pl. 
Approximately Ipg of DNA was used in each digest with 1-8 units 
of enzyme. All enzymes were used with the reaction buffers 
supplied by the manufacturers. Digestions were incubated at 
37*C for at least 4h, or overnight. Digests of chromosomal DNA 
also included 40mM spermidine.
Simultaneous double digests were prepared using a volume 
of 40fil and twice the amount of DNA. HamHI/FcoRI digests were 
performed in REact™3, Cla 1/Stu I double digests in REact*!.
Instances where the isoschizomers Cla I and Bsc I were used 
indisriminately at different stages of the study are shown as 
Cla I (Bsc I).
After digestion Spl loading buffer (Appendix A, 2, 7> was 
added to the sample prior to electrophoresis.
2.6.5. Size markers for electrophoresis.
2pg of X DNA was digested with Hindlll at 37“C for 3h. The 
ensuing fragments were then either used directly on agarose 
gels or labelled with d-ATP (see section 2.6.6.) before
use.
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TABLE 2: RESTRICTION ENZYMES USED IN THIS STUDY.
ENZYME
CLEAVAGE
SITE BUFFER* SUPPLIE
Apa I s'GGGCCC=' REact™4 BRL
Bam HI s'GGATCC^' REact”3 BRL
Bsc I ATCGAT=»' Bsc Buffer NBL
Cla I ATCGAT=' REact*l BRL
Eco R1 ='GAATTC=" REact*3 BRL
Hin dlll s'AAGCTT=' REact™2 BRL
Kpn I s'GGTACC=" REact™4 BRL
Pst I CTGCAG=' REact*2 BRL
Sph I ='GCATGC=" REact*6 BRL
Stu I s'AGGCCTS" REact™2 BRL
* Composition of buffers is given in Appendix 3.
NBL = Northumbria Biologies Limited, Cramlington, Northumbria.
TABLE 3: METHYLATION SENSITIVE RESTRICTION 
ENDONUCLEASES USED IN THIS STUDY.
ENZYME
RECOGNITION
SEQUENCE
METHYLATION
SENSITIVITY BUFFER'
Mbo I ®'GATC®' No cleavage if A residue
methylated, cleavage if
C residue methylated.
Sau 3A ^’GATC®' No cleavage if C residue
methylated, cleavage if
A residue methylated.
Dpn I G"*ATC^' Will cleave only if A
residue methylated.
REact"2
REact"4
REact™4
Alu I
Cfo I
'AGCT^' No cleavage if G or A
residue methylated.
GCGC^' No cleavage if either
C residue methylated.
M buf f er
M buffer
Hpa II
Msp I
CCGG®' No cleavage if internal
C residue methylated.
CCGG^' Cleavage irrespective of
méthylation of internal 
C residue.
REact”8
REact™1
All enzymes obtained from BRL, except Alu I and Cfo I obtained 
from Northumbria Biologicals Limited.
* See Appendix 3 for details of buffer composition.
Hae III fragments of 0X174 DNA (BRL) were used as size 
markers for low molecular weight fragments.
The size of the fragments generated in the above procedures 
are given in Appendix 5.
2.6.6. Radioactive labelling of size markers.
SOOng of K-Hin dlll digest fragments were resuspended in 
50|il of 1 X Core Buffer (BRL). To this was added lOpl of Â 
solution, Ijil of a-szp-dATP (300 Ci/ramol; Araersham Corp. ) and 
Ipl of the Klenow fragment of E. coll DNA polymerase (BRL). The 
reaction was incubated for -15 min at room temperature and then 
loaded onto agarose gels after the addition of loading buffer.
2.6.7. Agarose gel electrophoresis.
Horizontal gel systems (Pharmacia) were used throughout 
this study. Type ÎI-A medium EEO agarose (Sigma) was used in 
analytical gels, Low gelling temperature agarose (Seaplaque) 
was used in preparative gels. Analytical gels were prepared and 
run using 0.5 X TEE; preparative gels using 1 X TAE.
Gels were routinely run at l^5V/cm, After running, gels 
were stained for 15 minutes in ethidium bromide (final 
concentration Img/ml), then destained in distilled water for an 
equal length of time. DNA fragments were visualised under 
ultraviolet illumination. Photographs were taken through a red 
filter, using Polaroid type 667 film.
The size of fragments were calculated by using a graph of 
the mobility of the markers against the logio of their length 
in base pairs as a calibration curve for that gel. Restriction
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fragment maps were made using the technique of Fitch et al.
(1983) which employs a branch and bound technique.
2.6.8. Polyacrylamide gel electrophoresis.
5% polyacrylamide gels were used in this study. 16. 6ml of a 
30%(w/v) acrylamide solution were added to 71.3 ml of distilled 
HaO, 10ml of 10 X TBE and 2. Irai of freshly prepared 3%(w/v) 
ammonium persulphate solution. This mixture was deaerated using 
a side-arm flask. The solution was mixed gently and during 
mixing 30pl of TEMED (N, N, N', N*-tetramethylethylene diamine) 
was added. The solution was immediately poured between two 
grease-free glass plates sealed together with tape. The comb 
was inserted at the top of the gel, which was left for several 
hours until polymerisation was complete. The reservoirs of the 
electrophoresis tank were filled with 1 X TBE and the gel 
placed in position. The wells were filled with sample in 
loading buffer, and the gel run at 15V/cm for 3h, or until the 
gel front reached the bottom of the gel. After running, one 
glass plate was prised carefully from the gel and the gel 
stained and visualised as described for agarose gels.
2. 6. 9. Southern blotting.
DNA fragments were transferred from agarose gels onto nylon 
membranes using a vacuum blotting system (LKB 2016 Vacugene). 
Conditions employed were dependent on the membrane being used.
Zeta-probe membranes (Bio-Rad) were pre-wetted in 
distilled water and laid on the apparatus. The apparatus was 
assembled according to the manufacturer's instructions. The 
vacuum was switched on and stabilised at 50cm H^ O.
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Approximately 30ml of 0.25M HCl was pipetted over the surface 
of the gel and left for 4- min, after this time the excess was 
removed and the gel submerged in 0. 4N NaOH. The gel was left 
under vacuum for 50 min. After transfer the gel was lifted off 
and re-stained in ethidium bromide to check the degree of 
transfer. The membrane was then rinsed in 2 X SSC, left to air 
dry and then placed immediately in pre-hybridisation solution.
Hybond-N CAmersham) and nitrocellulose membranes were pre­
wetted in 2 X SSC and placed in the apparatus as above. 
Approximately 30ml of 0. 25M HCl was pipetted over the gel and 
left for 4 min. After removal of excess HCl, an equal volume of 
denaturing buffer was pipetted over the gel and left for 3 min, 
after which any excess was removed. An equal volume of 
neutralising buffer was then pipetted over the gel, left a 
further 3 rain and removed. The gel was submerged in 20 X SSC 
for the 50 rain transfer period. The membranes were rinsed in 2 
X SSC after transfer.
Hybond-N membranes were then wrapped in Saran Wrap (Dow 
Chemical Company) and the side of the membrane with the bound 
DNA was exposed to UV light for 5 rain. The membrane was then 
either used immediately or stored at 4*C.
Nitrocellulose membranes were baked in a vacuum oven at 
80*C for 2h and then used immediately.
2.6.10. Hybridisation conditions.
Hybridisation was carried out under two sets of 
conditions:- i) high stringency, and ii) reduced stringency.
1. High stringency conditions.
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Membranes were placed into heat-sealable polythene bags, 
20ml of pre-hybridisation buffer added and all air bubbles were 
removed from the bag before it was sealed. The membrane was 
incubated with this solution in a shaking water bath at 42"C 
overnight with gentle agitation. After incubation the pre- 
hybridisation buffer was discarded and 20ml of hybridisation 
buffer added to the bag. The radio-labelled probe was then 
added to the bag, the air bubbles removed and the bag sealed. 
The membrane was again incubated overnight at 42 "C.
After incubation the membrane was removed from the bag and 
rinsed twice in 2 X SSC at room temperature, twice in 2 X SSC,
0. l%(w/v) SDS at 65°C for 30 min with agitation and once in 0. 1 
X SSC, 0. l%(w/v) SDS at 65'C for 15 min with agitation.
2. Reduced stringency conditions.
The manipulation of the membranes was identical under both 
sets of conditions. However, different pre-hybridisation and 
hybridisation buffers, and washing conditions were employed. 
The composition of these buffers, the conditions they were used 
in and details of the washing procedures are given in the 
relevant Results section.
After washing, membranes hybridised under both sets of 
conditions were blotted dry and immediately wrapped in Saran 
Wrap. The wrapped membrane was then placed in an 
autoradiography cassette loaded with Kodak X-OMATR X-ray film 
and intensifying screens. Autoradiographs were exposed at 
-70*C or room temperature for varying periods of time. After
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exposure the film was developed in Kodak DXÔO developer and 
fixed using Kodak FX40 diluted fixing solution.
2.6.11. Preparation of radioactively labelled probes.
Probes were labelled using the random hexanucleotide primer 
method of Feinberg and Vogelstein (1984).
l-2pg of plasmid DNA was cleaved with the appropriate 
restriction endonuclease(s). The products were separated 
electrophoretically on l%(w/v) low melting temperature agarose 
gel made up and run in 1 X TAE. After staining to visualise the 
fragments the required band was excised and weighed. The gel 
slice was placed in a microfuge tube and 3ml of distilled H^O 
added per gram of gel. The two were boiled together for 7 min 
and then stored at -20*C.
When required the gel was reboiled for 5 min and incubated 
at 37*C for a further 15 rain. The following were added to a 
fresh microfuge tube in the given order:- i) H^O (to give a 
final reaction volume of 50pl), ii) lOpl of oligo-labelling 
buffer (OLE), iii) 2pl of bovine serum albumin (Sigma, 
lOmg/ml), iv) 10 - 30pl of the boiled DNA in low melting 
temperature (LMT) agarose (volume added being dependent on the 
concentration of DNA within the agarose), v) 5pl of oc-®==P-dATP 
(300pCi/mmol; Araersham), and vi) 2 units of Klenow fragment of 
E. coli DNA polymerase (BRL). The reaction was left overnight 
at room temperature, and terminated by the addition of 200pl of 
STOP buffer.
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2.6. 12. Blot In-labelled probes.
1. Labelling of probes with blotin.
The labelling reaction is essentially as described in
2.6.11. except that the a-^^P-dATP is replaced by the same 
concentration of biotin-7-dATP (BRL).
2. Use of biotin-labelled probes.
The filters used for hybridisation with biotin-labelled 
probes are prepared as described previously (section 2.6.9). 
The hybridisation conditions used were also as described 
(section 2,6.10). The concentration of formamide in the 
hybridisation mixture was decreased empirically due to the 
slight decrease in the melting temperature of the biotin- 
labelled probe/target duplex as compared to the ®==P-labelled 
probe/target duplex.
3. Development of filter after hybridisation.
The filter was removed from the hybridisation bag and 
rinsed for 1 rain in 0.IM Tris-HCl (pH 7.5), 0.15M NaCl (buffer 
A). The filter was then incubated in 3% (w/v) bovine serum
albumin (BSA) (Fraction V) (Sigma) made up in buffer A at 65"C 
for 1 hour. After incubation the filters were blotted dry and 
then baked in a vacuum oven at 80*C for 20 mins. Filters were 
then rehydrated in the 3% (w/v) BSA solution.
The following steps were performed in polypropylene or 
glass vessels. The streptavidin-alkaline phosphatase (SA-AP) 
conjugate (BRL) was diluted to 1.Opg/ml in buffer A. 
Approximately 7.0ml of SA-AP conjugate were prepared per iOOcm=® 
of filter. The filters were then incubated in this solution for
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10 mins with gentle agitation and occasionally pipetting. After 
incubation the used SA-AP conjugate was decanted and the 
incubation repeated using fresh SA-AP conjugate. After this 
second incubation the filters were washed in buffer A, using a 
volume at least 30 times that of SA-AP conjugate used in the 
previous incubation. Filters were washed for 15 mins and the 
wash repeated using fresh buffer A.
The dye solution was prepared, immediately prior to use, by 
adding 33pl of NET solution (BRL) to 7. 5ml of 0. IM Tris-HCl 
(pH9. 5), 0. IM NaCl, 50mM MgCl^, mixed gently, and 25pl BCIP
solution (BRL) added. Approximately 7. 5ml of this dye solution 
were prepared per 100cm=^  of filter. The filter was incubated in 
this dye solution in a dim light or darkness until a signal was 
observed. Filters were then washed briefly in 20mM Tris- 
HCl (pH7, 5), 0. 5mM EDTA and then baked in a vacuum oven at 80“C 
for 2 minutes.
2. 6. 13. Synthesis and labelling of oligonucleotide probes.
Oligonucleotides were synthesized on an Applied Biosystems 
model 3Ô0A DNA synthesizer at PHLS CAMR, Porton Down, using the 
phosphoramidite coupling procedure. By-products of the reaction 
were removed by gel exclusion chômâtography using a Pharmacia 
P-10 (Sepahdex G25) column pre-equilibrated with lOmM ammonium 
acetate elution buffer. The concentration of the 
oligonucleotide was estimated spectrophotometrically.
Labelling of oligonucleotide probes was performed using the 
method of Woods (1964). 15pl of fresh y-^zp-dATP (3000Ci/mmol; 
Amershara) and 200-300ng of oligonucleotide were dried under 
vacuum and resuspended in 7pl of H^ O. Ipl of 10 X T4
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polynucleotide kinase buffer and Ipl of T4 polynucleotide 
kinase (BRL) were then added and mixed. The reaction was 
incubated at 37*C for 30 min and terminated by heating to 65“C 
for 5 min,
2.6.14. Hybridisation with oligonucleotide probes.
Restriction digests of B. pertussis chromosomal DNA were 
transferred to nylon membranes as described. The membranes were 
then placed in a heat sealed polythene bag with 20ml of 
oligonucleotide pre-hybridisation buffer and incubated in a 
shaking water bath at 37'C for 3h, After this time the bag was 
drained and 20ml of oligonucleotide hybridisation buffer 
containing ®®P-labelled probe added. The membrane was then 
incubated overnight at varying temperatures. Following 
incubation the membrane was removed from the bag and rinsed 
several times at room temperature in 6 X SSC, 0. 05%(w/v) sodium 
pyrophosphate (SSC/PP). The membrane was then washed in SSC/PP 
for Ih at 30'C, followed by a 10 min wash in SSC/PP at various 
temperatures, the temperatures used for each different 
experiment are given in the relevant Results section. Membranes 
were then autoradiographed as described.
2,6. 15. Colony hybridisations.
Clones from the B. pertussis Tohama gene library were grown 
in sterile 96 well microtitre plates overnight in nutrient 
broth containing tetracycline. They were then transferred using 
a 46 prong replicator onto nitrocellulose filters placed on the 
surface of nutrient agar plates. The plates were incubated 
overnight at 37*C. The membranes were then placed on sheets of 
3MM paper (Whatman) saturated with denaturing solution for 3
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minutes. After denaturing the membranes were transferred onto 
3 MM paper saturated with neutralisation buffer for 5 min. 
Membranes were then placed on paper saturated with 3 X SSC for 
3 rain. The membranes were again transferred onto dry 3MM paper 
and allowed to air dry for 30 min. The membranes were then 
stacked between sheets of dry 3MM paper and baked in a vacuum 
oven at 50 “C for 2h. Subsequently, the membranes were 
hybridised with either oligonucleotide or plasmid DNA probes 
using the methods detailed previously.
2. 6. 16. Two-dimensional SI nuclease heteroduplex mapping.
The method is based on the protocol of Yee and Inouye
(1984).
At least lOOpg of B. pertussis DNA was used in each 
experiment. The DNA samples were concentrated down to
approximately lOOpl using alcohol precipitation and butanol 
concentration. Samples from parent and variant pairs were both 
digested with a four base-pair recognition restriction enzyme, 
usually Sau 3A. After overnight digestion at 37*C the reaction 
was stopped by the addition of EDTA to a final concentration of 
lOmM. Digestion was checked by removing -Ipg of both digests 
and running them on a l%(w/v) agarose mini-gel (Pharmacia), The 
remaining DNA was extracted twice with chloroform/isoamyl 
alcohol (24:1) then precipitated with an equal volume of 
isopropanol after the addition of 1/10 volume of 5M sodium
acetate. After pelleting by centrifugation and freeze-drying 
for fifteen minutes the pellet was resuspended in lOOpl of TE. 
The DNA was then re-precipitated with 2. 5 volumes of ethanol
after the addition of 1/20 volume of 3M sodium acetate. The
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pellet was then resuspended in 90pl of 50%Cv/v) deionised 
formamide/lOOraM Tris. HCl <pH8. 5>/10mM EDTA. A mixture of 30pl 
from each of the paired DNA samples was used to give a 
heteroduplex solution, the remaining 60pl of each sample were 
homoduplex solutions. All three samples were heat denatured for 
5 rain in a boiling water bath and left at room temperature for 
~20h to renature.
After renaturation, loading buffer was added to all three 
samples and they were then added to the 1. 6cm wells of a 5% 
polyacrylamide gel (17cm long by 0.25cm thick) prepared in TBE 
and electrophoresed at 15V/cm until the bromophemol blue in the 
running buffer had reached the end of the gel. Each lane
containing the DNA was then cut from the gel and trimmed to
11,5cm long. These strips were then sealed in polythene bags 
and incubated for two 2h washes in 50ml of SI nuclease reaction 
buffer. The strips were then soaked for 24h in 10ml each of SI 
nuclease buffer containing SI nuclease (BRL) at 70 units/ml for 
24h with occasional agitation at 4*0. The SI nuclease reaction 
was stopped by soaking the strips in 50ml of 2 X TBE for l%h 
followed by three soakings in 0.2 X TBE for a minimum of 2h 
each at room temperature. The gel strips were then loaded on to
the top of a second 5% acrylamide gel made up in 0.2 X TBE. Due
to swelling of the strips during the soaking procedures these 
second gels were prepared 25% thicker. The gel strips were 
sealed onto the surface of the second gels with 0. 7%(w/v) 
agarose made up in 0.2 X TBE. The second gel was 
electrophoresed at llV/cm until a sample of bromophenol blue 
added to the surface of the second gel reached the bottom. The
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gels were removed from one glass plate and stained with 
ethidium bromide (final concentration 0. 4p.g/ral) and visualised 
as previously described.
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3. RESULTS.
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3.1. ISOLATION AND TESTING OF Vlr~ VARIANTS ISOGENIC 
WITH THEIR PARENTAL B. pertussis STRAINS.
B. pertussis strains Taberman and Tohama were grown in 
Stainer and Scholte liquid medium and plated onto selective BG 
plates containing erythromycin (final concentration 0.25pg/ml) 
as described in section 2.4,2. Several erythromycin resistant 
non-haemolytic colonies of both strains were picked from the 
selective BG plates. The exact frequency of the variants was 
not calculated but was estimated to be within the limits quoted 
by Weiss and Falkow (1984). Parallel experiments in which 
B. pertussis grown in Stainer and Scholte medium were plated 
onto BG plates without erythromycin did not give rise to any 
non-haemolytic colonies.
Following removal from the erythromycin-containing 
selective BG plates, variant strains were then grown only on 
normal BG plates. In the course of this subculturing, up to 12 
passages in some cases, no revertant haemolytic colonies were 
detected. The colonies of the non-haemolytic, variant strains 
were more fluid and emulsified more easily in sterile saline 
than colonies from the parent strains.
Several of the virulence-associated properties of these 
non-haemolytic strains were tested and compared to those of 
several control strains. The results of these comparisons are 
shown in Table 4. Both strain Taberman and strain Tohama shared 
the same characteristics as strain L84I, the control virulent 
strain. The non-haemolytic variant strains of Taberman and 
Tohama had the same properties as strain BP347, an avirulent
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TABLE 4; COMPARISON OF SEVERAL VIRULENCE-ASSOCIATED 
FACTORS OF VIRULENT. AVIRULENT AND ERYTHROMYCIN 
RESISTANT STRAINS OF B. pertussis.
FHA HLY GROWTH CONGO RED
STRAIN_________ ACTIVITY______ ACTIVITY______ ON NA BINDING
L84I
L84IV
BP347
Tohama — -4- —
Tohama ery^ —  —  —  —
Taberman -+-
Taberman ery^ —  —  —  —
FHA activity was tested by haemagglutination of horse erythrocytes in 
microtitre trays (section 2. 4. 3,2) and haemolysin activity was assayed 
visually on BG agar sandwich plates (section 2.4.3.1). To confirm lack of 
growth on nutrient agar the strains were streaked onto nutrient agar plates 
and incubated for 7 days at 37’C in moist conditions, growth was checked 
visually. The ability of the cells to take up Congo red dye was tested by 
growing the cells on cyclodextrin medium containing 0. 002%(w/v) Congo red. 
The cells were incubated on this medium for 3 days at 37*C and uptake of 
Congo red checked visually.
strain containing a Tn5 insertion within the bvg locus, but did 
not grow on nutrient agar as LÔ4IV, a Phase IV control strain, 
did.
Whole-cell suspensions of both parent and variant strains 
were analysed using SDS-PAGE gels. These gels revealed that the 
avirulent and Phase IV control strains plus the variant strains 
were deficient in the 26 and 30Kd virulence-associated X-bands, 
which were present in both the virulent control strains and the 
parent strains <R. Parton, personal communication), In
addition, the variant strains did not express any dermonecrotic 
toxin activity when tested sub-cutaneously in mice (H.
Frampton, personal communication).
Conjugation of the cosmid clone pRMB2 (Brownlie et ai., 
1988) containing the bvg locus into the variant strains was
sufficient to restore expression of all the virulence- 
associated factors tested.
Cosmid pRMB2 was cured by three passages of the cosmid-
containing strains on BG plates unsupplemented by tetracycline. 
Loss of the cosmid was confirmed by replica plating onto BG 
plates + tetracycline (25pg/ml). All colonies which had been 
passaged three times had lost the cosmid and did not grow on BG 
plates containing tetracycline. When tested, the cured strains 
had lost the ability to express any of the virulence-associated 
factors tested.
Several of the virulence-associated factors produced by the 
strains containing pRMB2 were assayed. When grown on BG 
sandwich plates containing tetracycline (25pg/ral) the 
haemolytic zone surrounding the cosmid-containing colonies was
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noticeably larger than the zone surrounding the wild-type 
colonies. The cosmid-bearing strains grew only half as well as 
the parental wild-type strain in liquid culture but did produce 
three times as much dermonecrot izing toxin per gram of 
bacterial protein as the wild-type (H. Frampton, personal 
communication). This increase in haemolytic zone and 
dermonecrotizing toxin activity was also observed when pRKB2 
was conjugated into the parent virulent strains.
In view of these analyses the erythromycin resistant, non- 
haemolytic strains were deemed to fulfil the criteria required 
of avirulent (Vir— )strains using the definition of Weiss and 
Falkow (1984). These avirulent variant strains were assumed to 
be isogenic with the parent strains, apart from the genetic 
event responsible for the observed phase variation.
3.2. ANALYSIS OF CHROMOSOMAL DNA FROM ISOGENIC 
VIR-" AND VIR- B. pertussis STRAINS.
3. 2. 1. Analysis using restriction endonucleases.
Chromosomal DNA prepared from the isogenic virulent and 
avirulent strains of B. pertussis described above were digested 
to the same degree by all restriction endonucleases listed in 
Table 2 except Hin dlll, which did not digest B. pertussis DNA 
from any source. In stained agarose electrophoresis gels of 
chromosomal digests there was no apparent difference in 
restriction patterns between DNA from virulent and avirulent 
strains (data not shown). The inclusion of cyclodextrin into 
the Stainer and Scholte growth medium of J3. pertussis strains
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used for DNA preparation had no effect on the digestibility of 
the DNA produced.
Chromosomal DNA from the isogenic virulent and avirulent 
strains were digested with restriction enzymes which are 
affected by the méthylation status of specific residues within 
their recognition sequence (see Table 3). The results of these 
digests were run on 2% agarose gels and 5% polyacrylamide gels, 
see Figure 10.
The enzymes Mbo I, Sau 3A and Dpn I are isoschizomers, they 
recognise and digest the same sites. However, the effect of
méthylation is different for each enzyme (see Table 3 for 
details). Chromosomal DNA from the virulent and avirulent
strains was digested to an equal degree by both Mbo I and 
Sau 3A, although the digests of the paired DNA samples produced 
using the enzyme Mbo I appeared to have slightly different
restriction patterns. Several bands, of approximately 2-3kb, 
appear to be missing from digests of DNA from avirulent
strains. This difference is not apparent in the patterns 
obtained from Sau 3A digestion. The enzyme Dpn I will not 
digest DNA unless the adenine residue within the recognition 
site is methylated, Dpn I did not digest any DNA samples from 
virulent or avirulent strains.
There was no gross difference in the restriction pattern of 
the paired DNA samples digested with Alu I or Cfo I.
The restriction enzymes Msp I and Hpa II are isoschizomers, 
again differing in the reaction to méthylation within their 
recognition and cleavage sequence (Table 3). Chromosomal DNA 
from both virulent and avirulent strains was fully digested by
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FIGURE 10. DIGESTION OF B. pertussis CHROMOSOMAL DNA 
WITH METHYLATION-SENSITIVE RESTRICTION ENDONUCLEASES.
Photograph A shows digested B. pertussls chromosomal DNA running in a 
2% agarose gel:
Lane 1 contains Tohama DNA digested with Mbo I.
Lane 2 contains Tohama DNA digested with Dpn I.
Lane 3 contains Tohama Vli—  DNA digested with Mbo I,
Lane 4 contains Tohama Vi'i—  DNA digested with Dpn I.
Lane 5 contains Taberman DNA digested with Mbo I.
Lane 6 contains Taberman DNA digested with Dpn I,
Lane 7 contains Taberman Vii—  DNA digested with Mbo I, 
Lane 8 contains Taberman Vii—  DNA digested with Dpn I.
The two smaller arrows indicate the position of the =1.5kb bands 
missing from Mbo I digests of the Vii—  DNA samples.
Photographs B and C show digested B. pertussis chromosomal DNA running 
in a 5% polyacrylamide gel.
In both photographs, lane 1 contains Tohama DNA, lane 2 Tohama Vli—  
DNA, lane 3 Taberman DNA and lane 4 Taberman Vii—  DNA. The enzyme used to 
digest the samples is given above each quartet of lanes.
The molecular weight markers used in photographs B and C are 0X174 
Hae III fragments, the size of these fragments is given in Appendix 5.
In all the photographs the large arrow indicates the direction of 
migrât ion.
A I 2 1 4 ;  (i 7 S
M bv ' !  S.ui'^A 
n ,11 I 2 1 4 I 2 1 4
Al u I C f o !
C  ,11 1 2  3 4 1 2  3 4
Hpa II , whereas none of the DNA samples were digested by 
Msp I.
Chromosomal DNA was prepared from strains of B. pertussis 
grown in media that caused antigenic modulation. The virulence 
factors produced by these variant strains were tested and the 
absence of expression confirmed that the strains were C-mode 
cells (D. McGillivray, personal communication). The DNA from 
the X-mode parental and the C-mode variant strains exhibited 
the same digestion patterns as DNA from the Vir* parental and 
Vi:—  variant strains respectively.
3.2. 2. Analysis using 2-dimensional SI nuclease heteroduplex 
mapping.
Control experiments performed on chromosomal DNA prepared 
from E. coli strain HBlOl gave results similar to those 
described by Yee and Inouye (1984). However, the technique 
proved to be virtually useless for studying the DNA of 
B. pertussis. The region of the second dimension gel in which 
any putative rearrangement involved in phase variation would be 
seen was totally obscured by a mass of DNA.
3.2.3. Analysis using radioactively-labelled probes.
3. 2. 3. 1. The bvg locus.
The plasmid pRMB2 (Brownlie et al, , 1988) was radioactively
labelled and hybridised to chromosomal digests of parent and 
variant DNA samples. Eco RI digests probed with pRMB2 gave rise 
to the hybridisation pattern described by McGillivray et al. 
(1989). This pattern consists of six Eco RI fragments with the 
following sizes;- 10. Okb, 5. Ikb, 4. 7kb, 2. 7kb, 2. 5kb and l.lkb.
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All the variant DNA samples tested gave this pattern except 
BP347 in which the 2, 7kb fragment is replaced by an 8. 4kb 
fragment which contains Tn5 (data not shown).
3. 2. 3. 2. The flmZ gene locus.
The fim 2 gene isolated from a B, pertussis Wellcome 28 
gene library by Livey et al, (1987) is bracketed by a pair of 
Sph I cleavage sites. The plasmid pIL22, containing the fim 2 
locus, was digested with SphI and the 0.85kb fragment 
containing the fim 2 gene isolated and used as a probe. This 
fragment also contains part of the repeated sequence IS481v2 
(McPheat et al. , 1989).
DNA from the parent and variant strains of B. pertussis 
and B. parapertussis strain 10520, was double-digested with 
Bam HI and Eco RI, to yield small fragments which can be 
subsequently cloned, and blotted onto a nylon membrane. The fim 
2 probe hybridised to this blot under high stringency 
conditions ( final wash, 0.1 X SSC at 65*C for 30 minutes). The 
results of this hybridisation are shown in Figure 11.
The fim 2 gene probe hybridised to at least 40 bands in the 
B. pert ussis lanes. There are differences in the pattern of 
these bands between the DNA samples tested, particularly in the 
region of the low molecular weight fragments. The pattern of 
bands in the DNA derived from the two pairs of parent and 
variant strains are distinct from each other and from the 
pattern found in L84I DNA. Differences can also be seen between 
the paired DNA samples but the number of bands seen in these
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FIGURE 11. PROBING OF B. pertussis AND B. parapertussis DNA 
WITH THE fim 2 GENE PROBE.
The figure shows B, pertussis and B. parapertussis chromosomal DNA 
which had been double-digested with BcoRI and BanHl, run on a 0.8% agarose 
gel and then Southern-blotted as described (section 2.6.9). The blotted DNA 
was hybridised with the 0. 85kb Sph I fragment of pIL22 containing the fim 2 
gene and part of IS481v2. The final wash for this experiment was carried 
out in 0,1 X SSC at 65*C for 30 minutes.
The autoradiograph was exposed to the filter for five days at -70°C 
prior to developing.
Key to figure:-
m - position of X Hindlll fragments.
1 = L84 I DNA,
2 = Taberman DNA.
3 = avirulent Taberman DNA.
4 = Tohama DNA.
5 = avirulent Tohama DNA.
6 = B. parapertussis 10520 DNA.
7 - B. parapertussis 59521 DNA.

patterns does not allow any significance to be attached to 
these differences.
The probe hybridised to 4 bands in the B. parapertussis 
lanes and to 4 similar bands in a double digest of B. 
bronchiseptica chromosomal DNA (data not shown). In an 
experiment performed under identical conditions the B. 
pertussis results were repeated but there was no hybridisation 
observed to Bam HI/Eco RI double digests of DNA prepared from 
several strains of B. avium (data not shown).
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3.3. ISOLATION OF flm GENES FROM 
B. pertussis STRAIN TABERMAN.
3.3.1. Probing of B. pertussis strain Taberman gene library.
A gene library prepared using DNA from B. pertussis strain 
Taberman (fimbrial serotype 0,3) (Brownlie et al. 1986) was 
grown on nitrocellulose filters, as described, and probed with 
a radioactively-labelled oligonucleotide.
The oligonucleotide was formulated by Livey et al. (1987) 
and was homologous to the amino terminal sequence of the 
B. pertussis fim 2 gene. They used this oligonucleotide probe 
to isolate the fim 2 gene from a B. pertussis gene library 
constructed using DNA from strain Wellcome 28 (fimbrial 
serotype 2,3). The conditions used by Livey et al. (1987) to 
isolate the fim 2 gene involved an overnight hybridisation at 
65*C and a one hour final wash in SSC/PP also at 65*C. These 
conditions were specific only for the fim 2 gene.
The sequence of this oligonucleotide probe was as follows:- 
®•GTGTCGGTGATGGTGCCGGTGATGACGATCK5TGCCGTCGTC®'
This probe was radio-labelled and hybridised to the gene 
library overnight at 50'C with a final wash at 50*C for one 
hour in 6 X SSC/0. 05% (w/v) sodium pyrophosphate. Nine of the 
520 cosmid clones in the Taberman gene library hybridised with 
the probe under these reduced stringency conditions.
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3.3,2, Analysis of the putative fim gene-containing clones.
3.3.2.1, Analysis using restriction endonucleases.
The nine cosmids which hybridised to the oligonucleotide 
probe were analysed using Cla X (.Bsc I) and Sal I, Cla I (Bsc 
I) was used to check for the presence of the 0. 6kb fragment 
homologous with the bin-containing probe (section 3,4.3). Sal I 
was used to identify the signal fragments for the various genes 
identified by Mooi et al. (1987). The size of the Insert in 
each cosmid was found by estimating the total size of the 
cosmid and subtracting 21.6kb (the size of pLAFRl), the insert 
sizes are given in Table 5. Digestion of the cosmids revealed 
that the nine cosmids could be divided into three distinct 
groups sharing a number of common bands.
The Cla I (Bsc I) and Sal I bands shared by the clones are
summarised in Table 6. In all the restriction digests performed
cosmids pDA126 and pDA128 shared the same restriction patterns 
and were therefore deemed to be identical cosmids containing 
the same piece of DNA, thereafter only pDA126 was used.
As can be seen from Table 6 the eight clones can be divided 
into three groups. The clones in each group presumably contain 
the same flm gene, which is present on the shared fragments.
The number of shared Sal I fragments makes identification of
the flm gene carried by each clone difficult. The clones were 
therefore probed with a flm gene containing probe,
3.3.2.2. Hybridisation with flm 2 gene probe.
The 0.85kb Sph I fragment of B. pertussis DNA containing 
the flm 2 gene and a part of IS481v2 described in Section
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TABLE 5: INSERT SIZES IN THE NINE COSMIDS
CONTAINING PUTATIVE flm GENES.
COSMIDS________________INSERT SIZE.
pDA126 21. 2kb
pDA128 21. 2kb
pDA163 19. Okb
pDA192 25. Okb
pDA204 18.6kb
pDA216 22.5kb
pDA319 23, 3kb
pDA395 18, 6kb
pDA446 24. Okb
TABLE 6; Cla KBsc I) AND Sal I FRAGMENTS SHARED BY THE 
COSMIDS CONTAINING PUTATIVE fim GENES.
Cla 1 (Bsc I) FRAGMENTS
GROUP 1 
DDA126 dDA395 pDA216
GROUP
pDA319
2
pDA446 pDA163
GROUP 3 
pDA192 pDA204
4. 6kb 4. 6kb 6. 4kb 6. 4kb 4. 7kb 4, 7kb
2. 4k b 2. 4kb 3. 7kb 3. 7kb 3. 7kb 3. 9kb 3. 9kb 3. 9kb
0. Ô3kb 0.83kb
.
0. 8kb
3, Okb 
1. 32kb
3, Okb 
1. 32kb 
0. 8kb
Sal 1 FRAGMENTS
2. 3kb 2, 3kb 2. 7kb 2, 7kb 2. 7kb 5. Okb 5. Okb
2. Okb 2, Okb 2. 3kb 2. 3kb 2. Okb 2. Okb 2. Okb
1. 6kb 1. 6kb 1. 8kb 1. 8kb 1. 8kb 1. 8kb 1. 8kb
1, 5kb 1, 5kb 1, 65kb 1, 65kb 1. 5kb 1. 5kb 1, 5kb
0. 9kb 0, 9kb 1. 45kb 1. 45kb 1, 4kb 1. 4kb
0. ôkb 0, 8kb 1, 3kb 1. 3kb 1. 3kb 1. 3kb 1. 3kb 1. 3kb
1. 25kb 1, 25kb 1. 25kb 1. Okb 1. Okb
1, Ikb 1. ikb 1. Ikb 0.95kb 0. 95kb 0. 95kb
1. 07kb 1. 07kb 1. 07kb
1, 04kb 1. 04kb 1. 04kb
3. 1. 3.2. , was radio-labelled and used to probe Sal I digests of 
each of the eight clones. These hybridisations were carried out 
at reduced stringency conditions, final wash 1 X SSC, 0. l%w/v 
SDS at 50*C for 1 hour. The probe hybridised to three bands in 
pDA126 and pDA395 and to two bands in the other digests, see 
Figure 12. The bands divided the eight cosmids into the groups 
detailed above. The probe hybridised to a 2. 7kb, a 1. 6kb and a
0, 9kb band in the cosmids pDA126 and pDA395, to 0. 5kb and 0. 4kb
bands in cosmids pDA163, pDA192 and pDA204, and to 1. 65kb and
1. 4kb bands in pDA216, pDA319 and pDA446. Hybridisation was
noticeably stronger to pDA216,* pDA319 and pDA446.
Mooi et al. (1987) have reported that each fim gene is
carried on a distinct Sal I fragment. These fragments are:- a 
0. 9kb fragment containing the fim 3 gene, a 1. 7kb fragment 
carrying the fim 2 gene and a 3.9kb fragment containing the fim 
X gene. The data from this hybridisation experiment suggests 
that the group I cosmids contain a flm 3 gene and that the 
group 2 cosmids contain a fim 2 gene. The group 3 cosmids do 
not contain a fragment corresponding to the fim X gene from B. 
pertussis strain 165 sequenced by Pedroni et al. (1988) but 
appear to contain a different flm-like gene.
3. 3. 2. 3. Testing of E. coli strains.
All E. coli strains carrying the cosmids were tested using 
polyclonal anti-sera to AGGs 1, 2 and 3. None of the E. coli 
strains gave positive reactions in slide agglutination tests 
(section 2.5.2) using the polyclonal anti-sera raised against 
AGGs 1, 2 or 3.
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FIGURE 12. HYBRIDISATION OF THE flm 2 PROBE TO THE
COSMIDS CONTAINING PUTATIVE flm GENES.
The figure shows Sal I-digested cosmid DNA, run on a 0.8% agarose 
gel and Southern-blotted as described (section 2.6.9). The 
blotted DNA was then hybridised with the fim 2 probe (the 0.85kb 
Spb I fragment of pIL22) under reduced stringency conditions, 
final wash in 1 X SSC, 0. 1% (w/v) SDS at 50*C for Ih. These 
autoradiographs were exposed for 3 days at -70*C, The Figure is a 
composite of several filters performed under identical 
conditions.
Key to Figure:- 
A pDA126 
B pDA395 
C pDA216 
D pDA319 
E pDA446 
F pDA163 
G pDA192 
H pDA204
J pDI116
The members of the same cosmid groups have been placed together 
in this composite.
The small arrows indicate the position of the Sal I fragments 
that hybridise with the probe under these conditions, the size of 
the fragments is given alongside them.
A B C D
2.7-
1.6 -
0.9.
F G H
3.3. 2,4, Behaviour of the flm gene containing-cosmids in 
B. parapertussis.
B, parapertussis strain 10520 did not agglutinate when 
tested with polyclonal anti-sera raised against B. pertussis 
AGGs 2 or 3, However, partial agglutination was observed when 
B. parapertussis 10520 was tested with the polyclonal antibody 
raised against B. pertussis AGG 1.
The eight clones were conjugated into B. parapertussis 
10520 and tested with the polyclonal anti-sera raised against 
AGGs 2 and 3.
To test for expression of AGG 1, all the cosmid-bearing 
strains and B. parapertussis 10520 were dot-blotted onto 
nitrocellulose filters and tested with a monoclonal antibody 
raised against B. pertussis AGG 1 (section 2.5.3). The results 
of these tests are shown in Table 7.
Only B. parapertussis strains containing pDA126 and pDA395 
expressed AGG 3. After the cosmids were cured, by three 
passages on BG plates without tetracycline, the strains did not 
react with the anti-sera raised against AGG 3. This indicates 
that the expressed AGG 3 gene was carried on the cosmid.
None of the strains tested produced any detectable AGG 2.
5. Behaviour of AGG 3-encoding plasmids in AGG 3~
B. pertussis strains.
Plasmid pDA126, which encoded AGG 3 in B. parapertussis 
10520, was conjugated into the following B. pertussis strains:-
1, BP 347, fimbrial serotype 0,0.
2. B. pertussis strain Toharaa, fimbrial serotype 2,0.
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TABLE 7; RESULTS OF TESTING B. parapertussis 10520 
STRAINS CONTAINING COSMIDS BEARING PUTATIVE AGG GENES.
McAb PcAb PcAb PcAb
COSMID AGG 1_________ AGG 1_________ AGG2__________ AGG3
pDA126 —
pDA163 -—  —I- /  —  —  —
pDA192 —  • ~t- /  —  —  —
pDA204 -—  -+- y  —  —  —
pDA216 —  /  —  —  —
pDA319 —  /  —  '—  —
pDA395 —  -f- /  —  —  H“
pDA446 —  /  —  —  —
The strains were tested with the monoclonal antibody raised 
against AGG 1 (McAb AGG 1) by immunoblotting as described in 
sect ion 2, 5. 3.
The strains were tested using the polyclonal antibody raised 
against the three AGGs (PcAb AGG X) by slide agglutination 
(section 2.5.2).
KEY: - indicates no reaction,
+ Indicates a positive reaction,
+/- indicates a partial reaction.
3. B. pertussis strain ARG 40, fimbrial serotype 2,0.
4, B. pertussis strain 106V, fimbrial serotype 0,0.
These strains were tested by slide agglutination using the 
polyclonal anti-sera raised against AGGs 2 and 3, the results 
of these tests are summarised in Table 8. AGG 3 was expressed 
in all the AGG 3~ strains except strain BP347.
After loss of the cosmid, via three passages on BG plates 
without tetracycline, the strains were again tested with the 
agglutinating anti-sera raised against AGGs 2 and 3. None of 
these strains expressed AGG 3. Thus, none of the strains had 
regained expression of AGG 3 from a chromosomal locus after 
curing of the cosmid.
B. pertussis strains 106V and 106VCpDA126] were grown on BG 
plates, the latter supplemented with tetracycline (25pg/ml). 
Bacteria were lifted gently from the plates and emulsified in 
sterile saline. After émulsification the bacteria were 
negatively stained with ammonium molybdate and prepared for the 
electron microscope. Electron-mlcrographs of representative 
samples of both strains are shown In Figures 13 and 14. 
Assembled fimbrial structures can be seen extending from the 
surface of the bacteria containing pDA126, The electron- 
mlcrographs show a representative sample of the cells of each 
strain. Strain 106V[pDA126] gave a far greater degree of cell 
'clumping' when being emulsified in sterile saline than strain 
106V, which dispersed into single cells fairly readily. After 
loss of pDA126 the strain was once again afimbrlate (data not 
shown).
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TABLE 8; FIMBRIAL SEROTYPES OF B. pertussis
AGG 3“ STRAINS CARRYING PLASMID pDA126.
B. pertussis 
STRAIN
ORIGINAL
SEROTYPE
SEROTYPE 
* PLUS pDA126
SEROTYPE AFTER 
LOSS OF pDA126
BP347 0, 0 0, 0 0, 0
Tohama 2,0 2,3 2,0
ARG 40 2.0 2,3 2,0
106V 0, 0 0, 3 0, 0
The fimbrial serotypes of these strains were tested with the 
polyclonal antibodies raised against AGG 2 and AGG 3 by slide 
agglutination.
The cosmid was cured by three passages of the strain on BG plates 
unsupplemented with tetracycline. Loss of the cosmid was confirmed by 
re-streaking the strains after the final passage on BG plates 
containing tetracycline.
FIGURE 13. ELECTRON-MIGROGRAPHS OF B. pertussis STRAIN 106V, 
Cells have been stained with ammonium molybdate.
Final magnification of these electron-micrographs 
is 102, 000 X.

FIGURE U, ELECTRON-MIGROGRAPHS OF B. pertussis STRAIN 
106VEpDA126].
Cells have been stained with ammonium molybdate.
Final magnification of these electron-micrographs 
is 102, 000 X,
The arrows indicate some of the visible fimbrial structures.
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3.3.3. Probing of serovarlant chromosomal DNA with flm 2 probe.
Chromosomal DNA from the B. pertussis strains Tohama, 
Taberman, ARG 40, ARG 41, ARG 43 and ARG 44 was digested with 
Eco RI and Cla I (.Bsc I) and blotted onto nylon membranes. 
These filters were then hybridised with the 0. 85kb Sph I 
fragment of pIL22 described earlier. These experiments gave 
rise to multibanded patterns similar to those shown in Figure 
11. Visual analysis of these results could not differentiate 
between the banding patterns of any of the strains, despite 
their differing serotypes (data not shown).
3. 4. DETECTION OF SEQUENCES HOMOLOGOUS TO THE INVERTIBLE 
bin SEQUENCE OF Salmonella typhimurium,
3.4. 1. Probing of B. pertussis chromosomal DNA with a bin 
containing probe.
The plasmid pKKlOOlB contains the entire invertible region 
of S. typhimurium within an 8. 8kb insert of S. typhimurium DNA 
cloned into EcoRl/BaniM sites of pBR322. This plasmid did not 
bind to B. pertussis DNA under the high stringency conditions 
defined in section 2.6,10.1. Under the high stringency 
conditions the probe did bind to Sau 3A dlgested-pKKlOOlB. The 
stringency of the conditions was then systematically reduced 
until hybridisation was achieved. Significant hybridisation 
occurred using the following conditions: the probe was
hybridised in the standard hybridisation buffer described in 
section 2.6.10 except that the forraamlde concentration was 
reduced to 20% (v/v), and the SSC concentration was raised to 
6 X SSC. The filter was incubated In this hybridisation buffer 
at 42*C overnight. The filter was then washed twice In 2 X SSC, 
0. 1% SDS at room temperature for 30mins, follovred by washing 
twice in 2 X SSC, 0. 1% SDS at 55“C for 1 hour. The filter shown 
in Figure 15 was then exposed at -70'C for 4 hours.
The filter illustrated contains EcoRI-digested chromosomal 
DNA Isolated from the Taberman and Toharaa parent and variant 
strains described previously and Sau 3A-digested pKKlOOlB. The 
probe demonstrated a similar hybridisation pattern to 
B. pertussis DNA as that reported by Foxall at al. <1990). The 
probe hybridised to two high molecular weight EcoRI fragments 
<-15kb) In each sample. However, the degree of hybridisation
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FIGURE 15. PROBING OF B. pertussis DNA WITH pKKlOOlB.
The figure shows B, pertussis chromosomal DNA digested with EcoRI and 
plasmid pKKlOOlB DNA digested with Sau 3A, run on a 0. 8% agarose gel and 
Southern-blotted as described (section 2,6,9). The blotted DNA was 
hybridised with radio-labelled pKKlOOlB under low stringency conditions.
The hybridisation buffer contained 20% (v/v) formamide and 6 X SSC, and the 
filter was incubated in this buffer at 42°C overnight. The final wash was 
performed in 2 X SSC, 0,1% (w/v) SDS at 55*C for Ih. The autoradiograph was
then exposed at -70'C for 4h.
Key to Figure:-
m = position of X HindiII fragments.
1 = Taberman DNA,
2 = avirulent Taberman DNA.
3 = Tohama DNA.
4 = avirulent Tohama DNA.
5 = L84 I DNA.
6 = L84 IV DNA.
7 = pKKlOOlB.
The large arrow Indicates the direction of migration.
The smaller arrows indicate the position of the two high molecular
weight bands the probe hybridises to under these conditions.
m 2 3 4 5 6 7
I
varies between the Taberman and the Tohama strains. The probe 
consistently hybridised with greater intensity to chromosomal 
DNA derived from the Taberman strains than to the Tohama 
derived DNA. There is also a difference between the degree of 
hybridisation to the LÔ4I and L84IV-derived DNA, hybridisation 
is stronger to the LÔ4I DNA. This discrepancy in the binding of 
the probe is not related to the concentration of sample DNA as 
these were equilibrated prior to digestion. The DNA samples 
which display the greatest degree of homology also show the
probe hybridising to a number of lower molecular weight 
fragments. After initial expdsure the filter was rewashed in 
2 X SSC, 0. 1% SDS at 65'C for 2hrs and reexposed at -70*C. In 
order to achieve a comparable signal the exposure time was 
increased to 36hrs. This exposure still retained the circular 
areas of non-specific hybridisation, but had a greater general 
background due to the increased exposure time. The high 
stringency wash removed the probe from several of the lower 
molecular weight bands in the Taberman DNA samples. The amount 
of probe hybridised to the DNA was greatly decreased, although 
the relative proportions of the hybridisation signals was
retained.
3. 4. 2. Creation of a bin-specific probe.
The nucleotide sequence of the invertible DNA region of 
S. typhimurium contained in pKKlOOlB has been published (Zeig 
and Simon, 1980) and is shown in Figure 3. In the given 
sequence the bin gene begins at position 99 and ends at
position 671, the hix R sequence runs from position 12 to
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position 37, and the hix L sequence from position 1005 to 
position 1030.
This sequence was analysed using a computer program 
(DNAStar) which identifies restriction enzyme cleavage sites 
within DNA sequences.
The S, typhimurium hin sequence contains the following 
restriction sites:- i) Asp 700 @ position 775.
ii> Bgl I @ position 474.
iii) Cla I © position 144.
iv) Nar I @ position 514.
v) Sac I © position 352.
vi) Sati 3A © position 527. 
vii) Spe I © position 168.
viii) Stu I © position 822.
ix) Taq I © positions 145, 460, 963.
No cleavage sites were found within this sequence for 54 
other commonly-used restriction enzymes.
The 671 bp fragment bounded by the Cla I site at position 
144 and the Stu I site at position 822 contains the largest
possible amount of the hin gene coupled with the minimum of
redundant DNA. This 671bp sequence contains 527bp of the hin 
gene, including the dorsal domain of the recombinational 
enhancer sequence, and 144bp of non-coding DNA. The probe did 
not contain either of the hix sites, the H2 gene promoter or 
any of the H2 gene.
pKKlOOlB was digested with Cla I and Stu I together in a
single step using the buffer REact^l (See Appendix 3 for
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details of reaction buffers). The recommended restriction 
buffers for the two enzymes are different and thus the 
activities of each of the enzymes was investigated in different 
reaction buffers. Digests of E. coli chromosomal DNA were 
prepared with Stu I using the recommended buffer REact”2, the 
alternative buffer REact”! and M buffer (Appendix 3). Digests 
of E. coli DNA were also set up with Cla I using the 
recommended REact™!, REact™2 and M buffer. These digests were 
then incubated at 37*C for four hours, 20pl removed and frozen 
at -20'C. The remaining 20pl of each digest was then incubated 
overnight at 37*C. The products of these digests were run on a 
0. 7% agarose gel and compared. Both enzymes digested E. coli 
DNA in their recommended buffers, Stu 1 also digested the DNA 
fully in REact”!. The digests using M buffer and the Cla I 
digests using REact2 were unsatisfactory. A double digest of E. 
coll DNA with Stu I and Cla I was set up and incubated at 37*C 
overnight. A similar 40pl digest was prepared using Cla I and 
REact™! and digested at 37*C for eight hours. The digest was 
then heated at 65'C for 10 minutes, phenol/chloroform 
extracted, and the DNA alcohol— precipitated. After freeze 
drying the DNA was resuspended in REact™2 and digested with Stu 
I overnight. This sample and the Cla 1/Stu I double digest were 
then compared. There was no difference between the digestion 
pattern of either sample, although the yield of the DNA which 
had been precipitated prior to Stu I digestion was 
significantly lower.
Due to the small size of the required band, 671bp, 
approximately 2-2.5pg of pKKlOOlB was digested overnight with
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Cla I and Stu I using REact™ 1. The product of this digestion 
was run in a 1. 5% (w/v) low melting temperature ultra-pure
agarose gel using 0X174 Hae III fragments as size markers, see 
Figure 16. After staining with ethidium bromide the gel was 
inspected and the required fragment excised to be used as a 
probe,
3.4.3. Hybridisations using the bin-specific probe.
The bin-specific probe was radioactively labelled using the 
hexanucleotide primer method (section 2.6.11) and hybridised 
under high stringency conditions to chromosomal digests of B. 
pertussis chromosomal DNA and Sau 3A — digested pKKlOOlB. 
Hybridisation occurred between the probe and the digested 
pKKlOOlB but not between the probe and B. pertussis DNA. The 
experiment was repeated using the low stringency conditions 
described above (20% v/v formamide, 6 X SSC, etc. ). 
Hybridisation was then achieved between the probe and the two 
high molecular weight Eco RI fragments described above in DNA 
isolated from Taberman strains. Again the probe hybridised 
with greater intensity to the Taberman DNA samples than to the 
Tohama samples. The probe also hybridised to the plasmid 
RP4: : Mu under these conditions, indicating that these 
conditions allowed hybridisation between the bin-containing 
probe and the gin gene of phage Mu. As with the earlier 
experiment the background observed on filters hybridised under 
these conditions was very high and interfered with 
interpretation of the data.
The probe was then hybridised under the same conditions to 
B. pertussis chromosomal DNA, which had been digested
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FIGURE 16, PRODUCTION OF THE /li/î-SPECIFIC PROBE.
The figure shows pKKlOOlB DNA which has been double-digested with Cla I 
and Stu I and then run in a 1.5% low melting temperature agarose gel.
Key to Figure: -
m = 0X174 Hae III fragments (see Appendix 5 for size of the 
markers).
A = Cla I and Stu I double digest of pKKlOOlB.
The small arrows indicate the position of the Ain-specific 57lbp 
fragment, which was cut from the gel and used as a probe.
The large arrow indicates direction of migration.
A m A
separately with Cla I (.Bsc I) and Stu I. Representative results 
of these experiments are shown in Figure 17.
The probe hybridised to a 0.6kb Cla I (Bsc I) fragment and 
to 3. Okb and 3. 2kb Stu I fragments of B. pertussis DNA. Once 
again the probe hybridised more strongly to Taberman DNA than 
to Tohama DNA.
Under these conditions the probe did not hybridise with 
B. parapertussis DNA.
The probe hybridised to chromosomal DNA isolated from 
B, bronchiseptica and B. avium DNA under these conditions. The 
probe hybridised to a 0,9kb Cla I (Bsc I) fragment and a 0.5kb 
Stu I fragment in B. bronchiseptica DNA. The intensity of 
hybridisation to B, bronchiseptica DNA was lower than that 
observed with B. pertussis Tohama DNA.
B, avium DNA proved refractory to digestion with Cla I 
(Bsc I), but the probe hybridised to the undigested chromosomal 
DNA transferred onto the filter. The probe hybridised to a 
3.8kb and a 4. Okb Stu I fragment; the degree of hybridisation 
was greater than that observed for B. pertussis DNA.
The high amount of background observed using these 
conditions interfered with interpretation of the data and made 
reproduction of many of the blots pointless.
The hybridisation and washing conditions were then 
systematically altered to find a method which gave reproducible 
hybridisation with a minimum of background. The percentage of 
formamide in the hybridisation solution was varied between 0% 
(v/v) and 60% (v/v), using the washing conditions described
FIGURE 17. PROBING OF B. pertussis DNA WITH THE Ai/3-SPECIFIC 
PROBE UNDER LOW STRINGENCY CONDITIONS,
The figure shows B. pertussls chromosomal DNA which has been digested 
separately with Cla I and Stu I, run in a 0. 8% agarose gel and Southern-
blotted as described (section 2.6.9). The blotted DNA was then hybridised
with the 671bp Ain-specific probe under low stringency conditions. The 
hybridisation buffer contained 20% (v/v) forhamide and 6 X SSC, and the 
filter incubated in this buffer at 42*C overnight. The final wash was 
performed in 2 X SSC, 0. 1% (w/v) SDS at 55*C for Ih, This autoradiograph 
was exposed for 3 days at -70*C.
Key to Figure: -
m = position of X Hin dlll fragments,
1 = Cla I (Bsc I) digested Taberman DNA.
2 = Stu I digested Taberman DNA.
3 - Cla I (Bsc I) digested Tohama DNA.
4 = Stu I digested Tohama DNA.
The small arrows indicate the position of the 0. Bkb Cla I (Bsc I) 
fragment .and 3. Okb and 3. 2kb Stu I fragments which hybridise with the 
probe.
The large arrow indicates the direction of migration.
m 1 2  3 4
above. The alteration of formamide concentration in the 
hybridisation mixture did not reduce the background, but did 
affect hybridisation of the probe. The optimum hybridisation 
signal was obtained using a formamide concentration of 33% 
(v/v) at a constant incubation temperature of 42*C. The 
concentration of SSC in the hybridisation mixture was also 
varied using a constant 33% (v/v) formamide. Optimum
hybridisation was obtained at 6.6 X SSC at 42*C, again the 
background was not greatly reduced. The remainder of the 
hybridisation mixture was left as described previously.
The concentration of SSC in the washing buffer, the 
temperature of the washes and their duration were also 
systematically altered. The optimum conditions for washing were 
f ound t o be.* -
i) twice in 5 X SSC, 0. 1% SDS at 50*C for 30 mins, 
11) once in 1 X SSC, 0. 1% SDS at 50‘C for 120mins.
After washing, the film was exposed to the bound to the 
filters at -70*C for varying lengths of time until optimum 
exposure was reached. The autoradiograph shown in Figure 18 was 
exposed for 14 days before developing. In this blot the probe 
is shown to have hybridised cleanly to a 0, 6kb Cla I (Bsc I) 
fragment and to 3.5kb and 3,8kb Stu I fragments. The 
autoradiograph has been extensively cropped due to the large 
signal from the X markers and the positive control lane. As in 
the previous experiments the probe hybridised more strongly to 
Taberman DNA than to Tohama DNA. These conditions also gave 
clear hybridisation to 3.8kb and 4. Okb Stu I fragments in 
B. avium DNA (Figure 19).
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FIGURE 18. PROBING OF B. pertussis DNA WITH THE Ain-SPECIFIC 
PROBE UNDER OPTIMUM STRINGENCY CONDITIONS.
The figure shows B, pertussis chromosomal DNA which has been digested 
separately with Cla I (Bsc I) and Stu I, run in a 1% agarose gel and 
Southern-blotted as described (section 2.6.9). The blotted DNA was then 
hybridised with the 671bp Ain-specific probe under the optimum stringency 
conditions, The hybridisation buffer contained 33% (v/v) formamide and 6.6 
X SSC, and the filter was incubated in this buffer at 42*C overnight. The 
washing protocol used for this blot involved two washes in 5 X SSC, 0. 1% 
(w/v) SDS at 50"C for 30min, followed by a final wash in 1 X SSC, 0. 1%
(w/v) SDS at 50*C for 2h. This autoradiograph was exposed at -70°C for 14 
days.
Key to Figure: -
1 = Ci a I (.Bsc I) digested Taberman DNA.
2 = Stu I digested Taberman DNA.
3 = Cla I (Bsc I) digested Tohama DMA,
4 = Stu I digested Tohama DNA.
The small arrows indicate the position of the 0. 6kb Cla I (Bsc I) 
fragment and 3.Okb and 3.2kb Stu I fragments which hybridise with the probe 
under these conditions.
The large arrow indicates the direction of migration.
1 2 3 4
«
Throughout these experiments one of the major factors 
governing the signal to noise ratio of the exposed 
autoradiographs was the age of the ^^P-a-dATP used In the 
labelling reaction. Using fresh Isotope, less than 7 days old, 
the exposure time was restricted to approximately 14 days and 
the background was minimal. However, as the age of the Isotope 
increased the exposure time was Increased and, consequently, 
the background increased dramatically, Labelling of probes with 
blotln Is a simple procedure and the activity of the label does 
not decrease drastically with age. Labelling of probes with 
blotln does not alter the hybridisation kinetics of the 
labelled probe but does slightly decrease the melting 
temperature of the probe-target hybrid.
Control experiments using the hybridisation of blotln- 
labelled pBR322 to EcoRl digested pBR322 and blotln-labelled X 
to Bantil digested X DNA showed that the standard techniques and 
manipulations used In this study gave positive hybridisation 
results.
The 671bp Ain-speclfIc probe was labelled with Blotln-7- 
dATP (ERL) using the hexanucleotlde primer technique and 
hybridised to B. pertussis DNA using the conditions detailed 
above. These experiments gave no hybridisation signals using 
reduced stringency conditions. When the conditions were altered 
to allow for the reduced T„ of the hybrid, by decreasing the 
formamide concentration to 25%(v/v) with a final wash 
temperature of 45'C, hybridisation was still not observed.
The B. pertussis Taberman gene library constructed by 
Brownlie et aJ, <1986) was grown as described (section 2.6,15)
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FIGURE 19. PROBING OF B. avium DNA WITH THE Ain-SPECIFIC 
PROBE UNDER OPTIMUM STRINGENCY CONDITIONS.
The figure shows B, avium DNA (prepared using the same method as 
B. pertussis DNA, section 2.6. 1) digested with Stu I, run in a 0.8% agarose 
gel and Southern-blotted as described (section 2.6.9). The filter was then 
incubated with the 671bp Ain-specific probe under the optimum stringency 
conditions. The hybridisation buffer contained 33% (v/v) formamide and 6.6 
X SSC, and the filter was incubated in this buffer at 42°C overnight. The
washing protocol for this filter consisted of two washes in 5 X SSC, 0. 1
(w/v) SDS at 50"C for 30min, followed by a final wash in 1 X SSC, 0. 1%
(w/v) SDS at 50°C for 2h. This autoradiograph was exposed at -70*C for 3 
days.
Key to Figure: -
1 - B. avium 4041 DNA.
2 ~ B. avium 4049 DNA.
The small arrows indicate the position of the 4. Okb and 3.8kb Stu I 
fragments which hybridise with the probe under these conditions.
The large arrow indicates the direction of migration.
4 0
3 S
on circular nylon membranes (Pall Biodyne). After growth the 
cells were denatured and the chromosomal DNA bound to the 
membrane. The filters were then placed into hybridisation bags 
and hybridised using the ®^ P-oc-dATP labelled 671bp Ain-specific 
probe. From the 520 clones in the gene library one gave a 
strong positive signal (Figure 20). This clone was isolated 
from the library, designated pDI116 and characterized (section 
3. 5).
Hybridisation under the conditions described previously was 
found to be membrane-specific. These conditions were originally 
created for use with DNA immobilised onto Zeta-Probe (Bio-Rad) 
nylon membranes, and were also succesful using Gene Screen Plus 
(DuPont) nylon membranes. However, no hybridisation was 
observed using these conditions when the DNA was immobilised 
onto Hybond-N (Amersham) nylon membranes. From visual 
inspection of DNA transfer and the strength of radio-labelled 
markers transferred along with the chromosomal DNA it appeared 
that Hybond-N membranes bound the DNA as effectively as the 
other membranes.
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FIGURE 20. PROBING OF B. pertussis TABERMAN GENE LIBRARY 
WITH THE 671bp Ai/3-SPECIFIC PROBE.
The Figure shows representatives of the B, pertussis strain 
Taberman gene library which have been hybridised with the 671bp Ain-
specific probe as described (section 2.6. 15). Hybridisation was performed
under the optimum stringency conditions. The hybridisation buffer contains 
33% (v/v) formamide and 6.6 X SSC and the filters were incubated at 42*C 
overnight in this buffer. The washing protocol for these filters involved 
two washes in 5 X SSC, 0. 1% (w/v) SDS at 50*C for 30rain, followed by a
final wash in 1 X SSC, 0. 1% (w/v) SDS at 50'C for 2h. These
aoutoradiographs were exposed at -70*C for 10 days.
The cosmid clone which hybridised with the probe under these conditions 
is shokTi by an arrow, this cosmid was designated pDI116. The other 
colonies are representative negatives from the entire gene library.

3. 5. CHARACTERISATION OF pDI116.
3.5.1. Genetic characterisation of pDI116.
pDI116 contains an Insert of 22kb. This insert of 
chromosomal DNA was analysed using EcdRl, Cla I (Bsc I) and 
Xho I. These enzymes were chosen for ease of cloning any 
relevant fragments identified into the broad host range 
plasmids pKT230, pKT231 (Bagdasarian et al., 1981) and pMMB34 
(Frey et al. , 1983).
From the information a restriction fragment map of the 
insert was generated, this map is presented in Figure 21. The 
0. 6kb Cla I (Bsc I) fragment which hybridises to the Ain- 
specific probe is found within a 15kb fragment. This
agrees with the observations made from the chromosomal DNA 
experiments. Several candidate fragments for sub-cloning are 
apparent; these include the 9kb EccRl/Kho I fragment which 
contains the 0. 6kb Cla I fragment.
3.5.2. Hybridisation with the flm 2 gene probe.
The 0. 85kb Sph I fragment of pIL22 containing both the 
fim 2 gene and a part of IS481v2 was radio-labelled and 
hybridised to Sal I digested pDIllG. The probe hybridised to 
only a single l.Okb Sal I fragment, see Figure 12.
This fragment is different from those indicative of the fim 
genes and the repeat sequences associated with them (section 
3. 3. 2.2). This suggests that pDIli6 is not linked to the fim 
genes, but is linked with a repeat sequence similar to IS48v2.
- 99 -
FIGURE 21, RESTRICTION FRAGMENT MAP OF pDI116.
This map was generated from double-digest data using the Branch and 
Bound technique of Fitch et al, (1963).
Key to Figure: -
E = EcoRI sites.
B = Cla I (Bsc I) sites.
X = Xho I sites.
w
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3.5.3. Assays for the production of Invertase by pDI116.
3.5.3.1. Preliminary test of invertase production using 
pSH1313.
The indicator plasmid pSH1313 (section 2.2.2.4) was 
transformed into the cin* E. coll strain K12 and cln~ E. coll 
strain WA3782. Four 10ml cultures of each strain were grown 
overnight in nutrient broth containing ampicillln, to maintain 
pSH1313 within the cells, on an orbital shaker at 37*C. After 
incubation triplicate serial dilutions were made from each 
culture. Duplicate lOOpl aliquots of the undiluted culture, the 
10"' dilution and the 10"= dilution were spread onto nutrient 
agar plates containing kanamycin (final concentration 50pg/ml) 
and incubated overnight (16h). Duplicate lOOpl aliquots of the 
10"® and 10“® dilutions were also plated onto nutrient agar 
plates containing chloramphenicol (final concentration 50pg/ml) 
and Incubated overnight (IShrs). After incubation the numbers 
of colonies on each plate were counted. The ratio of kanamycin 
resistant colonies to chloramphenicol colonies was used as the 
relative frequency of inversion, a method used previously by 
Kahmann et al. (1985) and Hübner and Arber (1989). The results 
of this preliminary experiment are given in Table 9. This 
experiment proved that pSH1313 was functioning correctly in 
cln* and cln~ strains and that the plasmids which had inverted 
could be detected. The experiment also served to confirm that 
E. coll strain WA3782 was cln~ and would be able to serve as a 
neutral environment for conducting experiments on pDI116. The 
large difference between the relative inversion frequency in
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TABLE 9; RESULTS OF THE PRELIMINARY EXPERIMENT
USING p5H1313.
STRAIN RELATIVE FREQUENCY 
OF INVERSION EVENTS.
K12CSH1313]
WA3782CSH1313]
7.80 X 10-® 
2.06 X 10-®
the positive and negative background negated the need to score 
for the reverse process.
3.5.3.2. First experiment using pSH1313 in conjunction with 
other plasmids.
pSH1313 was transformed into E. coli strains K12 and WA37Ô2 
as above. After colony purification strain WA37Ô2CpSH1313] was 
separately supertransformed with i) pDIllB, ii)pLAFRl and ill) 
pDA126, which is non-homologous with the Ain-specific probe and 
encodes AGO 3.
The strains carrying pSHJ.313 were grown in nutrient broth 
plus ampicillln, whilst the supertransformed strains were grown 
in nutrient broth plus ampicillln and tetracycline. Five 10ml 
cultures of each strain were grown overnight <16h) at 37*C in 
randomised positions on an orbital shaker. After growth 
duplicate serial dilutions were made from each of the five 
cultures and duplicate lOOpl aliquots of these dilutions plated 
out onto nutrient agar plates containing either kanamycin or 
chloramphenicol as described above. All the nutrient agar 
plates used for growth of the supertransformed strains also 
contained tetracycline. After overnight growth, the numbers of 
colonies on the plates were counted and the relative frequency 
of the inversion events calculated as described above. The 
standard deviation of these frequencies was also calculated. 
The result of this experiment is shown in Table 10. These 
relative frequencies were recalculated as percentages of 
relative inversion, the mean of the positive control serving as 
100%, and the results are given in Table 11.
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TABLE 10; RESULTS OF THE FIRST EXPERIMENT
USING p5H1313.
STRAIN RELATIVE FREQUENCY 
OF INVERSION EVENTS, 
(mean + SD)
K12CSH1313] 
WA3782CSH1313] 
WA3782CSH1313, pDI1163 
WA3782CSH1313,pLAFRl] 
WA3782ESH1313, pDI1263
5. 90 X 10-® + 2.2 X 10-®, n = 5.
3 .6 1  X 1 0 -^  + 1 .0  X 1 0 -^ , n = 5.
3. 66 X 1 0 -^  + 2. 17 X 1 0 -^ , n = 5. 
1. 56 X 1 0 -’' + 6. 6 X 10-®, n  = 5.
1 .9 0  X 1 0 -’' + 8.4 X 10-®, n = 5.
TABLE 11: RESULTS OF THE FIRST EXPERIMENT USING
pSH1313 CONVERTED TO RELATIVE PERCENTAGES.
STRAIN RELATIVE PERCENTAGE 
OF INVERSION EVENTS, 
(mean + SD)
K12CSH1313] 
WA37Ô2ESH1313] 
WA37Ô21SH1313, pDI116] 
WA3782CSH1313,pLAFRl] 
WA3782CSH1313, pDI1263
100% ± 37%. 
0. 6% + 0. 1%. 
0.6% + 0. 3%. 
0. 3% + 0. 1%. 
0. 3% + 0, 1%.
3.5.3.3, Second experiment using pSH1313 in conjunction with 
other plasmids.
For this experiment fresh strains were constructed by 
transformation from plasmid stocks stored at -20*C. E. coli 
strains K12 and WA3782 were again transformed with pSH1313. 
After colony purification, strain WA37Ô2CpSH13133 was 
supertransformed with pDIllG. The manipulations of the previous 
experiment were repeated, although in this case 10 cultures of 
WA37821pSH1313, pDI1163 were used. Once more the relative
frequencies of the inversion events were calculated and the 
standard deviation of the results determined, these results are 
given in Table 12. These relative frequencies were recalculated 
as percentages of relative inversion as above, and these 
results are given in Table 13. The results of the experiments 
involving pSH1313 suggest that pDIllB does not encode a 
functional invertase in E. coll, this may be due to a 
requirement for the BvgA positive effector for promoter 
function. Also, the presence of both pSH1313 and one of the 
large cosmid clones in strain WA3782 affected the growth 
pattern of the strains. This excess genetic load may have been 
exerting selection pressure against the plasmids, which in turn 
may have led to unexpected recombination events, such as 
deletions. Attempts were thus made to transfer pSH1313 Into B. 
pertussis strain Taberman in order to assay any invertase 
protein produced in vivo.
The first method tried involved electroporation of B. 
pertussis cells with 50ng of pSH1313 using a number of 
different field strengths, no transformants were obtained. A
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TABLE 12: RESULTS OF THE SECOND EXPERIMENT
USING pSH1313.
STRAIN RELATIVE FREQUENCY 
OF INVERSION EVENTS, 
(mean + SD)
K12ESH1313] 9.70 X 10“® ±2.0 X 10“®, n = 5.
WA3782ESH1313] 2.62 X 10“® ±4.8 X 10” ,^ n = 5.
WA3782ESH1313, pDIliei 6,90 X 10“’' ± 1.3 X 10“ ,^ n = 10.
TABLE 13: RESULTS OF THE SECOND EXPERIMENT USING
pSH1313 CONVERTED TO RELATIVE PERCENTAGES.
STRAIN RELATIVE PERCENTAGE 
OF INVERSION EVENTS, 
(mean + SD)
K12CSH13133 100% + 2.0%.
WA3782ESH1313] 3% ±0.4%.
WA37821SH1313,pDI116] 0.7% ± 0. 1%.
study by Zealey et al. (1988) confirmed that extremely high 
field strengths <25kV/cm) were required for succesful 
electroporation, and that the Bio-Rad Gene Puiser, which was 
used in this study, was unsuitable for electroporation of 
B. pert ussis.
Plasmid pSH1313 does not possess the transfer genes 
necessary for activation by pRK2013 and cannot be conjugated 
into B. pertussis as described (section 2.4. 1). The plasmid 
pGJ28 which can supply these transfer functions in trans (D. 
Sherratfe^  personal communication), was supertransformed into 
E. coll strain WA3782C pSH1313]', and used as the donor strain in 
a plate conjugation with B, pertussis strain Taberman. No 
ampicillin resistant transconjugants were obtained by this 
procedure. This failure is probably due to the combination of 
the low frequency of conjugation of B. pertussis and the low 
frequency with which pGJ28 trans activates pSH1313.
3.5. 3. 4. First experiment using E. coll strain RZ211.
When grown on MacConkey agar or nutrient agar containing 
X-gal (final concentration 40pg/ml), E, coll RZ211 grew as pale 
colonies which were indicative of a lac" phenotype.
pDAlie and pLAFRl were separately transformed into strain 
RZ211 and grown on nutrient agar plates plus tetracycline. Five 
10ml nutrient broth cultures of each transformed strain plus 
strain RZ211 were grown overnight (16h) in randomised positions 
on an orbital shaker at 37*0. After incubation serial dilutions 
of the cultures were made. Duplicate lOOpl aliquots of the 10" 
e, iQ-s and 10"^ dilutions were spread onto MacConkey agar 
plates and further duplicate lOOp.1 aliquots spread onto
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nutrient agar plates containing X-gal (40pg/ml), The plates 
were then incubated overnight at 37“C and the colonies examined 
for jac^ phenotypes. No blue coloured colonies, indicating a 
switch to the lac'*' phenotype, were found . This experiment was 
repeated four times with the same result. The experiment was 
also performed with overnight incubation temperatures of 30°C, 
but this did not affect the result of the experiment.
3.5.3.5. Second experiment using E. coll strain RZ211.
E, coll strain RZ211 is able to grow on minimal agar 
supplemented with proline (final concentration 20pg/ml) and
0. 2% (w/v) glucose. The strain did not grow on minimal agar
supplemented with proline (20pg/ml) and 0. 2% (w/v) lactose. The 
two transformed strains described above, and strain RZ211, were 
grown, in duplicate, in 100ml volumes of minimal medium 
supplemented with prollne (20pg/ml)and 0.2% (w/v) glucose for 
24h at 37*C. The cultures were then harvested by centrifugation 
(10, OOOg for 10 min at 4*0 and resuspended in 10ml of sterile 
saline. In each case, 5ml of the saline suspension was used to 
inoculate a further 100ml of minimal medium supplemented with 
proline (20pg/ml) and 0.2% (w/v) glucose, whilst the remaining 
5ml was used to Inoculate 100ml of minimal medium supplemented 
with proline (20pg/ml), 0.01% (w/v) glucose and 0.2% (w/v)
lactose. These cultures were then incubated for 24h at 37*C. 
After Incubation all cultures in minimal broth supplemented 
with prollne (20pg/ml)and 0.2% (w/v)glucose had grown well 
whereas those cultures grown in minimal broth supplemented with 
proline (20pg/ml), 0.01% (w/v) glucose and 0.2% (w/v) lactose
had grown only slightly. Serial dilutions of all cultures were
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made and, as before, plated onto MacConkey agar and nutrient 
agar containing X-gal (4-Opg/ml). All colonies were pale 
indicating a lac~ phenotypes. As with the pSH1313 experiments 
the results of the RZ211 experiments suggest that pDI116 does 
not encode a functional invertase in E. coll.
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3. 6. CONSTRUCTION AND USE OF OLIGONUCLEOTIDE PROBES 
FOR THE CONSENSUS INVERTASE RECOMBINATION SITES.
Oligonucleotide probes were constructed which were 
homologous to the consensus dix sites previously published. The 
sequences of these dix sites is given in Figure 7, as is the 
homologous sequence discovered in the genome of M. bovls. The 
M. bovis sequence had not been described when these 
oligonucleotide probes were synthesized.
All of the oligonucleotide probes synthesised were based 
around the consensus sequence of the hln-like recombination 
sites, which is: -A-GTTT— GA-AA. The ambiguous residues were
decided using the table of recombination sites given in 
Figure 7, taking into account the preferred codon usage of 
B. pertussis (Glaser et al, , 1986), In most cases this meant
using a G if it was known to occur in that position in any of 
the other related sequences.
The first probe synthesised had the following sequence:- 
G'TTT GGA AGG TTT TTG ATA A®'
The sequence is based on that of hlxR; the recombination 
site that is thought to be least related to the other members 
of the family. This oligonucleotide was a single sequence probe 
and was synthesised at a concentration of 232pg/ml.
An alternative mixed sequence probe was also constructed 
using different residues around the consensus sequence.
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This probe had the sequence: ~
="AAA CCA AGG TTT ATG AAA AAG^ *
G C T T T
This sequence is based on blxR and the other recombination 
sites. The main sequence is that of and the other residues
were added if they occurred in that position in any of the
known Ain-like systems. This probe was synthesised at a 
concentration of 237pg/ml and consisted of 32 different
sequences.
Cla I (Bsc I) — digested B. pertussis DNA was immobilised 
onto Zeta-Probe (Bio-Rad) nylon membranes. These membranes were 
then placed into sealed bags containing the standard 
oligonucleotide pre-hybridisation buffer (section A. 2. 18) and 
manipulated as described (section 2. 6. 14). The optimum
concentration for an oligonucleotide probe in a hybridisation 
experiment ranges from 1 to 5ng/ml of each sequence (Zeff and 
Geliebter, 1967). The hybridisation experiments were all 
carried out in a constant 20ml volume of hybridisation buffer. 
A 2pl aliquot of the first oligonucleotide was diluted ten-fold 
and Ipl of this dilution dried down with the y-szp-dATP and
labelled. After dilution in hybridisation buffer this gave a 
final probe concentration of 1. 2ng/ml. For the second 
oligonucleotide 3pl of the undiluted solution was dried down 
and labelled with the y-szp-dATP. This procedure gave a final 
concentration for each sequence in the mixed-sequence probe of
1. Ing/ml. Each of the two probes was then incubated with the 
filters in separate experiments at 50'C, 37*C, 25'C and 15*C.
Each of the filters was then washed in SSC/PP at a final wash
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temperature 15*C below the Incubation temperature. In no 
experiment was hybridisation observed between either of the 
probes and B. pertussis DNA.
A new probe was then synthesized with the following 
sequence:-
®‘ACG TTT AGG AAA AAG s' 
G TT T T
The sequence of this probe is more closely based around the 
consensus sequence than the previous two probes. The sequence 
is most closely based on glxR and plxR, the other residues 
added in accordance with their presence in the known sequences. 
This probe was synthesised at a concentration of 210pg/ml, and 
consisted of 32 different sequences.
A 4)il aliquot of this solution was dried down and labelled 
with the y-32p-dATP. This gave a final concentration of each of 
the sequences in the probe of 1. 3ng/ml. The hybridisation 
temperatures used for this probe were 5 0 37*C and 30*C, This 
final Incubation temperature coupled with a final wash in 
SSC/PP at 37*0 for 10 minutes permitted hybridisation between 
the probe and chromosomal DNA of B, pertussis^ see Figure 22.
The probe hybridised to 14. 5kb and 12. 5kb Cla I (.Bsc I) 
fragments in the DNA from strain Taberman DNA and 18.6kb and 
16.5 kb Cla I (Bsc I) fragments of DNA from strain Tohama.
EcdRI digests of chromosomal DNA from a number of avirulent 
B. pertussis strains carrying transposon Insertions within the 
bvg locus blotted onto a Hybond-N (Amersham) nylon membrane
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FIGURE 22. HYBRIDISATION OF OLIGONUCLEOTIDE PROBE 
TO B. pertussis DNA,
The figure shows B. pertussis chromosomal DNA digested with Cla I (Bsc
I) and unlabelled X DNA digested with Hindlll which has been run in a 0.8%
agarose gel and Southern-blotted as described (section 2.6.9). The filter 
was incubated in the standard oligonucleotide pre-hybridisation buffer 
(Appendix 2, A. 2. 18) for Gh at 37"C.The oligonucleotide probe was then 
hybridised to this filter in the standard oligonucleotide hybridisation 
buffer (Appendix 2, A. 2. 19) overnight at 30*0. After incubation the filter 
was washed in SSC/PP several times at room temperature and once at 37*0 for 
15min. This autoradiograph was exposed for 14 days at -70*0.
Key to Figure: -
m = position of X HindiII markers,
1 = X HindiII fragments, unlabelled.
2 = CJa I (Bsc I) digested Tohama DNA.
3 = Cla I (Bsc I) digested Taberman DNA.
The small arrows indicate the position of the 18. 6kb and 16. 5kb Cla I 
(Bsc I) fragments in Tohama DNA, and the 14.5kb and 12. 5kb Cla I (Bsc I) 
fragments in Taberman DNA the probe hybridises to under these conditions.
The large arrow indicates the direction of migration.
m 1 2 3
were probed with Tn5. This hybridisation highlighted the 
component EcoRT bands of the bvg locus in each strain which 
carried a Tn5 insertion responsible for the loss of virulence 
CM. J, Ward, personal communication). The Tn5 probe was stripped 
from this filter by incubation in 0, 4N NaOH at 42*C for 30 
mine, followed by a further 30 min incubation in 0.1 X SSC, 
0. l%(w/v)SDS, 0. 2M Tris-HCl, pH7. 5, at 42’C with constant 
vigorous agitation. After stripping, the filter was exposed 
overnight at -70*C to check it was clean. The filter was then 
hybridised with the third oligonucleotide probe at 30'C with a 
final wash at 37‘C, After exposure for 40 days at -70"C the 
probe was found to have hybridised to the same 15kb HcoRI 
fragment in all the strains. This fragment was not one of those 
highlighted by the Tn5 probe. However, after stripping and re­
probing, the already weak signal from the oligonucleotide probe 
was virtully swamped by the background signal and reproduction 
of the filter was pointless.
This result suggests that sequences homologous to the Ain- 
like recombination sites exist within the chromosome of 
B. pertussis but are unlikely to be associated with the bvg 
locus.
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4. DISCUSSION.
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4. 1. PHASE VARIANTS AND DNA MODIFICATION.
The erythromycin-resistant non-haemolytic colonies isolated 
during the selection process appeared to fulfil the criteria 
demanded of avirulent strains by Weiss and Falkow (1984). 
During this study no colonies were observed which had reverted 
to virulent phase, despite the continues subculturing of the 
avirulent strains. All B. pertussis strains used in this study 
were grown on BG agar supplemented with 10% (v/v) defibrinated 
horse blood. The only revertants reported in the literature 
occurred within variant strains grown on BG agar supplemented 
with 15% (v/v) sheep blood (Weiss and Falkow, 1984; Stibitz et 
al., 1988). It is possible that some component of defibrinated 
sheep blood stimulates reversion, or, conversely, that some 
component of defibrinated horse blood may supress reversion.
The enrichment/selection procedure using increased 
resistance to erythromycin as a marker was more effective and 
less time consuming than the differential method which involved 
plating virulent B. pertussis onto cyclodextrin solid medium 
plates containing congo red (0, 002%(w/v)) and isolating 
spontaneous phase variants which did not take up the dye.
The mutation responsible for phase variation in several 
strains of B. pertussls has been located and occurs within the 
bvg locus responsible for the production of a positive effector 
which stimulates the expression of genes encoding several 
virulence-associated factors. The cosmid pRMB2 contains a copy 
of the unmutated bvg locus and is able to complement strains 
carrying mutations in the bvg locus (Brownlie et al., 1988;
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McGllllvray et al., 1989). The recombinant plasmid pRMB2 is 
composed of 26kb of B. pertussis DNA cloned into the cosmid 
vector pLAFRI and is present in low copy number in B. pertussis 
CR. M. Brownlie, personal communication). Introducing pRMB2 into 
the avirulent strains not only complemented the expression of 
the virulence-associated factors tested but increased the 
expression of these factors to a level above that of the 
virulent parent strains. It is possible that these strains may 
be useful in the production of components for a defined 
acellular vaccine, or could be used as vaccine strains 
themselves. It is thought that one of the major factors 
responsible for the adverse reactions to pertussis vaccines is 
the presence of lipooligosaccharide endotoxin in the final 
preparation. If these strains containing multiple copies of the 
bvg locus overproduce immunogenic proteins but retain otherwise 
normal biosynthetic metabolism, the number of bacteria needed 
to achieve a potent vaccine may be reduced, with a posssible 
concomitant reduction in reactogenicity. The reason for the 
reduced growth of these strains carrying pRMB2 may be explained 
not only by the extra genetic load but by observations made by 
Lee et al. (1989). Lee et al. placed multiple copies of the PT 
operon into strains of B. pertussis and found that strong 
selective pressure was exerted to reduce the amount of PT 
produced by each bacterium. They suggested that the excess PT 
was disrupting the internal biochemistry of the bacterium. If 
the PT genes in a strain carrying multiple copies of the bvg 
locus were mutagenised in a directed manner, as the results of 
Burnette et al. (1989) suggest may be possible, to give a non­
functional immunogenic protein, the unwanted effect on the
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growth of the bacteria may be removed and normal growth 
patterns recovered.
Evidence has beeen presented which suggests a 'hierachy" in 
the process of phase variation (Goldman et al,, 1984). In 
contrast to the one-stage virulent to avirulent switch 
suggested by Weiss and Falkow (1984) it has been proposed that 
phase variation may occur in an ordered manner, with the 
sequential loss of virulence factors in a given order. Goldman 
et al. (1984) isolated four distinct groups of B. pertussis 
variants:- i) Group A, equivalent to fully virulent strains, 
ii) Group B, haemolysin", but producing PT and FHA, iii) Group 
C, haemolysin", PT~, producing only FHA, and iv) Group D,
equivalent to fully avirulent strains. These patterns of 
expression appeared to be stably inherited.
All the avirulent strains tested in this study had lost 
expression of haemolysin, dermonecrotizing toxin and FHA, and 
consequently did not belong to any of the intermediate stages 
described by Goldman et al, (1984). No other group has reported 
this 'hierachy' of loss of virulence factors and the data
generated by this study suports the 'one-step' model of phase 
variation, at least for those avirulent strains selected via 
increased resistance to erythromycin. The low basal expression 
levels of several virulence factors observed in some avirulent 
strains may simply reflect the strength of the promoters
without the benefit of the positive effector BvgA. The 
apparently inheritable pattern of expression described by 
Goldman et al, (1984) may be the result of mutations in the 
promoter regions of various virulence factors which restore
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function These hypothetical back mutations may be
preferentially selected by the media used in those particular 
experiments.
Goldman et al. (1987) also studied the chromosomal DNA of a 
stable strain from each of the four groups they had defined. 
They found that DNA from virulent, Group A, strains was 
refractory to digestion by the restriction endonucleases EccRl,
Sac I, Pst I, Kpn I and Msp I. The DNA from avirulent, Group D,
strains was digested by all of these enzymes. These results are 
contradictory to the results obtained in this and other
studies. Digestion of chromosomal DNA from virulent strains of 
B. pertussis with EccMl is performed routinely and the 
restriction pattern was the same as that of DNA from an 
avirulent strain digested by EcdRI. The DNA prepared from 
virulent strains in this study was also digested by Sac I, 
Pst I and Kpn I.
The enzyme Msp I is not affected by méthylation of the 
recognition site (see Table 3 for details). However, Goldman et 
al. (1987) found that DNA from virulent. Group A, strains was 
not digested by Msp I, whereas avirulent. Group D, DNA was 
digested by the enzyme. However, they did not check the 
digestion patterns of their various DNA samples with //pa II, an 
isoschizomer of Msp I, which is sensitive to méthylation of the 
internal C residue. In this respect the results reported here 
are paradoxical; the enzyme affected by méthylation at the 
cleavage site, //pa II, digests the DNA samples from virulent
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and avirulent strains, whereas the enzyme unaffected by 
méthylation, Msp I, does not digest DNA from either source.
Goldman et al. (1987) were able to detect raised levels of 
6-methyl adenine in virulent strains as compared to avirulent 
strains, but were not able to reproduce evidence of raised 
levels of 5-methyl cytosine in virulent strains. The only 
evidence available from the experiments performed during this 
study suggests that a small amount of méthylation may be 
occuring to adenine residues within the cleavage site of Mbo I, 
Méthylation of guanine residues within the cleavage sequence 
recognised by Hpa II and Msp I may explain the anomalous 
results generated by these enzymes.
The reasons for the discrepancies between the results of 
this study and that of Goldman et al. (1987) is possibly due to 
the method by which the B. pertussis strains were grown prior 
to isolation of chromosomal DNA. The DNA used in this study was 
prepared from B. pertussis grown in the synthetic, chemically 
defined liquid Stainer and Scholte medium whilst the bacteria 
used by Goldman et al. (1987) were grown on BG agar 
supplemented with 15% (v/v) sheep blood. After the harvesting 
of the bacteria, the DNA isolation procedures used were very 
similar. Given the specificity of B. pertussis in vivo growth 
and the evidence that expression of virulence factors is 
governed by the chemical composition of the external 
environment it is possible that the growth conditions are 
responsible for these apparent differences in DNA modification.
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The inability of Hindlll to digest B. pertussis DNA is to 
be expected since the bacterium is known to produce a 
restriction enzyme, Bpe I, with the same sequence specificity 
as HindiII (Greenaway, 1980). Interestingly, B. pertussis DNA 
cloned into E. coll was also found to be refractory to Hindi 11 
digestion, suggesting that B. pertussis may have purged all 
Hindlll/Hpe I sites from its chromosome. This hypothesis could 
easily be tested by checking the various published B. pertussis 
nucleotide sequences for the presence of Hindlll cleavage 
sites.
The 2-dimensional SI heteroduplex mapping technique first 
described by Yee and Inouye (1982) has been used to detect 
differences between two isogenic DNA samples which differ in
only one, or a few, small locations. The technique can pick up 
small differences caused either by genetic rearrangement or
differential méthylation.
The first step in this technique involves digesting the 
chromosomal DNA isolated from the parent and variant strains 
with a restriction enzyme that recognizes a 4bp cleavage site. 
This digestion generates a large number of small DNA fragments. 
One-third of each of these homoduplex mixtures is removed and 
both are mixed in a separate tube. All three DNA samples are 
then boiled to dissociate the DNA strands and allowed to
reanneal slowly. The mixed DNA sample will now contain a 
proportion of heteroduplex DNA fragments, containing a strand 
from each of the two strains. The three samples are then
separated electrophoretically in a 5% polyacrylamide gel. After 
separation, each of the three DNA-containlng lanes of the gel
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are removed and incubated with SI nuclease. This enzyme only 
digests single-stranded DNA and does not affect double-stranded 
DNA. The homoduplex fragments may contain single-stranded DNA 
loops for a number of reasons: snapback of fragments containing 
two, or more, repeated sequences; reannealment of repeat 
sequences on different fragments may leave single stranded 
overhangs at either end. The heteroduplex fragments may contain 
the same single stranded loops as the homoduplex fragments but 
may also contain a region of single-stranded DNA caused by a 
rearrangement in one strand. A deletion in the DNA from one 
strand would result in a loop of single-stranded DNA in the 
other strand only in the heteroduplex fragments. An inversion 
in only one strand would result in several DNA loops depending 
on the location with respect to the restriction fragment.
When run on a second dimension polyacrylamide gel the 
majority of the fragments form a single diagonal streak. The 
fragments which have had single-stranded loops digested by SI 
nuclease migrate faster and form 'blobs' underneath the streak. 
Analysis of these faster migrating fragments from the three 
samples should allow the novel area(s) in the heteroduplex 
sample to be found. This DNA can be cut from the gel, purified 
and used to probe chromosomal digests or the relevant gene 
library to isolate the loci of interest.
In control experiments involving E. coli chromosomal DNA 
model results were obtained, consisting of a long diagonal 
streak of DNA on the second dimensional gel and a collection of. 
various small fragments of DNA migrating beneath the streak. In 
the case of the B. pertussis DNA the area beneath the streak
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was an undefinable mass of fragments. This mass was presumably 
due to the number of different insertion sequences which have 
been reported within the B. pert ussls chromosome.
Probing of the paired variant and parent strains with pRMB2 
did not reveal any differences between the two. When these same 
DNA samples were probed with the flm 2 gene probe containing a 
portion of IS481vl a complex pattern of bands was observed. 
However, scrutiny of this pattern also revealed no differences 
between the paired DNA samples, an observation confirmed by 
McPheat et aJ. <1989).
The data from this investigation into DNA from isogenic 
virulent and avirulent B, pertussis strains strongly suggests 
that no large-scale DNA rearrangements are involved in the 
phase variation of strains selected via increased resistance to 
erythromycin. This does not mean that small-scale DNA 
rearrangements either below the resolving power of Southern 
blotting techniques or involving areas we have not probed do 
not take place. The B. bronchlseptlca chromosome contains a 
locus similar in function and structure to the bvg locus of 
B, pertussis. Monack et al, (1989) have found that the vlr 
locus from some spontaneous B. bronchlseptlca phase variants 
can contain small deletions ranging in size from 50-bp to 
500bp. McGillivray et al. (1989) have also reported a deletion 
around the bvg locus in a B. pertussis phase variant. An 
avirulent Tn5 mutant of B. pertussis has been characterised. 
The Tn5 insertion in this mutant is not within the bvg locus, 
so it is possible that this is a spontaneous avirulent strain. 
Characterization of the bvg locus of this strain has revealed a
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deletion of approximately lOObp in a 2. 7kb Eco RI fragment 
encoding BvgA <M. J. Ward, personal communication). If these 
observations concerning spontaneous phase variants in B.
pertussis are confirmed it may be possible that the selection 
of B, pertussis avirulent variants via increased resistance to 
antibiotics, erythromycin in this case and rifampicin and
streptomycin in the strains investigated by Stibitz et al.
(1989), preferentially selects strains with the frame-shift 
mutation in the bvg locus. A proportion of spontaneous
avirulent mutants may therefore arise by deletions in the bvg 
locus. The deletion of a portion of the bvg locus would be a 
non-reversible genetic event which would be of little adaptive 
value to 5. pertussis as a pathogen.
The results of the investigation involving methylation- 
sensitive pairs of restriction endonucleases would suggest that 
large-scale méthylation of B. pertussis DNA is not involved in 
the Vir* to Vir—  switch. The major point of interest raised by 
this stage of the study was the loss of a band in the Mbo I 
digests of DNA isolated from the Vir~ strains. This implies 
that at least one Mbo I site has been either created or made 
available for digestion during the switching process. This 
phenomenat- could be investigated further by excising the 
relevant band from Mbo I digests of Vir**" DNA and using it to 
probe both Vir“ DNA and the gene library to isolate the 
involved locus for further study. This may reveal a level of 
DNA modification involved in the switching process that is too 
subtle to be picked up using Southern blotting techniques.
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4. 2. THE flm GENES OF B. pertussis STRAIN TABERMAN.
The oligonucleotide used to probe the B. pert ussls Taberman 
gene library for fimbrial subunit genes has previously been 
used to probe a B. pertussis strain Wellcome 28 (fimbrial 
serotype 2,3) gene library (Livey et al., 1987). The sequence 
of the probe was taken from the amino acid sequence of the 
first 14 amino-terminal residues of the fimbrial serotype 2 
subunit (Mr 22 500) from B. pertussis strain Tohama (fimbrial 
serotype 2,0). Livey et al. found that oligonucleotide probes 
constructed for use with B. pertussis DNA had to take account 
of the preferred codon usage of the organism. Simply, this 
requires substitution of a G residue at every ambiguous site, 
since there is a strong bias against codons ending with A or T 
(Glaser et al. , 1988). Experiments by Livey et al. (1987)
revealed that this probe was highly specific for B. pertussis 
DNA and they successfully hybridised this oligonucleotide probe 
to the B. pert ussls Wellcome 28 gene library using the methods 
described earlier (section 3.6). To isolate the flm 2 gene 
hybridisation was performed at 65 *C overnight and several 
washes at room temperature were followed by a Ih wash at 65*C. 
These conditions allowed hybridisation to occur only between 
the probe and cosmids containing the flm 2 gene.
A comparison of the amino-terminal amino acid sequences of 
the serotype 2, serotype 3 fimbrial subunit proteins (Cowell et 
al. , 1987) and the proposed product of the flm X gene (Pedroni
et al. , 1988) reveals extensive homology and this homology is
reflected in the nucleotide sequences of the three genes (Livey 
et aJ. , 1987; Pedroni et al. , 1988; Mooi et al. , 1990), At the
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time of the experiment the nucleotide sequence of only the flm 
2 and the flm X genes were known. Comparison of these sequences 
with that of the oligonucleotide probe demonstrated a 15% mis­
match between the two sequences; extrapolation of the flm 3 
nucleotide sequence from the amino-acid sequence predicted a 
13% mis-match between the gene and the probe. A 1% mis-match 
between a probe and a target sequence results in a I’C 
reduction in the Tm of the hybrid sequence. Thus, the 
hybridisation was carried out at 50‘C overnight, with the final 
wash also being performed at 50*C. These conditions should 
theoretically have permitted "hybridisation between the probe 
and the amino-terminal portions of the three fimbrial subunit 
genes. The B. pertussis strain Taberman (fimbrial serotype 0,3) 
gene library (Brownlie et al. , 1986) was then probed under
these conditions. The nine cosmids which hybridised to the 
probe were analysed to reveal which fimbrial subunit genes they 
contained. The results of the enzyme analysis grouped the nine 
cosmids into three groups each of which contains a different 
putative flm gene.
The group 1 cosmids contained pDA126 and pDA128, which were 
copies of the same cosmid, and pDA395. These cosmids contained 
restriction fragments characteristic of the flm 3 locus. The 
flm 2 probe hybridised to the 0. 9kb Sal I fragment which 
contains the flm 3 gene sequenced by Mooi et al. (1990). These 
two cosmids were thus deemed to contain a copy of the flm 3 
gene from strain Taberman, a strain which expresses AGG 3.
The group 3 cosmids contained restriction fragments 
characteristic of the flm 2 locus. The flm 2 probe hybridised
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to the 1. 7kb Sal I fragment indicative of the fim 2 gene (Mooi 
et al,, 1987). The probe hybridised more strongly to the bands 
from these three cosmids than to the other five. This data 
suggests that the group 3 cosmids contain the silent fim Z gene 
from strain Taberman, a strain which does not express AGG 2.
The group 2 cosmids did not contain any restriction 
fragments characteristic of the flm X locus described by 
Pedroni et al. (1988). The flm 2 probe hybridised to 0. 5kb and 
0. 4kb Sal I fragments and not to the 3. 9kb Sal I fragment 
characteristic of the flm X gene. It is therefore possible that 
strain Taberman contains a third fimbrial gene either different 
or distinctly altered from the one characterised by Pedroni et 
al. (1988).
The hybridisation experiments using the 0.85kb Sph I
fragment of pIL22 (the flm 2 probe) showed each cosmid insert
which contained a fimbrial subunit gene also contained a copy 
of the insertion sequence IS481. It is not yet known whether 
this observation is of significance or whether it results by 
chance simply due to the number of insertion sequences within 
the genome.
The high number of insertion sequences within the
B. pertussis genome also complicates interpretation of data 
involving the hybridisation of the flm 2 probe to digests of B. 
pert ussls chromosomal DNA. In experiments involving the probing 
of the chromosomal DNA isolated from serotype variants no 
evidence was found to suggest that large scale DNA
rearrangements had occurred (this observation is subjected to
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the same limitations as those described earlier for the 
investigation into phase variation). McPheat et al. (1989) have 
also probed serotype variants with a probe containing a copy of 
IS481v2 and found no rearrangements around this loci.
The eight cosmid clones containing putative flm genes were 
then conjugated into B. parapertussis strain 10520. It was 
decided to use the cosmids containing the entire large insert 
rather than smaller sub-clones since the regions controlling 
expression of the fimbrial genes may be some distance from the 
actual subunit genes themselves. The cosraid-containing strains 
were then tested for the expression of various agglutinogens. 
At the time of the experiment the identity of AGG 1 had not 
been published and it seemed reasonable to check for expression 
of AGG 1 from a fimbrial subunit gene. Unfortunately, the 
polyclonal antibody raised against AGG 1 gave weak but 
consistent agglutination with the wild-type B. parapertussis 
strain which did not carry any cosmids. The cosraid-bearing 
strains did not show any difference in the degree of 
agglutination with the polyclonal AGG 1 antibody. A monoclonal 
antibody raised against AGG 1 was then used; this antibody did 
not react with any of the B. parapertussis strains, but did 
react with several B. pertussis strains (unpublished 
observations). These results allowed us to conclude that either 
the absorbed polyclonal antibody is not monospecific or that a 
molecule on the surface of B. parapertussis shares partial 
identity with the B. pertussis AGG 1, but can by differentiated 
using a monoclonal antibody raised against a single epitope. 
If, as current results suggest (Li et al. , 1988), AGG 1 is the
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LOS A endotoxin it is unlikely that AGG 1 will be expressed 
from a gene homologous to a fimbrial subunit gene. However, 
since the production of liposaccharide endotoxins is a feature 
of Gram-negative bacteria it is not surprising that 
B. parapertussis expresses a similar molecule as part of the 
cell surface.
Two of the cosmid-carrying B. parapertussis strains reacted 
positively with agglutinin raised against AGG 3. These strains 
contained the cosmids pDA126 and pDA395. This region of 
chromosomal DNA obviously contains the strain Taberman flm 3 
gene. The strength of the agglutination observed in these tests 
was similar to that observed for B. pertussis strains 
expressing AGG 3 from a chromosomal locus. This result 
demonstrates that the B. parapertussis virulence regulatory 
system is able to recognise and positively regulate genes from 
B. pert ussls. It also further sugggests that the mechanism used 
by B. parapertussis to assemble and express fimbrial subunits 
functions equally well with fimbrial subunits derived from 
B. pertussis flm genes.
Lee ef al. (1989) found that B. parapertussls containing a 
plasmid-borne PT operon could not export active PT outside the 
cell. The chromosomal PT operon is not expressed in B. 
parapertussis due to an accumulation of deleterious mutations 
in the promoter region of the operon, thus the maintenance of a 
PT export mechanism is wasteful and deleterious mutations have 
probably also occured in the genes concerned with PT export.
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The six other cosmid-containing B. parapertussis strains 
did not react with agglutinins raised against either AGG 3 or 
AGG 2. Given the previous results indicating that active 
B, pertussis fimbrial subunit genes are expressed in B. 
parapert ussls it was assumed that these clones contained silent 
copies of the flm 2 and flm X-like genes.
In order to remove the possibility that trans-acting 
factors may control the suppression of the various flm genes, 
the behaviour of the active flm 3 gene in different B, 
pert ussls strains was tested. The strains used were all 
deficient in fimbrial serotype 3 expression; strain BP 347 has 
a transposon insertion within the bvg locus and does not 
express any of the bvg-regulated gene products, strain Tohama 
is a reference strain which expressess fimbrial serotype 2, but 
variants are known to express fimbrial serotype 3, strain ARG 
40 is a derivative of strain Wellcome 28 which has lost the 
ability to express AGG 3 after passage through infant mice, 
and, strain 106V has lost the ability to express both AGG 2 and 
AGG 3 and is afimbriate. After conjugation of pDA126 into 
strains Tohama, ARG 40 and 106V the agglutination experiments 
revealed agglutination at levels comparable to the wild-type 
expression of AGG 3, no agglutination was observed with strain 
BP347 carrying pDA126.
From this experiment it was deduced that strains which have 
lost the ability to express AGG 3 do not contain trans-acting 
factors which repress expression of the flm 3 gene. There is no 
evidence to suggest that the specificity of the transport 
process is altered during serotype variation; synthesized
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flmbrial subunits are assembled and exported as normal 
regardless of the status of the chromosomal flm gene.
B, pertussis strain 106V is a derivative of a fimbrial 
serotype 2,3 strain which has lost expression of both AGO 2 and 
AGO 3. Electronmicrographs of this strain demonstrated that the 
loss of expression had rendered the strain afirabriate. The 
addition of pDA126 to this strain restored both the AGG 3 
phenotype and the presence of fimbriae on the cell surface. 
This constitutes proof that the molecule referred to as AGG 3 
and recognised by the Preston antiserum is a fimbrial 
structure. The presence of fimbriae on this strain was linked 
to the tetracycline resistance encoded by the cosmid. During 
the course of the experimental work the strain did not revert 
to expression of either AGG 2 or AGG 3 from chromosomal loci. 
An interesting experiment would compare the infectivit y in 
animal models and adhesion in tissue culture models of strain 
106V + pDA126. There is still scant direct evidence to suggest 
that fimbriae are involved in the adhesion of B. pertussis to 
ciliated cells. The results from in vivo and in vitro studies 
of these isogenic strains may shed some light on the role 
fimbriae play in the disease process. These experiments may 
also allow investigation into the selective pressures 
responsible for serotype variation. B. pertussis cells 
containing cosmids encoding several virulence-related molecules 
were found to be retained during passage through mice even in 
the absence of antibiotic selection pressure CR. Brownlie and 
R. Parton, personal communication). Infection of mice immunised 
with various fimbrial subunits with sub-lethal doses of 106V +
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pDA126 and other control strains may allow the recovery of a 
number of different serotype variants. Will the flm 3 gene 
carried on the cosmid be affected in the same manner as the 
chromosomal gene If the mouse is immunised with AGG 3 
beforehand? If so, this would be a method of providing isogenic 
flm gene-containing cosmids which should differ only in the
mutation(s) responsible for serotype variation of that gene. 
Nucleotide sequencing of these clones and subsequent comparison 
with the wild-type sequence will reveal the nature of the
mutation(s). This method of selecting variants would not rely 
on passage of the strains through artificial media which may 
affect the mutation process.
In summary, the results of these experiments demonstrate 
that the B, pertussis chromosome contains three different 
unlinked genes with the potential to encode fimbrial subunit 
proteins. The products of the fim 2 and flm 3 genes are known, 
the product of the flm X gene, if there is one, is not known. 
The B. pertussis strain Taberman (fimbrial serotype 0,3) 
appears to contain a copy of the fim 3 gene which can be
expressed in both 5. pertussis and B, parapertussis. The
chromosome of this strain also contains a silent fim 2 gene and 
a fim X-like gene. The behaviour of the fim 3 gene in a variety 
of different AGG 3~ backgrounds was investigated. A hierachy of 
control levels was found. The fim genes require positive 
regulation by the bvg A gene product, this is the highest level 
of the hierachy, below this is the level of control responsible 
for serotype variation. The data generated by these experiments 
suggested that the control of serotype variation occurs at the
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cis-acting level. If the three fimbrial subunits arose by gene 
duplication(s) it is reasonable to assume that the genes are 
all controlled by a similar mechanism. This assumption is 
supported by the similar rates of variation reported for the 
two fimbrial serotypes.
One of the complications in proposing a model for serotype 
variation is that the pattern of variation involves three 
different possible events. Unlike flagellar phase variation of 
S. typhlmurlum which involves the either/or expression of one 
of two flagella types, the change in expression being linked, 
or the variation in the Type 1 pill of E. coll which also 
occurs in an either/or manner between two distint^ ' molecules, 
F. pertussls serotype variation involves the independent change 
in expression of two unlinked genes, with the possibility of a 
third gene being involved. A likely hypothesis for this 
situation involves each fimbrial subunit gene having its own 
separately regulated cis-acting control region. These regions 
may be controlled in a global manner from a single gene, or 
each control region may be autonomously regulated. Various 
proposals for these systems are shown in Figure 22. Example A. 
illustrates how serotype variation could be controlled by a 
single invertase gene. Each fimbrial subunit gene possesses an 
upstream invertible control region which contains the BvgA- 
dependent promoter for the gene. The invertase gene produces an 
invertase molecule which acts independently upon each control 
region. The invertase protein must be expressed only in small 
amounts as any selective advantage conferred by serotype 
variation lies in the novelty of a new serotype. Deletion of
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FIGURE 23. POSSIBLE MECHANISMS OF SEROTYPE VARIATION.
A. Invertase protein encoded by one gene independently causes 
inversion in control regions of 'flm genes. The invertible 
regions contain the flm gene promoters.
B. The control region of each flm gene contains a region 
susceptible to frame-shift mutations, analogous to the 
region within the bvg- locus.
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the control region upstream of the flm X (-like) gene or a 
mutation in the recombination site which traps the gene in the 
’OFF' position would result in the loss of any expression from 
that gene.
Example B. gives another method by which serotype variation 
could occur, this model is suggested by Mooi et al. (1990). The 
published sequence of the flm 3 gene contains a C-rich region 
upstream of the gene which appears also to be conserved 
upstream of the flm 2 gene. Mooi et al. (1990) suggest that 
this region may be involved in serotype variation in a manner 
analogous to the C-rich region in bvgA responsible for phase 
variation in several strains of B. pertussis (Stibitz et ai., 
1989). This suggestion Is circumstantially supported by the 
observation that the loss of fimbrial expression is more common 
than the gaining of expression. However, the rate of serotype 
variation is greater than that of phase variation, arguing 
against this hypothesis.
These possible mechanisms for serotype variation all assume 
that the event responsible for serotype variation occurs at the 
transcriptional level. No evidence has been published to 
support this assumption. A precedent does exist, however, in 
many other species of bacteria for variation of this kind to 
occur at the transcriptional level. Probing the mRNA from 
various serotype variants of B. pertussis for the presence or 
absence of fimbrial-specific mRNA molecules would establish 
whether the variation occurs at the transcriptional level or 
not. It would also be interesting to test a wide variety of
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B. pertussis strains for the presence of flm X-speciflc mRNA, 
in an attempt to find the product of this gene.
The most obvious next step involving these cosmids would be 
the sequencing of the flm genes and their control regions. The 
data generated by these experiments could then be compared to 
the published sequences for differences that may be related to 
the mechanism of serotype variation. Sequencing may also shed 
light on the identity of the flm X-like gene present in the 
strain Taberman chromosome. Gene libraries made from the 
chromosomal DNA of isogenic serotype variants may prove useful 
in similar studies in case serotype variation occurs by a 
number of mechanisms, as may happen during phase variation. All 
the information at present indicates that serotype variation 
occurs only between established fimbrial molecules. No evidence 
exists to show that new fimbrial configurations are generated 
during variation. This is an observation of importance in the 
construction of a comprehensive, defined-component pertussis 
vaccine.
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4.3. SEQUENCES WITHIN THE B. pertussis CHROMOSOME HOMOLOGOUS 
TO THE hin SEQUENCE OF 5. t vphimurium.
Foxall et al. (1990) used the plasmid pKKlOOlB as a probe 
to detect sequences within B. pertussis chromosomal DNA 
homologous to the entire invertible region of S. typhlmurlum. 
The major drawback of this experiment is that the probe 
contains adjacent sequences not directly related to the 
invertible region. These include the H2 flagellin gene and the 
rhl gene. Their experiments suggested that hybridisation did 
not occur between B. pertussis DNA and these other genes.
The preliminary hybridisation experiments in this study 
repeated the work of Foxall et al. and produced similar 
results. However, they observed hybridisation between pKKlOOlB 
and a single high molecular weight Eco RI fragment of 
approximately 15kb. In this study hybridisation clearly occurs 
between pKKlOOlB and two high molecular weight EcoRI fragments, 
both approximately 15kb in length. This discrepancy may be 
explained by the differences in the stringency of the final 
washes given to the filters. The filters hybridised by Foxall 
et al. were given a final wash in 6 X SSC, 0. l%(w/v)SDS at 55°C 
for Ihr, whereas the filters used in this study were given 
their final wash in 2 X SSC, 0.l%(w/v)SDS at 55*C for Ihr. This 
increase in the final wash stringency may have been responsible 
for removing excess probe and revealing the hybridisation to 
the two similarly sized Eco RI fragments. The removal of excess 
probe also contributes to the higher background in the filters 
used in this study, due to a necessary increase in the exposure 
time.
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One of the more interesting observations made from these 
results is the repeatable difference in the strength of
hybridisation of the probe to Taberman and Tohama chromosomal 
DNA. In every experiment involving a /lin-derived probe the 
chromosomal DNA from Taberman strains has bound the probe to a 
greater extent than DNA from Tohama strains. This effect does 
not appear to be due to the relative concentrations of
chromosomal DNA loaded into each lane, as care was taken to
load the same amount into each lane. The simplest explanation 
of this phenomenon is that there is greater homology between 
the sequence within the strain Taberman DNA and the probe than 
between the probe and strain Tohama DNA. Strain Taberman is a 
strain recently isolated from a patient whereas strain Tohama 
has a long history of laboratory use. The sequence in strain 
Tohama may have diverged due to inactivity during the
laboratory history of the strain whilst the sequence in strain 
Taberman may have retained greater functional homology in the 
infecting population. A similar difference was also found 
between strains L84I and L84IV, the history of these strains is 
not as well known as that of the other strains and a similar 
explanation cannot be proposed for this difference.
The previously characterised bin-like invertible DNA 
systems consist of three component parts; the gene encoding the 
invertase, the conserved dix sites and a recombinational 
enhancer. The pKKlOOlB probe includes all of these components 
as well as several other genes such as the H2 flagellin gene. 
The advent of the random hexanucleotide primer radio-labelling 
technique by Feinberg and Vogelstein (1983) allowed the 
labelling of short linear DNA fragments using a-®^P-dATP to
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high levels of activity. A short, highly specific DNA probe 
could thus be isolated from a larger piece of DNA with a known 
sequence. The sequence of the invertible region has been 
published (see Figure 3) and was scanned for restriction enzyme 
cleavage sites. The ensuing information allowed the selection 
of a probe which would be specific for a bin-like invertase 
gene. The 671bp fragment highlighted in Figure 3 appeared to be 
the optimum invertase specific probe which could be generated 
from the sequence.
This probe did not hybridise to B, pertussis DNA under high 
stringency, an unsurprising result, indicating that the 
Invertase-llke sequence differed from that of S. typhi murium. 
The major problem with the hybridisation protocol involved the 
large difference between the mol G+C% content of S. typhlmurlum 
and B. pertussis DNA, 50-53% and 66-70%, respectively. This 
difference Implies that there will be a relatively large 
divergence between the two nucleotide sequences whilst the
proteins retain a high degree of functional homology. Various 
studies have shown that a 1% mismatch reduces the T„ of the 
duplex by between 0. 5 and 1,4*C, in this case the mismatch is 
expected to be spread throughout the length of the target
sequence which further decreases the stability of the duplex 
(Anderson and Young, 1985). The ionic strength of the 
hybridisation and washing solutions can be used to help 
stabilise mls-matched duplexes, thus in these hybridisation 
experiments the probe was incubated in hybridisation buffer 
containing a higher salt concentration than normal (6. 6 X SSC)
and washed in higher salt buffers (2 X SSC).
The results indicate that a single copy of the hln
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homologous sequence exists within the B, pertussis chromosome. 
This hln homologous sequence is located on a large £cctf?I 
fragment and is closely bounded by Cla I (.Bsc I) sites. The 
second high molecular weight Eco RI fragment that hybridises to 
the probe may contain a gene encoding a protein similar to the 
invertase such as a transposase. This may be due to the 
presence of numerous insertion sequences within the 
B, pertussis chromosome, one of which may contain a gene 
bearing sufficient homology to the probe to allow hybridisation 
under the lowest stringency conditions. Hybridisation to the 
larger of the two Eco RI fragments did not take place when the 
stringency of the hybridisation reaction was increased. Under 
the least stringent conditions the probe hybridised to a single 
12kb FaMil fragment. If the probe is picking up a closely 
related sequence it would appear that the two are linked on the 
same large FamHI fragment.
Similar hln homologous sequences would appear to be present 
within the chromosomes of F. bronchlseptlca and F. avium. 
Curiously these low stringency conditions did not demonstrate 
hybridisation between the probe and the chromosomal DNA of 
F. parapertussis 10520. This is unusual, since there is a close 
genetic relationship between F. pertussis and F. parapertussis. 
Homology between the plasmid pKKlOOlB and the chromosome of a 
F. parapertussis strain has been observed CO.I. Duggleby, 
personal communication) so it is possible that this sequence 
has simply been deleted at some point in the history of F. 
parapertussis strain 10520. The sequence present within the F. 
bronchlseptlca genome is present on Cla I (Bsc I) and Stu I 
fragments of similar size to those in the F, pertussis
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chromosome. The Intensity of hybridisation appears to be less 
than that observed to the B. pertussis fragments, suggesting 
greater divergence from the probe.
The B. avium observations raise two interesting points. 
Firstly, B. avium DNA would appear to be refractory to 
digestion with Cla I (Bsc I). This would indicate that B. avium 
possesses a modification system which protects the Cla I 
(Bsc I) cleavage site. Secondly, the degree of hybridisation of 
the probe to the B. avium DNA samples is far greater than that 
observed for the B. pertussis samples. This may be due either 
to the mol G+C% content of B, avium being closer to that of the 
probe than F. pertussis, or the functional homology may 
actually be greater.
The major problem with the Southern blots using the low 
stringency conditions was the high degree of background 
interference. This continually made their interpretation 
difficult and also made their reproduction of little value. An 
attempt to increase the stringency of both the hybridisation 
and washing procedures to lower the background to acceptable 
levels was made. The concentration of formamide in the 
hybridisation buffer can be used to alter the Tm of the probe- 
target hybrid. A 1% increase in formamide concentration lowers 
the T„ of duplex DNA by 0.72'C. The optimum hybridisation 
signal is obtained using 33% (w/v) formamide, equivalent to a 
reduction in the T„ of 23,8'C. Standard protocols for the 
detection of perfectly matched probe-target hybrids recommend 
50% (w/v) formamide concentration, which is equivalent to a
reduction of 36*C in the T« of a perfectly matched duplex.
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Szekely and Simon C1981) detected homology between a bin- 
containing probe and Mu DNA with a final wash in 0. 24M Na 
phosphate, 1 X Denhardt’s solution and 0.2% (w/v)SDS at 55*C. 
When the wash temperature was reduced to 50*C the probe bound 
to PI DNA. The salt concentration in the final wash used in 
this study is =^0. 2M NaCl at a temperature of 50*C, thus the 
homology between the hln probe and the B. pertussis DNA is 
approximately equal to that described by Szekely and Simon 
(1981). Under these conditions the hybridisation of the probe 
to B. avium DNA was still considerably greater than to that of 
the B, pertussis DNA. The exact degree of homology between the 
various Bordet ella DNA samples and the probe could be 
investigated using a melting experiment similar to that
described by Szkely and Simon (1981). Alternatively this
information could be obtained by sequencing of the relevant 
loci and direct comparison.
The problems with high backgrounds did seem to be linked to 
the activity of the a-®^P-dATP because as the age of the 
isotope decreased the exposure time was increased and,
consequently, the background increased. If the filters were 
washed stringently enough to totally reduce the background, the 
probe was also removed. A solution appeared to involve 
labelling the probe with biotin, which could be recognised with 
an enzyme ccnjugate. The activity of the label using this
method did not decrease drastically over time and removed the 
need for autoradiography. However, a vital stage in the 
development of the signal using a biotin probe involves 
blocking the filter in a BSA solution at 65*C for one hour. The 
lack of signal in the bin-related experiments was probably due
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to the fact that this blocking reaction was more stringent than 
the final wash and removed virtually all of the probe from the 
filter prior to development of the signal. If this is the case 
this marks a serious flaw in the technique if applied to cases 
where non-homologous hybridisation is needed. The stringency of 
the blocking reaction was lowered to well below the threshold 
which would have removed the probe but this simply increased 
the level of background until any possible signal was obscured.
The hybridisation conditions detailed above were also found 
to be membrane-specific. Hybridisation was observed between the 
probe and the target when the *DNA was immobilised on Zeta-Probe 
and GeneScreen Plus membrane, but not when the DNA was 
immobilised on Hybond-N membranes. An investigation by 
Khandjian (1987) revealed large differences in the 
hybridisation signals obtained using different membranes under 
standard conditions. This study revealed that Hybond-N 
hybridised very poorly when the DNA was transferred using 
alkali, the method used thoughout this study.
These results demonstrate that the chromosome of B. 
pert ussls contains a sequence homologous to the bln gene of 
S. typhlmurlum. From the hybridisation data it would appear 
that the sequence is as closely related to the hln sequence as 
the invertible sequences present in bacteriophages Mu and PI. A 
similar sequence also appears to be present within the 
chromosome of B, bronchlseptlea and B. avium
The final step in this preliminary Investigation of the 
hin-like sequence in B. pertussis involved isolating the cosmid 
containing the relevant sequence from the Taberman gene 
library,
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Restriction fragment analysis of pDI116 allowed a map to be 
constructed with respect to EcoRI, Xho I and Cla I (Bsc I) 
cleavage sites. The major restriction fragments are in the 
correct order, although ambiguity exists as to the exact order 
of the 3. Okb, 3. Okb and 0. 6kb Cla I (.Bsc I) fragments. This 
ambiguity will be removed after nucleotide sequencing of this 
locus since the 0. 6kb fragment contains the hln homologous 
sequence. The order given in Figure 20 was chosen as this 
places the 0. 6kb fragment next to the llkb Cla I (Bsc I) 
fragment recognised by the recombination (target) site-specific 
oligonucleotide probe (Figure 21). The major use of this map is 
to suggest which fragment would be the most suitable to sub­
clone for further investigation.
Cloning of the lOkb EcdRl/Xho I fragment which contains the 
0. 6kb Cla I (Bsc I) fragment would yield a DNA fragment which 
could be sequentially deleted in both directions, placed under 
the control of a strong promoter and tested for invertase 
activity. The 0. 6kb Cla I (Bsc I) fragment could also be placed 
under the control of a strong promoter but the fragment may 
well be too small to produce an active protein. This lOkb 
fragment, or the entire 15kb EcoRI fragment, would also be 
candidates for nucleotide sequencing. These fragments contain 
not only the hln homologous fragment but enough surrounding DNA 
to give a clue as to the possible function, if any, of the 
Invertase gene.
The 0.85kb Sph I fragment of pIL22, which contains the 
flm 2 gene and a portion of IS481vl, hybridised to a single 
2. 65kb Sal I fragment of pDI116. This fragment is different 
from any of the Sal I fragments the probe hybridised to In the
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cosmids containing the flm genes. This result implies that the 
hln-like sequence carried by pDI116 is not linked with any flm 
genes but is linked with another copy of IS4&1 (McPheat et 
al, , 1989). As mentioned before it is not known whether this 
juxtaposition of insertion sequences and possibly virulence- 
associated genes is meaningful or simply the result of the 
number of insertion sequences within the genome.
A number of assays exist which can test for Invertase 
activity encoded by plasmid borne invertase genes. The major 
assay used in this study involved the plasmid pSH1313 (Huber et 
al,, 1985). In its 'ground* state this plasmid encodes 
resistance to ampicillin and chloramphenicol, in the presence 
of an exogenous invertase the cartridge containing the 
resistance genes (see Figure 9) inverts and the plasmid then 
confers resistance to ampicillin and kanamycin. The experiments 
involving this plasmid and pDIllB did not reveal any invertase 
action encoded by pDI116. This may have been due to several
reasons:- a) the gene simply does not encode a functional
invertase in E, coll or even in its natural state in
B. pertussis, b) the promoter of the hln homologous gene may 
require positive regulation by Bvg A, c) the recombination 
sites of pSH1313 are derived from the cln system of 
bacteriophage PI and may not be complementary with the
invertase encode by the hln homologous gene. The experiments 
involving E. coll strain RZ211 lead to the same conclusions.
The invertase gene, plus attendant recombinational enhancer 
sequence, form only one half of a functioning invertible DNA 
sequence. Inversion also requires a pair of inverted repeat 
target sequences to act as the recombination sites between
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which inversion occurs. In the hln~l±ke invertible sysytems so 
far characterised the recombination sequences are fairly highly 
conserved. The newly discovered invertible DNA sequence 
responsible for pilin variation in M. bovis has recombination 
sites which share homology with the bin-like recombination 
sites. This high degree of homology between the various 
recombination sites was exploited in the creation of 
oligonucleotide probes which should have had the ability to 
detect related sequences. At the time of synthesis the sequence 
of the M, bovis recombination sites was not known and the 
information was not incorporated into the design of the 
oligonucleotide probes.
The final probe synthesised was able to hybridise, albeit 
weakly, to B, pertussis chromosomal DNA. The low hybridisation 
signal suggested that either only one of the 32 possible 
sequences was able to hybridise under the conditions used or 
that several hybridised very weakly. The major finding of these 
experiments was that sequences related to the bin-like 
recombination sites do occur within the B. pert ussls genome. 
The probe hybridised to different sized bands in the chromosome 
of strain Taberman and strain Tohama, this may be indicative of 
an inversion event which has occurred at some point in the 
history of one of the strains. The bvg and flm 2 probes used in 
this study found no differences in the banding patterns between 
these two strains.
Weiss and Falkow (1984) had suggested that an invertible 
DNA sequence may be responsible for phase variation in 
B. pertussis. The oligonucleotide probe did not hybridise to 
any of the Eco R1 fragments implicated in the bvg locus. The
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nucleotide sequence of the bvg locus from a number of sources 
CStlbitz et al. 1988; Reiman et al. , 1989) does not share any
homology with the bin-like invertible regions. It therefore 
seems a fair conclusion that the sequences within the 
B. pertussis genome homologous to invertible DNA sequences do 
not play any role in the phase variation process. The sequence 
data of the fim genes CLivey et al. , 1987; Pedroni et al. , 1988;
Mooi et al. , 1990) also reveals no homology to invertible
sequences around these loci. The fim containing cosmids could 
be probed with a range of mixed-sequence oligonucleotide probes 
homologous to variants of the consensus sequence to ascertain 
if they contain sequences related to invertase recombination 
sites. However, if the suggestion by Mooi et al, (1990) that 
serotype variation occurs via a frame-shift mutation is correct 
it would appear that the bin-homologo us sequences play no part 
in serotype variation. This raises the question of what 
function these sequences may play.
The pin invertible sequence in several E. coll strains has 
been cloned (Kutsukake et al. , 1985) and sequenced (Plasterk et
al., 1983), yet no group has so far been able to ascribe a 
function to this sequence. The invertase gene and the 
recombination sites are usually linked as are the invertible 
region and the area under its control. Thus, probing the gene 
bank with an oligonucleotide probe with a greater degree of 
specificity to the B. pertussis sequences should allow the 
cosmid containing the genes under the control of the invertible 
region to be isolated. This cosmid may prove to be one which 
codes for a known virulence-associated factor, in which case 
the function of the invertible sequence should be fairly
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straightforward to deduce, or may contain DNA with no apparent 
function, in which case the role of the invertible sequence may 
be almost impossible to define.
The results generated by this study with regard to the bin­
like sequences found within the B, pertussis genome can be 
regarded only as preliminary studies. Nucleotide sequencing of 
the invertase gene and surrounding DNA will shed light not only 
on the relationship of the sequence to other invertible DNA 
systems but may reveal the role of this sequence within the 
B. pertussis genome.
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APPENDIX 1.
All media and sterile equipment used in this study was
sterilised for 15 mins at 121‘C before use.
A.1.1. Stainer and Scholte medium (+ cyclodextrin).
For one litre medium:-
Sodium L-glutamate 10. 70g
L-proline 0.24g
NaCl 2. 50g
KHaPO* ' 0. 50g
KCl 0.20g
MgCla"6HaO 0.lOg
CaCla 0, 02g
Tris 1. 50g
Heptakis(2,6-0-dimethyl)p-cyclodextrin 1. OOg)
Distilled water added to a volume of 1 litre and the pH 
adjusted to 7. 4 with concentrated HCl, The medium was then
autoclaved and stored at 4*C.
The following growth supplements were prepared:- 
L-cysteine 0.04g
FeSO^ 7H=0 0.0Ig
Niacin 0.004g
Glutathione (reduced) 0.lOg
Ascorbic acid 0.02g
The supplement was made up in 100ml of distilled HgO and
filter sterilized (Millipore filters, pore size 0.22pm). The
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supplement was stored at 4*C for no longer than 2 weeks. The 
supplement was added as 1ml per 100ml basal medium
For Stainer and Scholte medium plus oc-cyclodextrin Ig/litre 
of cyclodextrin and l%(v/v) casamino acids were added to the 
basal medium described above. Casamino acids (Dlfco) were made 
up as a 25%(w/v) solution in distilled H^ O, autoclaved and 
stored at 4'C. Cyclodextrin was supplied by Dr, J. Shimizu, 
Medical and Pharmaceutical Division, Teijin Ltd, Tokyo, Japan.
A. 1.2. Bordet Gengou agar.
40g of BG agar (Gibco-BRL) and lOg of glycerol were made up 
to 900ml with distilled H^O and autoclaved. The agar was 
allowed to cool to =50'C before the addition of 100ml of 
defibrinated horse blood (InterMed).
For sandwich plates the medium was split into 600ml and 
400ml lots. The first was poured without the addition of blood 
and allowed to set. The blood was added to the second lot and 
this was poured thinly over the set plates.
A. 1.3. CSM Media.
For one litre medium:-
Sodium L-glutamate 10.70g
L-proline 0. 24g
NaCl 2. 50g
KH=POa 0. 50g
KCl 0, 20g
MgCla-6H2O 0. lOg
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CaCla 0.02g
Tris 6. 10g
Casein hydrolysate peptone 5 (Gibco) 0. 50g
Heptakis (2, 6-0-dimethyl)p-cyclodextrin 1. OOg
Bacto-Agar (Difco) 18.00g
The pH was adjusted to 7.4 prior to autoclaving.
The following growth supplements were prepared:- 
L-cysteine 0. 04g
FeSO*-7H2O 0. lOg
Niacin 0. 004g
Glutathione (reduced) 0. 15g
Ascorbic acid 0. 02g
The supplement was made up in 10ml of distilled H^O and 
filter sterilised (Millipore filters, pore size 0.22pm). The 
supplement was stored at 4'C for no longer than 2 weeks. The 
supplement was added to 11 basal medium immediately prior to 
use,
A. 1. 4. Nutrient agar.
Nutrient agar (Oxoid) was made up with 2.8g per 100ml 
distilled H2O.
A. 1. 5. Nutrient broth.
Nutrient broth number 2 (Oxoid) was made up as 1. 4g per 
100ml distilled H=0.
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A. 1.6. Minimal medium
For 1 litre of minimal medium:-
NaCl 5. Og
NH^NOa l.Og
Na^SO* 2.Og
K=HPOa 3. Og
KH=PO^ l.Og
MgSO.*. 7HaO 0. Ig
(Noble Agar 15.Og if needed).
A. 1. 7. 4-chloro" 1-napsolution.
Mix 1 part solution A with 5 parts solution B immediately 
prior to use.
A) 3mg/ml 4-chloro-l-napkWl in methanol.
B) 0. 018%(v/v) H=0=.
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APPENDIX 2.
Solutions and buffers used in DNA manipulation techniques 
throughout this study. Unless otherwise stated all solutions 
were made up in sterile distilled water.
A. 2.1. Tris-EDTA buffer (TE). 
lOmM Tris. HCl (pH8.0)
ImM EDTA
A. 2.2. Chromosomal lysis buffer.
25% (w/v) sucrose 
50mM Tris. HCL (pH 8.0)
ImM EDTA.
A. 2.3. TE-saturated phenol.
Hydroxyquinoline was dissolved in liquid phenol to a final 
concentration of 0.005g/ml. The phenol was twice mixed with an 
equal volume of IM Tris. HCl (pH 8.0) and the excess buffer 
removed. The phenol was then mixed with TE + 0. 1% (v/v)
p-mercaptoethanol and excess buffer removed. Phenol was then 
stored at 4*C under the final buffer.
A. 2. 4. Plasmid lysis buffer.
50mM glucose
25mM Tris. HCl (pH8.0)
lOmM EDTA
4mg/ml lysozyme (Sigma) added immediately prior to use.
A.2.5. Acidified potassium acetate solution.
The acidified potassium acetate solution is prepared as 
f ollows: -
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60ml 5M potassium acetate 
11.5ml glacial acetic acid 
26. 5ml distilled H^O 
A. 2. 6. A solution.
0. ImM dCTP 
0. ImM dGTP 
0. ImM dTTP 
A. 2. 7. Loading buffer.
10% Cw/v) Ficoll 
0.05% (w/v) bromophenol blue 
0.005% (w/v) xylene cyanol FF 
0. 05% (w/v) orange G
5pl loading buffer used per 20pl of sample. 
A. 2. 8. TBE buffer.
0.089M Tris-borate 
0.069M boric acid 
0. 002M EDTA 
pH 8. 2
Made up as 10 X concentrate.
A. 2. 9. TAE buffer.
0. 04M Tris-acetate
0. 002M EDTA 
pH 8. 2
Made up as 50 X concentrate.
A. 2. 10. 30% (w/v) acrylamide solution. 
acrylamide 29g
N, N' -methylene bisacrylamide Ig
HgO to 100ml.
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A. 2. 10. Denaturing buffer.
1. 5M NaCl
0. 5M NaOH
A. 2. 11. Neutralising buffer.
1. 5M NaCl
IM Tris-HCl (pH8. 0)
A. 2. 12. SSC solution.
1 X SSC = 0. 15M NaCl
0. 015M sodium citrate 
Made up as 20 X SSC.
A. 2. 13. High stringency hybridisation buffer.
6 X SSC
1% (w/v) SDS 
5 X Denhardt's solution 
50% formamide 
sssDNA lOOpg/ral
Denhardt's solution = 0.02% (w/v) bovine serum albumin
0.02% (w/v) Ficoll
0.02% (w/v) polyvinyl pyrrolidine
6 X SSC
sssDNA = single-stranded salmon sperm DNA made up at 
lOmg/ml, denatured by repeated passage through a G25 hypodermic 
needle. Before use the sssDNA is boiled for 5 minutes and added 
to the hybridisation buffer immediately.
A. 2. 14. Low stringency hybridisation buffer.
7 X SSC
1% Cw/v) SDS 
5 X Denhardt's solution 
33% deionised formamide
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sssDNA lOOpg/ml 
A. 2. 15. OLB buffer.
OLB buffer made up as follows:- 
Solution 0 = 1.25M Tris. HCl (pH8. 0)
0.125M MgCl=
Solution A = 1ml solution 0
18pl p-mercaptoethanol 
5pl dCTP (lOOmM in TE)
5pl dGTP (lOOmM in TE)
5pl dTTP (lOOmM in TE)
Solution B = 2M Hepes pH 6:6
Solution C = hexadeoxynucleotides (Pharmacia) suspended in 
TE to 90 CD units per ml.
Solutions A, B and C are mixed in the ratio 100:250:150 and 
stored at -20"C.
A. 2. 16. STOP buffer.
20mM NaCl
20mM Tris. HCl (pH7. 5)
2mM EDTA 
0.25% (w/v) SDS 
IpM dATP 
Stored at -20'C.
A.2.17. T4 polynucleotide kinase buffer.
0. 05M Tris. HCl (pH8.0)
0. OIM MgCla
50mM dithiothreitol (Sigma)
0. ImM spermidine (Sigma)
0. ImM EDTA
Made up as a 10 X concentrate, stored at -20*C.
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A. 2. 18. Oligonucleotide pre-hybrldisatlon buffer. 
6 X SSC
1 X Denhardt's solution 
1% (w/v) SDS 
sssDNA lOOpg/ml
0.05% (w/v) sodium pyrophosphate 
A. 2. 19. Oligonucleotide hybridisation buffer.
6 X SSC
1 X Denhardt's solution 
0. 05% (w/v) sodium pyrophosphate 
20pg/ml tRNA 
A. 2. 20. SI nuclease buffer.
300mM NaCl
30mM sodium acetate (pH4. 6)
4. 5mM ZnCla
lOOpg bovine serum albumin/ml
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APPENDIX 3.
A. 3. 1. REact" BUFFERS.
REact" buffers are supplied with enzymes ordered from BRL 
at 10 X concentration. The formulas given below are the working 
concent rat ions.
REact"l; 50mM Tris-HCl (pH8.0) 
lOmM MgCl=
REact"2: 50mM Tris-HCl (pH8. 0)
10mm MgCla 
50mM NaCl 
REact™3: 50mM Tris-HCl (pH8.0)
lOmM MgCla 
lOOmM NaCl 
REact”4: 20mM Tris-HCl (pH8.0)
5mM MgCla 
50mM KCl
REact™6: 50mM Tris-HCl (pH8. 0)
6mM MgCla 
50mM KCl 
50mM NaCl 
REact™8; 20mM Tris-HCl (pH8.0)
lOmM MgCla 
A. 3. 2. Other buffers.
Bsc I buffer: supplied by NBL at 10 X concentration:
50mM Tris-HCl CpH7. 5) 
lOOmM NaCl 
lOmM MgCl=
ImM dithioerythritol
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M buffer: 6mM Tris-HCl (pH8. 0)
50mM NaCl 
6mM MgCla
6mM p-mercaptoethanol
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APPENDIX 4: SINGLE LETTER CODES FOR AMINO ACIDS.
Alanine A
Arginine R
Asparagine N
Aspartic acid D
Asparagine or Aspartic acid B 
Cysteine C
Glutamine Q
Glutamic acid E
Glutamine or Glutamic acid Z
Glycine G
Histidine H
Isoleucine I
Leucine L
Lysine K
Methionine M
Phenylalanine F
Proline P
Serine S
Threonine T
Tryptophan W
Tyrosine Y
Valine V
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APPENDIX 5: LENGTHS OF NUCLEIC ACID SIZE MARKERS.
XHln dlll 
FRAGMENTS
23, Ikb 
9, 4kb 
6. 5kb 
4. 3kb 
2. 3kb 
2. Okb 
0.56kb 
0.125kb
0X174#ae III 
FRAGMENTS
1353bp
i078bp
872bp
605bp
310bp
281bp
271bp
234bp
194bp
118bp
72bp
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